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Abstract 
Introduction and Objectives: Nephrolithiasis is one of the most common renal 
diseases, but with poorly understood pathophysiology. The current 
understanding of how genetic, environmental, and metabolic factors act singly 
or in concert to trigger stone formation remains patchy, and the progress of 
medical therapy has been very modest. Vertebrate models for nephrolithiasis are 
limited in their ability to rapidly screen multiple and varied interventions that 
modulate urinary stone formation. Therefore, we hypothesis that the basic 
research directed at model systems that elucidate the pathophysiology of stone 
disease  is the best hope for advancing the field and leading to the development 
of new therapeutic approaches that have the potential to reduce the morbidity, 
mortality, and cost associated with this disease. Further, most studies have 
confounded that age and temperature share some contribution in precipitation 
of kidney stones. We also hypothesise that change in temperature (from colder 
to warmer, low temperature to higher temperature) may have a greater impact 
on the formation rate of nephrolithiasis. 
Methods: A short lifespan, rapid deployment of transgenic lines and conception 
of rapid stone formation makes Drosophila melanogaster an ideal system to 
screen large numbers of interventions to assess their effect on kidney stone 
formation. Knockdown of gene candidates for their ability to vary the formation 
of urinary stones was employed utilising Drosophila. Microdissection, imaging 
and quantification facilitate identification and collection of fly stones within the 
lumen of the Drosophila Malpighian tubules (the functional equivalent of the 
human renal tubule). Further,  UAS-RNAi knockdown efficiency was validated  by 
qPCR . The genes which upon knockdown modulated the concentration of 
accumulated stones were further studied using various genetic, immunostaining 
and molecular techniques. In addition to that I also identified role of 
temperature and age in kidney stone formation by rearing flies at 18, 22, 26 and 
29  for different time frame (day 7, day 14, day 21 and day 28)  and quantifying 
accumulated stones during that period. The stones obtained were further 
validated by genetic, temperature switch, colorimetric and biochemical assays. 
Results: Calcium oxalate stone formation was associated with the stones 
accumulated intraluminally in parental lines and gene knockdown or mutant 
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panel of genes fed with sodium oxalate (0.2% for 2 days). An unbiased 
knockdown screen of more than 20 RNAi lines was performed utilising the GAL4-
UAS RNAi system and identified 8 genes that rescued kidney stone accumulation 
compared to parental lines. Microdissection and microscopy confirmed that five 
genes decreased stone formation in the fly, including genes Waterwitch (Wtrw), 
Serine Pyruvate Amino Transferase (Spat), Cinnamon (Cin), Na+-dependent 
inorganic Phosphate Co-transporter (NaPi-T), Sarcoplasmic Calcium-binding 
Protein 2 (Scp2) and Secretory Pathway Ca2+/Mn2+-ATPase (SPoCK). From the 
hits, I showed that mutation of SRY interacting protein (Sip1) in Drosophila MTs 
Stellate cells resulted in the accumulation of uric acid stones with a particularly 
notable interaction with Moesin and NHE2. I also demonstrated a combined 
impact of age and temperature in stone formation. Critically, I confirmed that 
they cause an accumulation of stones due to variation in expression of phosphate 
transporters NaPi-T and Picot. Our work also provides more precise insight into 
the impact of age and temperature in stone formation, given that we have 
shown that stone accumulation increases with age and in flies reared at high 
temperature compared to flies reared at a lower temperature. 
Conclusions: A Drosophila urinary stone model was leveraged to perform large 
scale genetic screens to identify novel genes that modulate calculi formation. 
Our hits may now be screened as a candidate gene in future cases with a clinical 
presentation. Our study documents the first case of uric-acid stone formation 
caused by mutations of a gene using Drosophila as a model organism. 
Confirmation of these mutations as a causative factor and that the stones 
accumulated were uric acid stones was done by genetic, molecular and 
physiological experiments. 
Keywords: Kidney stones, calcium oxalate monohydrate, stone accumulation, 
temperature, Sip1, NaPi-T 
Subject Terms: Calcium Oxalate monohydrate, polarised optical microscopy, 
Immunostaining, crystallisation. 
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Terms and Terminologies 
Kidney stones: Throughout the thesis different terms as nephrolithiasis, 
urolithiasis, concretions, stones refer to kidney stones. 
Sip1: Sip1 in this thesis represents SRY interacting protein. 
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Chapter 1 Introduction 
 
1.1 Summary 
Nephrolithiasis is a metabolic and biochemical disorder, with an increasing 
incidence (in the year 2000, an incidence of 1116 per 100,000 was reported for 
18- to 64-year) and prevalence (5-10% globally), which has substantial economic 
impact associated with its medical costs and morbidity. Despite all these, our 
fundamental understanding of the pathogenesis, as well as their prevention and 
cure, remains rudimentary. Hence to overcome the issue, there is an urgent 
need to develop reliable animal models to study the aetiology of stone formation 
and to assess novel interventions. Here in this chapter, I describe various kinds 
of kidney stones, their formation mechanisms, and different organisms used for 
kidney stone studies for the discovery of novel genes involved in stones 
formation. Further, I describe the importance of Drosophila melanogaster, an 
emerging model for kidney stone disease research. I also explain the suitability 
of this model as a high throughput functional drug screening platform for 
different drugs to treat various human diseases. In summary, this chapter 
explains the importance of Drosophila, Drosophila genetics and opens the valid 
reason for using Drosophila in the identification of the genetic basis of kidney 
stone disease. 
1.2 Human Genetic Diseases 
Human genetic diseases are categorised based on the observed inheritance of 
traits in offspring. Pedigrees charting the inheritance of traits within a family 
tree help to conceptualise a novel means for the transmission of disease 
susceptibility via heritable or genetic factors (Acheson et al., 2000). The 
heritability of a wide range of traits and diseases has been explored through 
family-based studies that looked at phenotypic heritability between related 
individuals who consequently were less genetically heterogeneous compared to 
the general population (Fischer, 2007). 
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Genetic disorders are traditionally classified into three main groups: a single 
gene involved disorders (Monogenic), multiple genes involved multifactorial 
disorders (Polygenic) and chromosomal disorders (Mahdieh and Rabbani, 2013).  
1.2.1 Monogenic disorders 
Monogenic Disorders (MDs) are the conditions caused due to mutation of a single 
gene. Several studies have identified approximately 10,000 types of monogenic 
disorders (Jimenez-Sanchez et al., 2001). Though these diseases are relatively 
rare, they affect millions of people globally. The symptoms and nature of the 
disease caused due to these disorders depend on the functions performed by the 
modified gene. Hence, once the gene gets modified, it causes a disorder which is 
rare and mostly unpredictable. These conditions are most common in the 
underdeveloped countries, more specifically in the rural areas where 
consanguineous marriage is common, e.g. Sickle cell anaemia, Huntington's 
disease, Fragile X syndrome. Pedigree analyses of large families with many 
affected members are very useful for determining the inheritance pattern of 
single-gene diseases. These disorders run in the families and can be dominant or 
recessive and autosomal or sex-linked (Chial, 2008). 
Human has two sets or copies of each gene which is also known as “allele”; one 
copy on each side of the chromosome pair.  Mutation or damage in this allele 
causes monogenic disorders. 
a. Dominant diseases are monogenic disorders that involve damage to only 
one gene copy. As this mutation is carried on an autosome, both males 
and females are equally affected. Because this inheritance pattern is 
dominant, the chance of it being passed on during pregnancy is 50% for 
each pregnancy. If the faulty gene is inherited, it will result in an 
affected individual. This disease includes severe and most common 
genetic disorders like Huntington’s disease, polycystic kidney disease.  
b. Recessive or minor unexpressed disorder are monogenic disorders that 
damage to both copies or allele.  Usually, in these cases, the parents are 
carriers of the mutated gene. The risk of an affected child being born is 
25% for each pregnancy, e.g. Tay Sachs disease. 
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c. The X-linked disorder is monogenic disorders which can be either be 
dominant or recessive. The mutation in the X-chromosomal gene of the 
sex chromosomes leads to numerous disorders which are said to be X-
Linked Disorders. Usually, the mother carries the affected gene on the X 
chromosome. Hence females are careers and that usually only males are 
affected by the disorder e.g. Fragile X syndrome.  
1.2.2 Polygenic disorders 
Polygenic disorders are caused by the joint contribution of several independently 
functioning or interacting polymorphic genes, accompanied by non-genetic 
factors like lifestyle and environmental factors. These disorders are often 
clustered within the families, but they do not have a clear pattern of 
inheritance; hence the individual contribution of each gene may be small or 
even unnoticeable (Lvovs et al., 2012). The carriage of a specific combination of 
genes determines the occurrence of clinically heterogeneous forms of the 
disease, thereby simplifying the efficacy of treatment. On a pedigree, polygenic 
diseases tend to "run in families", but the inheritance does not fit simple 
patterns with Mendelian diseases. In humans, polygenic disorders are more 
frequent than monogenic disorders; hence, it has an adverse impact on social 
and economic aspects. Polygenic disorders cause various diseases like asthma, 
autoimmune diseases such as multiple sclerosis, cancers, cleft palate, diabetes, 
heart disease and hypertension (Lvovs et al., 2012, Mitchell, 2012, Curtis et al., 
2001).  
1.2.3 Chromosomal disorders 
Chromosomal disorders result due to change in the number or structure of the 
chromosomes. The number of chromosome changes when there are either more 
or fewer copies of chromosomes. The change in the structure of the chromosome 
happens when the material in an individual chromosome is disrupted or 
rearranged (Eichenlaub‐Ritter, 1996). The major causes of chromosomal 
disorders are described below. 
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1.2.3.1 Change in chromosome number 
A normal human cell contains 46 chromosomes. Whenever there are fewer or 
more chromosome numbers in the baby, it causes genetic disorders. For 
example, Down syndrome is a condition caused because of an extra chromosome 
with three copies of chromosome 21 instead of two (Mahdieh and Rabbani, 
2013). 
1.2.3.2 Change in chromosome structure 
Changes in the structure of the chromosomes occur when the material in an 
individual chromosome is broken or rearranged (Salem, 2016). It may involve 
addition or removal of the chromosomal material.  
 
1.3 Inborn errors of metabolism (IEMs) 
Metabolism is defined as the chemical processes that occur within a living 
organism to maintain life. Complications in metabolism can cause numerous 
human diseases. While most of them are the consequences of the diet and 
lifestyle (e.g., diabetes, obesity, atherosclerosis), there is a high proportion due 
to genetic mutations. Such disorders with a genetic base and which are also an 
outcome of failure in biochemical pathways are called inborn errors of 
metabolism (IEMs). IEMs occur if the enzyme(s) is missing or the enzyme 
function(s) is deficient. However, even if the enzyme/protein is present at an 
optimum concentration, the transport system might fail, or the regulation of the 
metabolic pathway may be disrupted, all of which are associated with IEMs (Dent 
and Philpot, 1954, Martins, 1999).  
IEMs were first described by Sir Archibald Garrod, the British physician, in 1908, 
during the famous Croonian lectures on the inborn errors of metabolism, i.e., 
alkaptonuria, cystinuria, albinism and pentosuria (Scriver, 2008). Since then, the 
use of the word IEMs has been ever-expanding, and also named/known as 
inherited metabolic disorders, hereditary metabolic disorders, or congenital 
metabolic diseases. For simplicity, IEMs has been used throughout the thesis.  
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1.3.1 Classification of IEMs 
IEMs are also classified based on the metabolic and molecular mechanism of 
inherited disease. On this basis, they can be mainly classified into two major 
categories: I and II. 
a. Category I 
IEMs affecting the functional as well the anatomical system such as endocrine 
system, immune system or coagulation factors or lipoproteins fall under this 
category. The indications of the majority of disorders are uniform, and hence, 
the correct diagnosis is usually easy because the basis of the biochemical defect 
incorporates the given consequence. For example, the tendency to bleed as a 
consequence of coagulation defects (Garrod and Harris, 1909). 
b. Category II 
This category  includes the conditions in which the biochemical basis affects one 
metabolic pathway common to a significant number of cells or organs (e.g., 
problems in storage diseases due to lysosomal disorders), or is restricted to one 
organ with humoral and systemic consequences, such as hyperammonaemia in 
defects of the urea cycle or hypoglycaemia in hepatic glycogenesis (Martins, 
1999). 
1.3.2 Nephrolithiasis related to inborn metabolic diseases 
Nephrolithiasis associated with inborn metabolic diseases is a rare condition 
which may occur with many kinds, but with common characteristics: early onset 
of symptoms, family history, associated tubular impairment, bilateral, multiple 
and recurrent stones, and association with nephrocalcinosis. The initial 
symptoms could be primary hyperoxaluria, cystinuria and the late symptom 
could be the occurrence of glycogen storage disorders. Such diseases may lead 
to life-threatening conditions, not only because of persistent kidney damage but 
also because of the progressive extra-renal factors involvement (Torres et al., 
2007).  
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Furthermore, patients with other inborn metabolic diseases present only with 
recurrent stone formation, such as cystinuria, adenine phosphoribosyl-
transferase deficiency, xanthine deficiency (Weinstein et al., 2001). 
Furthermore, nephrolithiasis may be the consequence of other metabolic 
diseases, such as glycogen storage disease type 1 or inborn errors of metabolism 
leading to Fanconi syndrome (nephropathic cystinosis, tyrosinemia type 1 
(Cochat et al., 2010), fructose intolerance, Wilson’s disease, respiratory chain 
disorders) as shown in Table 1.1. Furthermore, urine supersaturation may be 
related to the biochemical defect itself (oxalate, cysteine) or a secondary 
disorder (urate, citrate). 
Nephrolithiasis due to the 
metabolic defect itself 
Nephrolithiasis due to the secondary 
metabolic effect 
1. Nephrolithiasis is usually an 
initial/early symptom 
2. Primary hyperoxaluria types 1 
and 2 
3. Cystinuria 
4. Disorders of purine and 
pyrimidine metabolism, e.g. 
Xanthinuria 
1. Nephrolithiasis occurs during the 
evolution 
2. Glycogen storage disease type 1 
3. Treatment of secondary Fanconi 
syndrome 
 
Table 1.1. Nephrolithiasis associated with inborn metabolic diseases due to 
presentation and pathophysiology. Adapted from (Cochat et al., 2010). 
 
1.4 Kidney stones 
1.4.1 Overview 
Kidney stones, also known as renal calculi (singular calculus) or nephrolithiasis, 
is the most common kidney disease and known risk factor of chronic kidney 
diseases (Moe, 2006). These unwanted mineral aggregations can result in 
extreme pain, morbidity, and is often related to other chronic diseases such as 
high blood pressure, coronary artery disease and diabetes mellitus. This 
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condition has afflicted humans for centuries, affecting populations of every 
region, race, culture, gender and age (López and Hoppe, 2010). So far, precise 
mechanisms behind the stone formation and pathophysiology behind it have 
been largely unknown. Nephrolithiasis is often misunderstood as Urolithiasis. 
However, they have some difference; urolithiasis refers to stones originating 
anywhere in the urinary system, including the kidneys and bladder. However, 
nephrolithiasis refers to the presence of such stones in the kidneys. 
Kidney stones are one of the most painful medical conditions to afflict human 
beings, with an approximate incidence of 1116 per 100,000 per 16-64-year-old 
persons in the USA in 2000 (Romero et al., 2010). It is a common problem 
worldwide with a marked increase in prevalence (12% of the world population) 
and recurrence rate (Alelign and Petros, 2018). After an initial stone, there is a 
50% chance of forming a second stone within seven years (Sutherland et al., 
1985). Numerous epidemiologic studies suggest that the prevalence of stone 
disease over the last 35 years has increased dramatically (3.8% in the late 1970s 
to 8.8% in the late 2000s) (Curhan, 2007). Importantly, it affects mainly 
productive young individuals, with a peak incidence in the third and fourth 
decades of life. Interestingly, the gender distribution among these patients, 
which initially was reported to have a ratio of three to one male to female 
predominance, has now been reported to be moving closer to parity (Romero et 
al., 2010).  
A kidney stone begins as a little precipitate to form a nidus which subsequently 
grows to a stone. They are a crystal aggregation formed in the kidney (renal 
pelvis) from dietary minerals in the urine. The physical process of stone 
formation is a complex cascade of events. It begins with urine that becomes 
supersaturated with stone-forming salts (e.g., calcium, oxalate, uric acid, 
magnesium, phosphate) resulting in their precipitation out of solution to form 
crystals (Shafiee Jr, 2012). The aetiology of the first precipitation is 
heterogeneous (Ratkalkar and Kleinman, 2011). A detachment of the stone from 
the tissue will cause it to travel through the urinary tract, thereby showing 
initial symptoms of kidney stones or injury.  
The pathogenesis of kidney stone is complex and diverse and include an 
understanding of how genetic and non-genetic risk factors act singly or in 
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concert to trigger stone formation. Recent studies have reported a significant 
percentage of adult kidney stone patients identified due to the monogenic 
causes (cystinuria being the most prevalent i.e. about 1% of all stones and up to 
7% of stones in children (Goldfarb, 2014). Perhaps this might be one of the 
primary reasons why research efforts to elucidate the pathophysiology of kidney 
stone formation has been severely hampered. It causes uncertainty in the 
identification of the genes involved in the formation of stones.  
Therefore, this thesis explores the issues by performing basic research directed 
at model systems (Drosophila) that elucidate the pathophysiology of stone 
disease in combination with clinical research in order to  advance the field and, 
ultimately, leading to the development of new therapeutic approaches that have 
the potential to reduce the morbidity, mortality, and cost associated with the 
disease. Furthermore, the thesis also encompasses investigation about the 
different genetic disorders that cause kidney stones and focuses on the 
importance of understanding the role of genes on kidney stones development.  
1.4.2 Causes of Kidney Stones 
Kidney stone disease is widespread, with a lifetime incidence estimated at 1% to 
15% (Campbell et al., 2007, Halbritter et al., 2015). Stones are formed due to 
the various etiological factors which result in various dysfunction or damage to 
the function of the kidney. The probability of developing kidney stones varies 
with numerous factors including age, gender, race, geographic location and body 
mass index (Stamatelou et al., 2003). Several studies support an increased 
incidence of the stone disease to be influenced by dietary habits and lifestyle, 
predominantly decrease in consumption of green vegetables and an increase in 
the consumption of animal proteins (Turney et al., 2012). The significant risk 
factors can be divided into two major categories: urinary risk factors and pre-
urinary risk factors. 
1.4.2.1  Urinary risk factors 
Some urinary factors have been suggested as the major risk factors for renal 
stones formation. Disease conditions such as hypercalciuria, hyperoxaluria, 
hyperuricosuria and hypocitraturia, have been associated with urinary risk 
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factors. Change in the urine due to the below-mentioned factors is believed to 
influence stone formation. 
a. Urinary salt concentration 
Urinary salt concentration plays a critical process in kidney stones formation 
(detail in section 1.4.4). In normal conditions, various forms of urinary salts such 
as calcium oxalate, uric acid stones, cystine or xanthine dissolve in urine and are 
excreted. With an increase in the number of crystals, the excretion of the urine 
decreases significantly, thereby reaching the supersaturation point favouring the 
precipitating and formation of the crystals. 
In vitro studies have shown that oxalate, either in crystalline or insoluble form is 
responsible for the formation of the crystals. Activation of the cytosolic 
phospholipase A2 plays a vital role in oxalate actions, thereby triggering the 
signalling cascade and mediating the crystal attachment (Yoo et al., 2001). 
Similarly, increased production of the reactive oxygen species (ROS) also triggers 
the formation of crystals. ROS causes an increment in cell death and induction of 
genes involved in cell survival, some of which may also promote proliferation for 
the replacement of damaged cells or may promote the secretion of urinary 
macromolecules that serve to modulate crystals formation (Nita and Grzybowski, 
2016). Additionally, it was also found that calcium oxalate monohydrate gets 
precipitated at membrane lipid rafts (Backov et al., 2000). 
b. Urinary volume 
Urinary volume is one of the most critical factors for crystallisation. When the 
urine volume increases, it dilutes the crystallisation phenomena, thereby 
decreasing the oxalate load to calcium and phosphate, which finally reduces the 
number of accumulated crystals (Borghi et al., 1999). 
c. Urinary pH 
Urinary pH plays an essential role in uric acid stone formation. Uric acid is 
frequent in patients with urine pH below 5.5. It is very insoluble in urine at pH 5 
but becomes significantly more soluble in urine at pH 7. Any combination of low 
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urinary pH concentrated urine and increased uric acid excretion make one at risk 
for the uric acid stone disease. In some patients, this very low urine pH is caused 
by a defect in renal ammonia secretion that results in less buffering of secreted 
hydrogen ion and low urine pH (Alelign and Petros, 2018). 
d. Enzymes in urine 
The initial step in the pathogenesis of kidney stones formation is the 
precipitation of an organic matrix of mucoprotein (detail 1.4.4). An essential 
factor in this process may be the activity and/or concentration of the urinary 
enzyme urokinase, which would affect the level of urinary mucoprotein. A 
decrease has been observed in urinary urokinase concentration of renal stones 
patients, which again underlines the possible involvement of urokinase in renal 
stone formation (Du Toit et al., 1997). 
1.4.2.2 Pre-urinary factors 
These factors could be both intrinsic and extrinsic in nature. Intrinsic factors 
include hereditary, age and sex. While, extrinsic factors include geographical 
location, climatic factors, dietary factors and total water intake. 
a. Age 
Idiopathic kidney stones are relatively uncommon before the age of 20, but the 
rate increases rapidly (10.6% of men and 18.4% of women) until the age of 40-60 
years and then declines after the age of 65 and beyond (Romero et al., 2010, 
Marshall et al., 1975, Lieske et al., 2014). Further details are in Chapter 4. 
b. Gender 
Typically, men are more susceptible to kidney stone formation as compared to 
females. The inhibition of calcium oxalate crystal growth is influenced by a 
combination of both gender and sex. With age vigorous ability to inhibit 
crystallisation is reduced (Krambeck et al., 2013, Lieske et al., 2014, Soucie et 
al., 1994). Urinary citrate and magnesium excretion are lower, and 
glycosaminoglycan and zinc excretion are higher in men as compared to women. 
Furthermore, the citrate creatinine excretion ratio is significantly higher in 
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women, which may explain the lower incidence of calcium stones in women 
compared to men. Details about the influence of age and gender in kidney stone 
formation are in Chapter 4. 
c. Race 
Interestingly, Caucasian people are more susceptible to kidney stones 
occurrence as compared to the African descents and mixed-race people 
together. (Denstedt and Fuller, 2012). According to Reyes et al., there is a racial 
difference in electrolyte excretion related to lithogenesis such as sodium and 
magnesium (Akoudad et al., 2010, Reyes et al., 2002). Idiopathic kidney stones 
are more common in Caucasians as compared to African Americans regardless of 
the geographical location of residence, e.g. 5.9% vs 1.7% in the US. The 
difference is not maintained when dietary habits and environmental factors are 
the same. There was a significant increase in the prevalence of urolithiasis in 
African Americans once they had adopted Caucasian dietary habits (López and 
Hoppe, 2010). 
d. Geographical location 
Kidney stone disease is highly prevalent in hot, arid, or dry climates such as in 
mountains, deserts, or tropical areas, as geographic variability tends to reflect 
environmental factors. Previously, it has been reported that warmer areas had 
higher stone prevalence in the US, British Isles, Scandinavian and Mediterranean 
countries, northern India and Pakistan, northern Australia, Central Europe, 
portions of the Malay peninsula, and China (Mente et al., 2007). Further details 
are in Chapter 4. 
e. Genetics 
25% of new patients with kidney stones have a family history (1st-degree 
relatives). However, there is a less known fact whether the risk of disease is due 
to the genetics alone or combination of genetics with other factors including 
environmental or socio-economic combinations. A positive family history of 
urolithiasis has been reported in 16-37% of patients who have formed kidney 
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stones, compared with 4-22% of healthy people with no history (Park et al., 
2010). 
Similarly, a study by Curhan et al. showed that family history and the risk of 
urolithiasis in a cohort of 37,999 male participants, with a follow-up of 8 years; 
4873 (12.8%) had a family history of kidney stones, 2957 of which (7.8%) 
reported a personal history of kidney stones. Finally, the study confirmed that 
men who had urolithiasis are approximately three times more likely to report a 
family history of kidney stones (Curhan et al., 1997, Türk et al., 2010). Also, 
there are also intrinsic epidemiological factors, such as autosomal recessive 
syndromes, with increased susceptibility to stone formation (Martínez et al., 
2007). 
1.4.2.3 Primary hyperoxaluria 
Primary hyperoxaluria (PH) instigates a broad spectrum of diseases, ranging from 
occasional stone passage to systemic oxalosis in infants. Two distinct inherited 
enzyme defects have been related to primary hyperoxaluria. On this basis, they 
are divided into two major categories: PH1, a condition which is a defect in 
enzyme alanine: glyoxylate aminotransferase (AGT) and PH2 which is a defect in 
enzyme glyoxylate reductase/hydroxy-pyruvate reductase (GR/HPR). 
PH1 is an autosomal recessive disorder (~1:120,000 live births per year in 
Europe), caused by the functional defect of the hepatic, peroxisomal, pyridoxal 
phosphate-dependent enzyme AGT. This condition leads to oxalate 
overproduction; the disease occurs because AGT activity is either absent or 
mistargeted to the mitochondria (Cochat et al., 1995). Similarly, PH2 has been 
documented in fewer cases; and in this condition, glyoxylate and 
hydroxypyruvate are metabolised by lactate dehydrogenase to oxalate and l-
glycerate, respectively  (Rumsby et al., 2001). Further details are in chapter 3. 
1.4.2.4 Inborn errors of amino acid metabolism 
Inborn errors of metabolism which can be detected by the accumulation of 
specific amino acids as metabolites in body fluids like serum and urine are 
inborn errors of amino acid metabolism. Amino acid metabolism uses active 
trans-tubular transport, which is usually associated with active sodium transport; 
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such tubular transport may be specific to either one single amino acid (e.g. 
glycine, histidine) or a group of amino acids (e.g. cysteine, lysine, ornithine and 
arginine) (Schmidt-Nielsen and Sands, 2001). 
a. Fanconi syndrome 
Hyperaminoaciduria (mainly histidine, glycine, serine, alanine and glutamine) is 
a marker of proximal tubular dysfunction together with variable increased 
urinary excretion of glucose, phosphate, bicarbonate, potassium, calcium, uric 
acid, carnitine, etc. Such Fanconi syndrome may either be primary (idiopathic 
primary Fanconi syndrome), or it may occur secondarily to various inherited 
metabolic disorders, i.e. cystinosis (cystinosin), tyrosinemia type 1 
(fumarylacetoacetate hydrolase), fructose intolerance (fructose 1,6-
bisphosphate aldolase), Wilson’s disease (copper-transporting P-type 
ATPase, ATP7B gene), glycogen storage disease type 1 (glucose-6-phosphatase), 
respiratory chain disorders, Fanconi–Bickel syndrome (GLUT-2), lysinuric protein 
intolerance (y+LAT1 protein encoded by SLC7A7 gene), etc (Wilson et al., 1983). 
b. Cystinuria 
Cystinuria is an autosomal recessive inherited aminoaciduria that leads to 
recurrent nephrolithiasis with a prevalence between 1 in 2,500 and 1 in 100,000. 
Cystine represents 4–8 % of all renal stones in children in France (Daudon and 
Jungers, 2004). The solubility of these stones is pH-dependent, with a modest 
increase if pH rises to 7·5, and a steeper increase with a pH above 7·5. However, 
the solubility of these stones also depends on the urinary pH, owing to the 
solubilising action of electrolytes and macromolecules. With a urine pH<7, 
cystine solubility is generally exceeded when the urinary cystine concentration is 
higher than 250 mg/L. In Type I cystinuria, mutations in the gene for the dibasic 
amino acid transporter (SLC3A1) have been uncovered. The molecular defects in 
Type II and III cystinuria have not yet been determined (Daudon et al., 2003). 
1.4.2.5 Inborn errors of purine and pyrimidine metabolism 
Inborn errors of purine and pyrimidine metabolism are often associated with 
nephrolithiasis of various composition and pathophysiology. They represent 1–3% 
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of renal stones in children in France (Daudon and Jungers, 2004). All these 
calculi are primarily radiolucent, but they can be identified by ultrasound, which 
usually does not show any nephrocalcinosis. Some of the common disorders 
under this group are: 
a. Phosphoribosylpyrophosphate synthetase superactivity 
Phosphoribosylpyrophosphate (PRPP) synthetase superactivity is an inborn error 
linked to X-linked inheritance. The disease usually shows in young male patients 
with gouty arthritis and uric acid nephrolithiasis, sometimes leading to early-
stage renal disease (ESRD). Under abnormal conditions plasma uric acid may 
reach maximum up to 600–900 μmol/l (average adult values 170–320 μmol/l), 
and urine uric acid concentration might increase so that the urinary uric acid to 
creatinine ratio approaches 2.5 mmol/mmol (average adult values 0.2–
0.3 mmol/mmol). The condition mentioned above may appear during infancy, 
together with neurological abnormalities, i.e. sensorineural deafness, hypotonia, 
motor delay, ataxia and autistic features (Becker et al., 1988). 
b. Hypoxanthine-guanine phosphoribosyltransferase deficiency: Lesch–Nyhan 
syndrome 
Deficiency of hypoxanthine-guanine phosphoribosyltransferase (HGPRT) activity 
is an inborn error of purine metabolism associated with uric acid overproduction 
and various degrees of neurological disorders, depending on the amount of 
enzyme deficiency. The prevalence is estimated at 1 in 380,000 live births in 
Canada and 1 in 235,000 in Spain (Torres et al., 2007). 
c. Adenine phosphoribosyltransferase deficiency 
The deficiency may lead to clinical manifestations in early childhood, but it can 
also remain silent for decades. Symptoms include the passage of crystals, gravel, 
and stones. Such nephrolithiasis is responsible for abdominal colic, dysuria, 
haematuria, urinary tract infection, and, sometimes, acute anuric renal failure 
(Di Pietro et al., 2007). 
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d. Xanthine-Oxidase deficiency 
Two deficiencies of xanthine oxidase (or dehydrogenase) are known: isolated 
hereditary xanthinuria (type 1, with nephrolithiasis) and combined xanthine 
oxidase and sulphite oxidase deficiency (type 2, with prominent neurological 
involvement). Isolated xanthine oxidase deficiency can be asymptomatic, but 
one-third of affected patients suffer from kidney stones. Xanthine stones are not 
visible on X-ray and may appear at any age. Studies have shown that some 
patients with myopathy are also associated with crystalline xanthine deposits 
(Ichida et al., 1997). 
e. Hereditary renal hypouricemia 
Familial renal hypouricemia is a sporadic disease caused by mutations in the 
SLC22A12 gene. The disease condition is caused by a defect in the tubular 
reabsorption of urate.  
1.4.3 Epidemiology of Kidney stones 
Globally, the prevalence and recurrence rate of kidney stone disease is 
increasing (3.25% in the 1980s and 5.64% in the 1990s), with limited options for 
effective drugs (Campbell et al., 2007). It affects about 12% of the world 
population at some stage in their lifetime (Chauhan et al., 2009). The 
prevalence of kidney stones varies with age, sex, and race but occurs more 
frequently in men than in women within the age of 20–60 years, exceeding 12% 
in men and 6% in women (Moe, 2006, Romero et al., 2010, Edvardsson et al., 
2013). Recent studies have reported that the prevalence of kidney stones has 
been increasing in the past decades in both developed and developing countries 
(Figure 1.1). This growing trend is believed to be associated with a change in 
lifestyles such as lack of physical activity, exercise, dietary habits and global 
warming (Moe, 2006, Alelign and Petros, 2018).  
In England, in between 2009-2010, there were over 83,000 recorded hospital 
episodes due to kidney stones (Turney et al., 2012). The data represents a 63% 
increase over the previous 10 years and an 11% calculated lifetime risk of 
forming a stone. In the US, kidney stone affects 1 in 11 people (Scales Jr et al., 
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2012), and it is estimated that 600,000 Americans suffer from urinary stones 
every year (Kovshilovskaya et al., 2012). Furthermore, the US nationwide 
occurrence and prevalence of kidney stone were investigated in two major 
studies. The first study, which was carried for two periods in between 1976 to 
1980 and second from 1988 to 1994, revealed that the prevalence of kidney 
stones increased from 3.8 %  ± 0.21% in the first period  to 5.2 % ± 0.34% in the 
second (Romero et al., 2010). Apart from six states, there was an average of 41% 
increase in urinary stone rates. Also, assuming 50 years of exposure, 12% of the 
total US population will experience kidney stones at some point in their lifetime 
Figure 1.1. 
 
Figure 1.1.  Percentage prevalence of a history of kidney stones in the US for 
two different time frames; 1976 to 1980 and 1988 to 1994 in each age group for 
(A) Gender and (B) race group. Reproduced with permission from (Stamatelou et 
al., 2003). 
 
Furthermore, the study showed that the prevalence was gender and age-
dependent. Men were more prone to the disease compared to females. Similarly, 
regular kidney stone occurrence was observed with increasing age, up to the age 
of 70 for men and 60 years of age for women (Stamatelou et al., 2003). For both 
genders, age groups between 20 and 39 years were the least affected. A similar 
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trend was also observed in other countries in the world, such as Argentina, 
Brazil, Canada, Germany, United Kingdom, Italy, Sweden, Turkey, Japan, and 
South Africa. The detail is described in section 1.4.2.   
In the US and during the period between 1988 and 1994, non-Hispanic Caucasians 
(5.9 %± 0.43%) were more affected by kidney stones compared to Mexican 
Americans (2.6 %± 0.19%) or non-Hispanic African Americans (1.7 %± 0.16%) 
(Stamatelou et al., 2003). Asian Americans also had lower kidney stone 
incidence than White Americans. The variation in kidney stone prevalence 
among the different races was attributed to lifestyle factors such as dietary 
habits and socioeconomic differences of the study subjects. The lower 
occurrence of kidney stones in the African American community in the US or 
other countries such as South Africa is due to (1) lower serum and urinary 
calcium levels because of lower intake and absorption of calcium (Sorensen, 
2014), (2) higher carbohydrate intake resulting in higher urine volume (Reddy et 
al., 2002), and (3) higher liver damage in this group which fails to metabolise 
circulating oestrogens resulting in increased urinary citrate excretion (Kovacs, 
2000). 
Early reports suggest that if kidney stones are left untreated, the likelihood of 
forming another stone after the initial episode averages 30 to 40% at 5 years 
(Johnson et al., 1979), for all stone types. These figures from observational 
studies are similar to the recurrence rates in the control samples of published 
randomised trials (Ettinger et al., 1986, Resnick et al., 1968). Encouragingly, the 
treatment arms of many of the randomised trials have shown dramatic 
reductions in recurrence rates by 50% or more. These reductions by medication 
or dietary interventions emphasise that recurrent stone disease may be 
preventable. In this regard, recurrence rates of 50% after 10 years and 75% after 
20 years has been reported.  
1.4.4 Mechanism of stone formation 
The mechanism of kidney stone formation is a complex process which remains 
incompletely understood. It is a biochemical sequence that is the consequence 
of an increase in urinary supersaturation due to excess of crystalline particles 
and low urinary volume. Supersaturation leads to the formation of the crystals 
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which further form a concretion beyond which there is no further dissolution. 
When the concentration of two ions exceeds their saturation point in the 
solution crystallisation occurs. Although all types of stones share a similar 
mechanism of formation, the sequence of events leading to their formation 
differs depending on the type of stones, urinary pH and urine chemistry. For 
instance, crystallisation of calcium-based stones (calcium oxalate or calcium 
phosphate) occurs in supersaturated urine with low concentrations of inhibitors 
(Ratkalkar and Kleinman, 2011).  
The transformation of a liquid to a solid phase is influenced by pH and solubility 
of the substances. If more salt is added, it crystallises in solution, provided the 
temperature and pH remains unchanged (Ratkalkar and Kleinman, 2011). The 
concentration at which saturation is attained and crystallisation begins are 
called the thermodynamic solubility product (Ksp).  Thus, the crystallisation 
process depends on Ksp and kinetics of a supersaturated solution. Hence, 
prevention of supersaturation can decrease the formation of the stones (Alelign 
and Petros, 2018). Additionally, stone formation depends on the imbalance 
between urinary stone promoters and inhibitors (Evan et al., 2015). If the 
concentration of inhibitors of crystallisation, becomes low, then it results in 
nephrolithiasis.  
The schematic diagram for Kidney stone formation is represented in Figure 1.2. 
The detailed process is explained below: 
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Figure 1.2. Schematic representation of various cellular and extracellular 
events during stone formation. *(OPN: osteopontin, HA: hyaluronic acid, SA: 
sialic acid, MCP-1: monocyte chemoattractant protein-1). Adapted from 
(Aggarwal et al., 2013). 
 
 
1.4.4.1 Nucleation: 
It is an early step for the formation of the solid crystals from liquid forms. It 
begins with the combination of stones and salts into clusters forming a nucleus 
(termed as nidus) which gradually increases in size, thereby forming new 
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components or clusters. Nuclei form the first crystals in the characteristic lattice 
pattern by heterogeneous nucleation (Alelign and Petros, 2018). Once the 
nucleus is created, crystallisation can occur at lower chemical pressure for the 
formation of the initial nucleus. 
Epithelial cells, urinary casts, RBCs, and other crystals can act as binding agents 
by increasing heterogeneous nucleation and crystal aggregation (Alelign and 
Petros, 2018). On the other hand, nanobacteria form apatite structures serving 
as a crystallisation centre for stone formation. Furthermore, renal tubular cell 
injury also promotes crystallisation of CaOx crystals, thereby providing 
substances for their heterogeneous nucleation. In vitro cell degradation 
following renal tubular cell, injury produces numerous membrane vesicles, which 
are good nucleators of calcium crystals. In vivo crystals observed in the renal 
tubules of hyperoxaluric rats are always associated with cellular degradation 
products (Tsujihata, 2008). 
1.4.4.2 Growth 
Once a crystal nucleus has achieved a critical size, and relative supersaturation 
remains above one, the overall free energy is decreased by adding new crystal 
components to the nucleus. This process is called crystal growth. The process of 
stone growth is a slow and long-lasting process. It was reported that the crystal 
surface binding substance, which is found in CaOx crystals generated from whole 
human urine, is a potent inhibitor of CaOx crystal growth and contains proteins 
mainly the Tamm–Horsfall glycoprotein, also known as uromodulin, and 
osteopontin also known as bone sialoprotein I (Aggarwal et al., 2013). Under in 
vitro study, crystals induced in human urine demonstrated an intimate 
association between calcium-containing crystals and organic matrix (lipids and 
proteins) (Basavaraj et al., 2007). 
1.4.4.3 Aggregation 
This is the most crucial step in stone formation in which all the crystals within 
the solution stick together to form a more massive particle. This process is slow 
because the crystals are small, and it takes a long time to obstruct the renal 
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tubules and show its impact; hence, this process is thought to be the most 
critical step. 
1.4.4.4 Crystal-cell interaction 
This is the complex and unexplored step of stone formation. In this step, there is 
an attachment of the grown crystals with the renal tubule lining of epithelial 
cells due to crystal retention or crystal-cell interaction. These structural and 
functional studies of crystal-cell interactions indicate that calcium oxalate 
monohydrate (COM) crystals rapidly adhere to microvilli on the cell surface and 
are subsequently internalised. Khan et al. concluded that crystal-cell interaction 
is an essential element in the development of urinary stone disease (Khan et al., 
1999).  
In hyperoxaluric patients, renal tubular epithelial cells are injured due to 
exposure to high oxalate concentrations or sharp COM crystals. Crystal-cell 
interaction results in the movement of crystals from the basolateral side of cells 
to the basement membrane. Further, crystals could be taken into cells and 
anchored to the basement membrane of the kidneys. The interaction of COM 
crystals with the surface of renal epithelial cells could be a critical initiating 
event in nephrolithiasis. An increased retention force between the crystal and 
injured renal tubule epithelial cells promotes CaOx crystallisation. Most of the 
crystals attached to epithelial cells are thought to be digested by macrophages 
and/or lysosomes inside cells and then discharged with the urine. A role for 
crystal uptake in renal stone disease is disputed because intracellular crystals 
seldom are observed in the kidney and in cell culture, crystals are taken up by 
proximal tubular cells where crystals are expected to be formed (e.g., the distal 
tubule, collecting ducts). Studies by Kok and Khan observed crystal attachment 
to the brush border of proximal tubules in rats (Khan et al., 1999). Experimental 
induction of CaOx urolithiasis starts with hyperoxaluria followed by crystalluria 
and deposition in the kidney. 
1.4.4.5 Infection stones 
During the infection of the urinary tract with urea-splitting organisms (Proteus 
sp., Haemophilus sp., Ureaplasma urealyticum, Klebsiella sp.), the hydrolysis of 
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urea yields ammonium and hydroxyl ions (Sakhaee et al., 2012), which further 
results in infection stones formation. The consequent alkaline pH of the urine 
increases the dissociation of phosphate to form trivalent phosphate, and there is 
supersaturation of struvite (magnesium ammonium phosphate) and carbonate 
apatite. 
1.4.4.6 Endocytosis of CaOx Crystals 
Endocytosis or engulfment of crystals by renal tubular cells is the initial process 
in the formation of kidney stones. Studies by Lieske noted that engulfment of 
crystals into tubular epithelial cells and cell proliferation in a transplanted 
kidney in a patient with PH1 indicated that COM crystals rapidly adhere to 
microvilli on the cell surface and subsequently internalised (Lieske et al., 1992). 
Further, they also confirmed this phenomenon experimentally using calcium-
containing crystals and tubular cells in culture. Various substances inhibit the 
effect on CaOx endocytosis in tubular fluid/urine such as glycosaminoglycans, 
glycoproteins, and citrate may coat crystals and inhibit the binding of COM 
crystals to the cell membrane. Tamm–Horsfall glycoproteins (THP) leads to a 
decrease in COM endocytosis by 34%, suggesting that it promotes renal stone 
formation by interaction with COM crystals with distal tubular cells. Further, the 
inhibitory effect of fibronectin (FN) on CaOx crystal endocytosis was only 18.4% 
at the physiological concentration of excreted FN (0.5 mg/mL), though 
morphological examination revealed that FN inhibited the endocytosis of crystals 
by renal tubular cells (Tsujihata, 2008). 
1.4.4.7 Randall's Plaques 
Randall's plaques appear to be the precursor to the origin of renal stone. 
However, the pathogenesis of Randall's plaque itself is not precisely known 
(Ettinger et al., 1986). The majority of CaOx stones are found to be attached 
with renal papillae at the sites of Randall's plaque (Lieske et al., 2014). It is 
located at the interstitial basolateral membrane in the loop of Henle (Evan et 
al., 2003, Evan et al., 2006). Calcium phosphate (apatite), and purine crystal 
compositions were identified in plaques, whereas the quantity of apatite is 
dominant (Daudon et al., 2015). Initially, calcium phosphate crystals and organic 
matrix are deposited along the basement membranes of the thin loops of Henle 
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and extend further into the interstitial space to the urothelium, constituting the 
so-called Randall’s plaques. Evidence suggests that a primary interstitial apatite 
crystal also leads to CaOx stone formation (Knoll, 2010). In supersaturated urine, 
crystals adhere to the urothelium, which may enhance subsequent stone growth 
(Dawson and Tomson, 2012). 
Due to renal cell injury, the plaque is exposed to supersaturated urine. Renal 
epithelial cell degradation product promotes heterogeneous nucleation and 
crystal adherence in renal cells. Randall’s plaque calcification is triggered by 
oxidative stress. Cells may express molecules at distal and collecting tubules 
which act as crystal binding sites such as phosphatidylserine, CD44, osteopontin, 
and hyaluronan (Joseph et al., 2005, Yuen et al., 2010). Renal epithelial cells of 
the loop of Henle or collecting ducts produce membrane vesicles at the basal 
side, which leads to plaque formation (Khan, 2014). Thus, apatite crystal 
deposits have been proposed to act as a nidus for CaOx stone formation by 
attachment on further matrix molecules (Khan, 2014, Hayes, 2015). However, 
the driving forces in plaque formation and the involved matrix molecules remain 
elusive. 
Kidney stones are either attached to the renal papillae or found freely (Kok and 
Khan, 1994). According to the fixed particle pathway, the beginning of CaP 
deposition in the interstitium establishes a nucleus for CaOx formation. CaP 
formed in the basement membrane of the loops of Henle, the inner medullary 
collecting ducts, and ducts of Bellini serves as an attachment site for stone 
development. Idiopathic stone formers develop CaOx attached to fixed sites of 
interstitial plaque. Stones of the distal tubular acidosis attach to plugs 
protruding from dilated ducts of Bellini, whereas cystinuria stones do not attach 
to the renal plagues (found freely)(Evan, 2010). CaP, uric acid, or cystine 
crystals formed in the renal tubules plug at the terminal collecting ducts. When 
mineralisation reaches the renal papillary surface, plaques rupture exposing CaP 
crystals to the pelvic urine. Then, urinary macromolecules deposit over the 
exposed CaP crystals and promote CaOx deposition on CaP.  
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1.4.5 Types of stones 
There are different types of stones categorised based on their nature (physical 
and chemical) and percentage of occurrence Figure 1.3. 
 
Figure 1.3. Some of the different types of kidney stones.  
 
 
1.4.5.1 Calcium stones 
Calcium stones in the form of oxalate or phosphate are the predominant form of 
renal stones comprising about 80% of the total urinary calculi (Coe et al., 2005), 
i.e.  Calcium Oxalate (CaOx; 50%), calcium phosphate(CaP; 5%) and a mixture of 
both around 45% (Chaudhary et al., 2010). The primary constituent of the 
calcium stones is brushite (calcium hydrogen phosphate or hydroxyapatite). 
Calcium oxalate also exists in the different form of CaOx monohydrate (COM, 
termed as weddellite; CaC2O4.H2O) and CaOx dihydrate (COD, weddellite, 
CaC2O4·2H2O), or as a combination of both, with the monohydrates accounting 
for more than 60% of total stones (Alelign and Petros, 2018). COM is the most 
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thermodynamically stable form of stone and is, therefore, more frequently 
observed than COD. 
In the human body, many factors are responsible for calcium oxalate stone 
formation such as hypercalciuria, hyperuricosuria, hyperoxaluria, hypocitraturia, 
hypomagnesuria and hyper cystinuria (Dal Moro et al., 2005) (detailed in section 
1.4.2.5). These stones are mostly dependent on urinary pH, i.e. urinary pH of 
5.0 to 6.5 promotes CaOx stones, whereas CaP stones occur in pH greater than 
7.5 (Dal Moro et al., 2005, Coe and Coe, 1983). The recurrence of calcium stones 
is higher than other types of stones. 
1.4.5.2 Struvite or Magnesium Ammonium Phosphate Stones 
Struvite stones often referred to as infection stones or triple phosphate stones; 
are the second most abundant (10-15%) stone types. These stones are most 
frequent among patients with a history of chronic urinary tract infections that 
produces an enzyme called urease. Urease is most commonly produced by 
Proteus mirabilis, and less common pathogens, including Klebsiella pneumonia, 
Pseudomonas aeruginosa, and Enterobacter (Barbas et al., 2002, Coe et al., 
2005). However, Escherichia coli is bacteria not capable of splitting urea and is 
therefore not associated with the formation of struvite stones (Griffith, 1978, 
Dursun et al., 2015). 
1.4.5.3 Uric acid stones of Urate 
Uric acid stones are the third most common stones accounting 3-10% of total 
stones (Giannossi and Summa, 2012, Coe et al., 2005). These stones are frequent 
among patients eating high purine diets, especially those containing high protein 
diets such as meat and fish, which results in hyperuricosuria, low urine volume, 
and low urinary pH (pH<5.5) (Barbas et al., 2002, Coe et al., 1992). The most 
prevalent cause of uric acid stones is idiopathic, and these stones are more 
common in men compared to women. The detail in Chapter 5. 
1.4.5.4 Cystine stones 
These stones account for around 2% of the total kidney stones population and 
are triggered by a mutation in the transport of amino acid and cystine. These 
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stones cause cystinuria, an autosomal recessive disorder instigated due to a 
defective SLC3A1 (rBAT) gene on chromosome 2, resulting in impaired renal 
tubular absorption of cystine or leaking cystine into the urine. These stones are 
not soluble in urine; hence patients with cystinuria excrete more than 100 
millimoles insoluble cystine per day (Parmar, 2004, Scales Jr et al., 2012, Wells 
et al., 2012). The development of urinary cystine is the only diagnosis of the 
disease. 
1.4.5.5 Drug-induced stones 
These stones are the least common stones accounting for around 1% of the total 
occurrence rate. They are formed from the aggregation of lithogenic agents due 
to the side effects of drugs such as guaifenesin, triamterene, atazanavir, and 
sulfa-containing drugs. For instance, people who take the protease inhibitor 
indinavir sulphate, a drug used to treat HIV infection, are at risk of developing 
kidney stones. Such lithogenic drugs or/and its metabolites may deposit to form 
a nidus or on renal calculi already present. On the other hand, these drugs may 
induce the formation of calculi through its metabolic action by interfering with 
calcium oxalate or purine metabolisms (Daudon et al., 2018). 
1.4.6 Kidney stone diagnosis and treatment 
Significant advances were seen over the past three decades in the diagnosis and 
treatment of kidney stones. Helical computed tomography (CT) imaging and 
ultrasound coupled with X-ray, provide a powerful diagnostic tool. Relatively 
non-invasive techniques, such as shock wave lithotripsy (SWL), percutaneous 
nephrolithotomy (PNL), and ureteroscopy (URS) have eased the treatment of this 
disease. However, it remains challenging to visualise remaining kidney stone 
fragments after SWL, and hence, these remaining fragments can act as nidi, or 
sources of origins, for another episode of stone disease. Besides the 
aforementioned method, stone can be treated without operating it, called 
medical expulsive therapy (MET). MET is the use of pharmacologic agents to 
promote ureteral stone passage by relaxing ureteral smooth muscle. Both α-
adrenergic blockers and calcium-channel blockers have been shown to increase 
the likelihood of spontaneous stone passage. However, a recent meta-analysis 
found that α-adrenergic blockers were superior to the calcium-channel blocker 
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nifedipine and as such may be the preferred agent for MET. MET is commonly 
utilised now in patients who undergo conservative/expectant management for 
ureteric stones. 
1.5 Animal models for Kidney stones 
Nephrolithiasis may also be associated with nephrocalcinosis, i.e., crystal 
depositions in the tubular lumen, an entity which suggests specific pathological 
processes. Stones are common in obese and diabetic individuals.  
Several animal models, including rodents’ have been studied to understand the 
pathophysiology of intrarenal crystal formation (Tzou et al., 2016). Here in this 
part of the thesis, the benefits and limitations of different model organisms have 
been reviewed in preference to their uses in kidney stone studies. 
1.5.1 Rat 
Rat represents a well-established model for mimicking the urinary stones 
diseases. These models replicate two primary conditions (hypercalciuria and 
hyperoxaluria), like humans and play a vital role in the observation of the 
pathophysiological changes associated with these conditions. 
1.5.1.1 Anatomic and physiological comparison of a rat with humans 
The kidneys of rats are uni-papillary, but the kidneys of human are multi-
papillary. Similarly, an average human has around 170 g of the kidney with 
around one million nephrons, but an average mouse has 0.75-1.3 g kidney with 
around 30,000 nephrons. Despite these gross differences, the cortex-medulla 
ratio (2:1) of the rat is similar to humans (Khan, 2013). Therefore, the mouse 
can be a good model for the following type of stone studies: 
a. Hypercalciuria 
Hypercalciuria is one of the most common risk factors for the development of 
urinary stone diseases (Coe et al., 1992, Bushinsky et al., 1995). Researchers 
have established a strain of multigeneration inbred Sprague-Dawley rats to 
produce hypercalciuric progeny (Bushinsky and Favus, 1988). Different studies 
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have shown that an increased number of vitamin D receptors in the GI tract, 
kidneys and bone leads to increased calcium absorption in  rats (Li et al., 1993, 
Yao et al., 1998, Krieger et al., 1996). 
b. Hyperoxaluria 
This is a disease condition in which patients excrete an excessive amount of 
oxalate in urine. Individuals with hyperoxaluria often have calcium oxalate 
kidney stones. For the induction of kidney stones, different lithogenic agents 
causing oxalate stones need to be supplemented externally, for example, 
feeding rats with sodium oxalate, ethylene glycol (EG), glycolic acid and hydroxy 
L-Proline. The summary is inlisted in (Table 1.2). Administration of such agents 
causes physiological changes in rats and induces stones. 
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Table 1.2. Rat models related to hypercalciuria and hyperoxaluria. Adapted 
from (Tzou et al., 2016).  
  
Type of 
approach 
Lithogenic agent, 
reference 
Diet/administration Effects 
Crossbreeding Inbreeding 
hypercalciuric 
progeny (Bushinsky 
et al., 2000, 
Bushinsky et al., 
2002) 
• Multiple 
generation 
inbred  
• Multiple 
diets/agents 
applied 
• Hypercalciuria   
• Hyperoxaluria                    
• CaOx crystals 
• CaP crystals 
Exogenous 
induction 
Sodium oxalate 
(Khan et al., 1979, 
Khan et al., 1992, 
Khan and Hackett, 
1993) 
• Intraperitoneal 
injection of 10 
mg/kg sodium 
oxalate 
• Prompt CaOx 
crystal deposits 
•  Crystal aggregation 
in the ducts of 
Bellini 
Glycolic acid 
(Ogawa et al., 
1990) 
• Free drinking of 
water with 
powdered 3% 
glycolic acid 
• Hyperoxaluria 
•  Hypocitraturia 
•  CaOx crystal 
deposits 
Ethylene Glycol 
(EG) (Khan et al., 
1992, Boeve et al., 
1996, Thamilselvan 
et al., 1997) 
• 0.75% EG in 
water 
with/without 
ammonium 
chloride, vitamin 
D, calcium 
chloride 
• Hyperoxaluria 
• CaOx crystalluria 
•  CaOx crystal 
deposits 
•  Renal toxicity 
Hydroxy-L-proline 
(HLP) (Tawashi et 
al., 1980, Khan et 
al., 2006, 
Bushinsky et al., 
2002) 
• 0.75% EG in 
water 
with/without 
ammonium 
chloride, vitamin 
D, calcium 
chloride 
• Hyperoxaluria 
•  CaOx crystal 
deposits 
•  Less toxic 
compared to other 
agents 
Dietary 
manipulation 
Potassium oxalate 
supplement 
(Wiessner et al., 
2011) 
• 5% level of 
potassium 
oxalate 
• CaOx crystal 
deposits 
Magnesium (Mg) 
deficiency 
(Rushton and 
Spector, 1982) 
• Dietary Mg 
deprivation 
• Increase of CaP 
crystal deposits 
Vitamin B6 
(pyridoxine) 
deficiency (Andrus 
et al., 1960, 
Gershoff and 
Andrus, 1961) 
• Dietary 
intentional 
deficiency of 
pyridoxine 
• Hyperoxaluria 
•  Hypocitraturia 
•  CaOx crystal 
deposits 
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c. Dietary Manipulation 
An alternative method of induction of stone formation is an alteration of the 
diet by adding external components. Dahl salt-sensitive and Brown Norway male 
rats were fed with 5% of potassium oxalate in order to develop calcium oxalate 
stones (Wiessner et al., 2011). Meanwhile, hyperoxaluric rats deprived of dietary 
Mg demonstrated increased production of calcium phosphate (apatite) stones 
(Rushton and Spector, 1982). These methods of induction of kidney stones in rat 
help us to understand the underlying biological progress as well to access the 
pathophysiological changes in the body. 
1.5.1.2 Limitations of a Rat model 
As a vertebrate the rat requires ethical approval for performing experiments and 
the cost of rearing is also. (DiMasi et al., 2003). Rats are coprophagic (eat their 
own stool), and therefore consume unnecessary elements hence might not be 
relevant to compare with a human. Additionally, very few humans suffer from 
primary hyperoxaluria, which makes the study limited to few numbers 
practically. 
1.5.2 Mouse 
Beside rat models, the mouse is also a useful model organism for the prevention 
and treatment of kidney stones. Furthermore, the genetic and physiological 
complexities of the mouse are similar to human and can be used to observe the 
variation on the primary process underlying stones formation. 
1.5.2.1 Genomic/anatomic/physiologic comparison between mice and 
humans 
The respective genomes of mice and humans are similar as both genomes 
contain approximately 3.1 billion base pairs and are ~85%identical on average, 
with some greater than 95% identical. Mice generally weigh between 25 and 35 
g, approximately 1/2500 the size of humans(Liebelt, 1998). However, the mean 
weight of mouse kidney comprises 0.8% of the total mouse weight whereas in 
human, it comprises 0.2% of body weight (Meneton et al., 2000, Sands and 
Layton, 2009). Meanwhile, maximal urine concentration of mice is around 3.3 
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times higher as compared to a human. Under microscopic examination, mouse 
kidneys have a distinct; cortex, medullary components, glomerular, tubular 
structure and vascular framework (Liebelt, 1998). 
a. Hyperoxaluria 
Hyperoxaluria is the most common risk factor for the development of urinary 
stone diseases. In mouse, hyperoxaluria is induced by feeding with lithogenic 
agents like EG, HLP and sodium oxalate to develop oxalate stones. Chemical 
food treatment of mouse develops not only hyperoxaluria but also form sodium 
oxalate crystals in the kidney (Khan and Glenton, 2010, Okada et al., 2007). This 
helps investigators to establish the role of a gene in stones formation. Summary 
of the use of a mouse model for different stones formation is in (Table 1.3). For 
example, researchers found that the selective knockout of osteopontin (OPN) 
and Tamm-Horsfall protein (THP) established the critical role of macromolecules 
in stones formation (Okada et al., 2007). 
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Table 1.3. Summary of mice models of nephrocalcinosis. CaP=calcium phosphate, COD=calcium oxalate dihydrate, COM=calcium 
oxalate monohydrate, EG=ethylene glycol, GOX=glyoxalate, HLP=hydroxy-L-proline, KO=knockout, MetS=metabolic syndrome, 
THP=Tamm Horsfall protein Adapted from (Tzou et al., 2016). 
Mouse; References Exogenous method Urinary features Nephrocalcinosis 
Slc7a9 KO (Feliubadaló et al., 2003) Normal diet Cystinuria, cystine crystalluria Cystine stone in pelvis and bladder 
OPN KO (Wesson et al., 2003) 4 weeks administration of 1% 
EG in drinking water 
hyperoxaluria, COD/COM 
crystalluria 
 intratubular COM crystals 
THP KO (Mo et al., 2004, Mo et al., 
2007) 
normal diet or 4 weeks 
administration 
of 1% EG and 4 IU/ml VitD3 
in drinking water 
not described intratubular and interstitial 
CaOx crystals 
NHERF-1 KO (Weinman et al., 2006) normal diet hypercalciuria, 
hyperphosphaturia, 
hyperuricosuria 
interstitial CaOx crystals 
Slc26a6 (Jiang et al., 2006) normal diet  hyperoxaluria, CaOx crystalluria intratubular COD/COM crystals 
C57BL/6 (Okada et al., 2007) daily 80 mg/kg GOX 
intraperitoneal injection 
hyperoxaluria, high CaOx index intratubular COM crystals 
Npt2a KO (Khan and Glenton, 2010) 4 weeks administration of 
1.5% GOX 
or 5% HLP in chow 
COD/COM crystalluria intratubular/interstitial 
CaOx crystals and interstitial 
CaP crystals 
Sat1 (Slc26a1) KO (Dawson et al., 
2010) 
normal diet hyperoxaluria intratubular CaOx crystals 
and bladder stone 
MetS model (Taguchi et al., 2015)  2 weeks administration of 
1% EG in drinking water and 
high-fat diet 
hyperoxaluria, hypercalciuria intratubular CaOx crystals 
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b. Transport knockout model 
Several studies have been conducted by knocking out different transporters in 
the mouse model to induce hyperoxaluria, hypercalciuria, hyperuricosuria and 
cystinuria.  
1.5.2.2 Limitations of Mouse model 
Despite the advantage of having its genome sequenced, its overall accuracy and 
consistency in relation to human kidney stone disease have always been 
controversial among researchers. So, is mouse an ideal model for the study of 
kidney stones? Although this model imitates similar pathophysiological changes 
experienced in human models suffering kidney stones, it can be only useful for 
the study of hyperoxaluria. Also, the prevalence of cystinuria is rare (less than 
1% of urolithiasis patients). Therefore these mice models are not 
representative of most humans who suffer from the urinary stone disease. 
1.5.3 Drosophila 
Studies performed by the laboratory of Julian Dow (Hirata et al., 2012) and 
Marshall Stoller (Chi et al., 2015) now present Drosophila melanogaster as a 
model for kidney stones research. They have shown that Drosophila has 
numerous advantages over vertebrates for the study of kidney stones.  
1.5.3.1 Anatomic/Physiologic comparison between fly and humans 
Drosophila is often overlooked as an ideal model organism for kidney stone 
studies. The previous study by Hirata and colleagues have presented and 
validated CaOx nephrolithiasis in the fruit fly. The fly Malpighian tubules (MTs) 
are considered the fly kidney and represent the excretory and osmoregulatory 
system similar to that of a human. Some of the significant differences between 
them are:  
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1) Drosophila is invertebrate.  
2) Drosophila has an open circulatory system with a fluid-filled hemocoel 
cavity that uses haemolymph to circulate ions and regulation of water 
and nutrient excretion (Miller et al., 2013).  
3) Drosophila has two pairs of MTs which have similar functions to human 
kidney (Dow and Romero, 2010). Homologous to human renal tubules, 
the Malpighian tubule functions to filter the fly haemolymph similar to 
how human tubules filter blood. The detail in section 1.6.   
4) Unlike the vertebrate kidney, the Drosophila kidney does not have a 
glomerular-like structure, so the luminal fluid is not generated by a 
filtration process (Dow and Romero, 2010, Knauf and Preisig, 2011).  
Despite all these differences, the conservation of genetic composition and 
transport protein structure as well as the similarities of the physiological 
function of the MTs (Reiter et al., 2001) have facilitated the development of 
several Drosophila stone models, including those of genetically linked and 
environmentally induced nephrolithiasis (Chung et al., 2016).  
a. Diet-induced stones 
Similar to other vertebrate models, hyperoxaluria can be induced in Drosophila 
by feeding with lithogenic agents such EG, HLP and sodium oxalate (Chen et 
al., 2011). The incidence of crystal formation with different lithogenic agents is 
discussed in Table 1.4. 
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Crystal formation (%) 
Male Female Total 
Control 6.6±3.6 46.8±3.4 24.3±3.0 
EG 
0.10% 
0.50% 
0.75% 
1% 
 
54.8±9.4* 
94.2±1.5* 
100.0±0.0* 
100.0±0.0* 
 
67.0±4.9* 
98.4±0.1* 
100.0±0.0* 
100.0±0.0* 
 
61.3±2.8* 
97.7±1.4* 
100.0±0.0* 
100.0±0.0* 
HLP 
0.01% 
0.10% 
1% 
 
4.6±7.5 
9.0±5.7 
15.3±2.8* 
 
90.3±8.3* 
91.2±8.2* 
91.6±11.7* 
 
38.5±3.1* 
42.4±9.9* 
48.7±7.5* 
NaOx 
0.01% 
0.05% 
 
49.6±3.5* 
91.0±5.3* 
 
98.0±3.4* 
96.0±3.5* 
 
73.8±4.3* 
93.7±4.5* 
 
Table 1.4. The incidence of crystal formation for different lithogenic agents 
in Drosophila. Adapted from (Chen et al., 2011). Abbreviations: EG, ethylene 
glycol; HLP, hydroxyl-L-proline; NaOx, sodium oxalate. *A probability, P-value 
of 0.05, was considered significant compared with control. Values were 
expressed as means±SEM. Statistical evaluation was performed using one-way 
analysis of variance (ANOVA) followed by Bonferroni test. 
 
 
 
Adult Drosophila supplemented with EG produced CaOx concretions in as little 
as 6 h (Chung et al., 2016). Feeding Drosophila larvae with sodium oxalate 
dissolved in standard growth media resulted in CaOx microliths within 2 days 
(Hirata et al., 2012). However, adult flies fed with sodium oxalate develop 
crystals within an hour. Polarised light applied to dissected MTs permits the 
visualisation and quantification of the stones (Bagga et al., 2013, Miller et al., 
2013). 
b. Genetic models of stone diseases 
The previously established GAL4-UAS (details in section 1.6.2.1) transgenic 
expression system allows researchers to perform targeted gene knockdown in 
Drosophila in relation to stone formation in a particular cell type or tissue of 
interest (Brand and Perrimon, 1993). With the immense resources available for 
Drosophila, investigators can directly order their desired transgenics to express 
or silence specific gene end products. Besides that, cost and time efficiency 
also make this model an ideal as compared to available model organisms (Dow 
and Davies, 2001, Dow and Romero, 2010).  
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Numerous inborn metabolic diseases such as hyperoxaluria, cystinuria, and 
hyperaminoaciduria (Fanconi syndrome) manifest with the urinary stone disease 
in humans. Although these disorders are rare, exploring the genetic basis of 
these diseases in Drosophila may reveal mechanisms underlying stone 
formation and its regulation that are common to other stone types. 
1) Hyperoxaluria: As in the mice model, mSLC26A6 is an essential oxalate 
transporter in flies. Hirata and colleagues have shown that Drosophila 
Prestin (dPrestin) is the homologue of mSLC26A6 (Hirata et al., 2012, 
Monico et al., 2008). Drosophila Prestin has been shown to act as a 
chloride/oxalate exchanger, analogous to the role of the apical SLC26A6 
Cl-/Ox2- exchanger in the human kidney (Brand and Perrimon, 1993). 
Knockdown of dPrestin, mainly in the principal cells of the initial and 
main segments of the anterior MTs resulted in the reduction of calcium 
oxalate stones (Hirata et al., 2012).  
2) Xanthinuria: Xanthinuria types I and II are a rare autosomal recessive 
defect in purine metabolism, i.e. deficiency of xanthine oxidase which 
results in the accumulation of xanthine and hypoxanthine stones 
(Levartovsky et al., 2000, Ichida et al., 2001). In xanthinuria type I, 
there is a deficiency of xanthine dehydrogenase, causing 
hyperxanthinemia with low or absent uric acid and xanthinuria, leading 
to urolithiasis (Aggarwal et al., 2017, Chi et al., 2015). The gene 
responsible for type I xanthinuria has been localised to chromosome 
2p22-23 (Ichida et al., 1997). Utilising the fly GAL4/UAS system, Thomas 
et al. have silenced xanthine dehydrogenase enzyme in flies, which 
resulted in the formation of xanthine stones. They performed a series of 
experiments showing/demonstrating that flies can be an essential model 
for the study of xanthine stones. 
Stone composition 
1) Calcium oxalate and hydroxyapatite: As described in the rodent feeding 
flies with a stone causing lithogenic agents as described in Error! R
eference source not found. results in the formation of calcium oxalate 
crystals in the MTs (Chen et al., 2011). Studies using X-Ray diffraction, 
37 
 
scanning electron microscopy (SEM) and energy-dispersive X-ray 
spectroscopy (EDS) can also be used to identify crystal deposition and 
composition in flies (Chi et al., 2015, Wessing et al., 1992). Hence in 
flies, calcium-based stones, as well as non-calcium based human stones, 
may be generated from a hydroxyapatite nidus (Evan, 2010). This finding 
highlights potential similarities between Drosophila fly stone and human 
stones (Tzou et al., 2016a).  
2) Zinc stones: The majority of human stones are composed of oxalate or 
uric acid stones. However, other minerals have essential roles in stones 
formation (Chi et al., 2015). Analysing the mineral components of fly 
concretions, human Randall's plaques, and human xanthine stones 
demonstrated that calcium (Ca), magnesium (Mg) and zinc (Zn) were the 
major metal components within each specimen (Wang et al., 2009). 
Inductively coupled plasma optical emission spectroscopy (ICP-OES) 
showed that the relative amount of each of these metals was consistent 
across the stone source. Additionally, it has been shown that there are 
traces of zinc in the food which is responsible for stones formation (Yin 
et al., 2017). Additionally,  three Drosophila ZnT transporters (CG3994, 
CG11163, and CG17723) have been reported to be highly expressed in 
the MTs. Their function is to regulate Zn movement across the cell 
membrane (Wang et al., 2009, Yepiskoposyan et al., 2006).  
1.5.3.2 Limitations of the Drosophila model 
Despite having many benefits in terms of reliability, duration and cost-
effectiveness, there are some limitations to its use and applicability. As an 
invertebrate, Drosophila does not have bones, and hence, they lack a calcium 
reservoir, so it becomes hard to compare the calcium metabolism as well as 
transport across the tubules. Next, the fly is not an ambulatory model and 
relies on a different feeding cycle compared to humans. Additionally, it can be 
challenging to measure how much food and medication that Drosophila ingest. 
Another limitation is that since the fly's MTs drain into the hindgut, there is a 
combination of waste products in a single-elimination chamber and the GI tract 
can contribute to the elimination of electrolyte and water waste.  
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1.6 Drosophila melanogaster 
1.6.1 History of Drosophila melanogaster  
Drosophila melanogaster (fruit fly or vinegar fly) has been extensively used for 
scientific research since 1910 when Thomas Morgan described Drosophila’s first 
mutant, white (Morgan and Bridges, 1916). In 1933 he was awarded the Nobel 
Prize for his work in sex-linked gene transmission in Drosophila. In 1927, Muller 
studied the hereditary characteristics of fruit flies and demonstrated that 
mutations and hereditary changes could be caused by X-ray. in 1946, Muller 
was awarded the Nobel Prize in physiology or medicine for the same. Again in 
In 1995, the Nobel Prize in Medicine was awarded to Dr Edward Lewis, 
Christiane Nuesslein-Volhard, and Eric Wieschaus, for discovering the genes 
playing a vital role in embryonic development (Lewis, 1978, Nüsslein-Volhard 
and Wieschaus, 1980). Importantly, these genes have human homologues and 
also have an essential function in development. Again in 2011, Jules Hoffmann 
was awarded Noble prize for his contribution in immunology in understanding 
how human and other organisms protect themselves from the attack of bacteria 
and other organisms. Recently in 2017, The Nobel Prize in Physiology or 
Medicine was awarded jointly to Jeffrey C. Hall, Michael Rosbash and Michael 
W. Young for their discoveries of the molecular mechanism controlling 
Drosophila circadian rhythm. Hence it is apparent that Drosophila is one of the 
most intensely studied organisms in biology and has provided essential general 
insights into developmental and cellular processes including neuroscience 
(Crocker and Sehgal, 2008), immunity (Davies and Dow, 2009), sex 
determination and development (Telonis-Scott et al., 2009), circadian cycle 
(Sofola et al., 2008), insecticide resistance (Yang et al., 2007),renal function 
(Terhzaz et al., 2012, Dow et al., 1994) and neurodegenerative researches 
(Brumby and Richardson, 2005, Reiter et al., 2001).  
1.6.2 Drosophila as a genetic model 
The availability of a complete genome sequence published in 2000, as well as a 
number of stock centres that can provide strains that carry a mutation in the 
given gene, makes this model an ideal organism for genetic research. 
Furthermore, the friendly nature of Drosophila researchers worldwide having a 
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common philosophy of making their resources available to other research 
groups by sharing it makes this community close and intact.  
Therefore, Drosophila is considered as an ideal model for studying human 
disease genes, applying the genetic approach. In addition to the advantages 
mentioned in section 1.5.3, some of the critical reasons behind using 
Drosophila as a model organism are:  
a. The life cycle of Drosophila is short (around 2 weeks at 22 °C). Hence, it 
permits investigation for several generations in a relatively short period. 
Additionally, they are small (2-3 mm long); hence, a considerable 
number of flies can be kept in small vials.  
b. Cost - maintenance of fly lines is inexpensive ($20 per year per fly line) 
and relatively easy as compared to other model organisms. For example, 
it costs >$10K/year to keep a single strain of transgenic mouse. 
c. In terms of genetics, Drosophila is well defined, with the complete 
sequence of the genome published in 2000 (Adams et al., 2000). This 
makes Drosophila a more comprehensive model with the well-annotated 
genome, easily manipulated transgenes and an excellent pedigree of 
physiology. Additionally, about 70% of Drosophila genes (around 13,500) 
have human homologues (Chien et al., 2002). 
d. Drosophila is genetically very pliable; gene manipulation has been 
accessible with the use of transposable elements (e.g., P-elements) 
(Rubin and Spradling, 1982, Spradling and Rubin, 1982). Systemic 
mutagenesis has been directed to the production of RNAi lines for nearly 
all Drosophila genes (Dietzl et al., 2007). These lines are available from 
Drosophila stock centres such as the Vienna Drosophila RNAi Centre 
(VDRC) and the Bloomington Drosophila Stock Centre (BDSC) for a 
minimal cost (Dow and Romero, 2010). 
e. Presence of specific online resources including Flybase 
(http://flybase.org/) (Drysdale et al., 2005), FlyAtlas 
1(http://flyatlas.org/atlas.cgi) (Chintapalli et al., 2007) and FlyAtlas 2 
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(http://flyatlas.gla.ac.uk/FlyAtlas2/index.html) (Leader et al., 2017) 
providing information on gene sequences, transcriptomic data and 
expression of genes in different tissues. Additionally, FlyBase also 
provides information about RNAi (RNA interference) knockdown lines, 
mutant alleles, human disease homologues, etc.  
1.6.2.1 The UAS/GAL4 system 
GAL4 is a yeast transcriptional factor, which activates transcription 
downstream of the yeast promoter Upstream Activating Sequence (UAS) in 
Drosophila. GAL4 does not normally activate Drosophila promoter sequences 
but is capable of driving transgene expression under the control of a UAS 
promoter. P-elements are frequently used in conjunction with the UAS/GAL4 
binary system (Brand and Perrimon, 1993). By cloning a transgene into a P-
element construct downstream of a UAS promoter, it is possible to control 
transgene expression using a GAL4 driver to knockdown or overexpress any 
gene of interest with cell and tissue specificity, Figure 1.4. 
The first GAL4 ‘driver’ line was developed by Brand and Perrimon as an 
enhancer trap GAL4 construct (the original P-element plasmid; pGAWB) (Brand 
and Perrimon, 1993). In the last 25 years, an impressive array of GAL4-driver 
lines has been constructed by modifying pGAWB. It is now possible to drive 
transgene expression from a subset of neural cells to a whole organ, depending 
on your tissue of interest. There are many advantages to maintaining GAL4 
lines with specific temporal and spatial expression patterns. Driver lines can be 
maintained as stable stocks and used to drive expression in any fly line 
containing a transgene with a UAS promoter, reducing the complexity of 
cloning when making a new fly line. Many UAS transgenes are lethal or 
debilitating when expressed in Drosophila and would be difficult or impossible 
to maintain if both the GAL4-driver and UAS-transgene elements were inserted 
in the same line. Maintaining them in separate parental fly-lines means they 
are much more likely to be viable. It also allows the experimenter to change 
the UAS-transgene expression pattern by crossing to different GAL4 parental 
lines, which is much easier than making and microinjecting a new construct 
with a different driver. 
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Figure 1.4. The GAL4/UAS system used for targeted gene expression. To 
obtain flies expressing a gene of interest ("Gene X") in a tissue-specific pattern, 
flies must both contain a transgene expressing the GAL4 transcriptional 
activator protein under the control of a tissue-specific enhancer, and a 
transgene containing the GAL4 DNA binding sequence adjacent to the reporter 
gene. The target gene is silent in the absence of GAL4. To activate the target 
gene in a cell- or tissue-specific pattern flies carrying the target (UAS-Gene X) 
are crossed to flies expressing GAL4 (Enhancer Trap GAL4). In the progeny of 
this cross, it is possible to activate UAS-Gene X in cells where GAL4 is 
expressed and to observe the effect of this directed misexpression on 
development. Reproduced with permission from (Brand and Perrimon, 1993). 
 
 
The UAS/GAL4 system can be used to express full gene sequences for protein 
over-expression, with or without additional tags. It can also be used for gene 
knockdown through the action of a specific double-stranded RNA (dsRNA). RNAi 
lines can be made by inserting a double-stranded hairpin loop sequence into a 
P-element so that it expresses a dsRNA when driven (Kennerdell and Carthew, 
2000). Dicer recognises the dsRNA and breaks it down, along with any other 
RNA which contains the same sequence as the dsRNA. This decreases the 
amount of that particular transcript, effectively suppressing the expression of 
that gene.  
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In summary, when these two systems (UAS and GAL4) or in another word two 
flies containing different components are crossed together, they will give rise 
to progeny that have both components. This, in turn, activates the transgene 
under the control of UAS in a GAL4-specific expression manner. As the GAL4 
expression depends on the upstream elements, it was inserted or fused with; 
this system is useful in elucidating tissue- and cell-specific functions. For 
example, ClCa-GAL4 can be placed under the control of the Sip1 gene promoter 
as this gene is expressed exclusively in the MTs; the ClCa-GAL4 line drives 
transgene expression with exquisite precision in stellate cells (Dow and Davies, 
2003).  
1.6.2.2 Balancer Chromosomes 
One of the advantages of Drosophila genetics is the presence of balancer 
chromosomes. They prevent recombination and enable the maintenance of 
deleterious mutations in stable fly populations. This is due to the presence of 
chromosomal inversions in the balancers, which prevent the formation of 
crossovers. As a result, there is no recombination between homologues 
chromosomes, and the mutation is maintained. Since most recessive mutations 
have no phenotype, balancers allow the geneticists to indirectly follow the 
recessive mutation (by scoring dominant markers on the balancer) without 
losing the mutation (due to inhibited recombination). Balancers are also used 
to maintain chromosomal deficiencies that would otherwise be lethal due to 
the deficiency. Moreover, they carry visible dominant marker genes (such as 
curly wings or stubbly bristles), which enable selection of progeny, which 
inherited the balancer. Balancer chromosomes also carry at least one recessive 
lethal locus in order to maintain mutations in the stocks (Dow and Davies, 
2003). 
1.6.3 Malpighian tubules 
Similar to many other insects, the central excretory tissue in Drosophila is the 
Malpighian tubules (MTs), which performs a renal role analogous to the 
vertebrate kidney (Figure 1.5). The tubules transport excess fluid and solutes 
from the haemolymph and secrete the primary urine into the hindgut for 
excretion. They are an excellent model not only for morphogenesis of epithelia 
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in general but also for transport mechanisms and maintenance of homeostasis, 
especially in D. melanogaster (Dow and Davies, 2003, Dow et al., 1994), which 
have helped elucidate biological functions at both tissue and single-cell level. 
 
 
Figure 1.5. Schematic diagram of D. melanogaster excretory tract. Two 
pairs of Malpighian tubules, one anterior and one posterior, are each connected 
to the gut by a common ureter. All the segments are clearly labelled in the 
image. Adapted from (Sözen et al., 1997). 
 
 
 
1.6.3.1 History 
The Malpighian tubules are named after Marcelo Malpighi (1628-1694), who was 
a physician of the Pope, 500 years ago. Besides his work as a comparative 
anatomist, he was a pioneer in the use of microscopy, contemporaneously with 
Hooke, and followed the discoveries of William Harvey on the nature of 
circulation. This interest allowed him to apply his skills in microscopy to 
investigate insect anatomy, which further resulted in the discovery of the 
Malpighian tubules. However, it was not demonstrated until the 20th century, 
that they could produce urine. Since then, tubules have been extensively 
studied for their excretory and osmoregulatory functions. Furthermore, various 
research has been conducted using insect tubules as an epithelial system and a 
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targeted organ for insecticide development (Dow and Romero, 2010, Miller et 
al., 2013). 
 
1.6.3.2 Morphology 
Drosophila has two pairs of MTs, which are tubular and blind-ended epithelia 
joined in pairs by a short common ureter to the alimentary canal, which floats 
freely in the haemocoel (Wessing and Eichelberg, 1979). Each fly possesses a 
pair of anterior and posterior tubules, which contribute equally to tubule 
function (O'Donnell and Maddrell, 1995). A single Malpighian tubule is 
approximately 2 mm in length, with an inner luminal diameter of 17 µm (Figure 
1.6).  
 
Figure 1.6. Overview of the Drosophila Malpighian tubules showing the six 
domains of the tubule and the numbers of principal and stellate cells in 
each. Adapted from (Sözen et al., 1997). 
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The anterior and posterior tubules can be divided morphologically into three 
segments; the initial segment, the transitional segment and the main segment, 
which joins to the common ureter to the alimentary canal (Miller et al., 2013). 
In contrast to anterior tubules, the posterior pairs have a short initial segment 
(Weiss et al., 1988, Wessing and Eichelberg, 1979). Furthermore, there is no 
apparent morphological difference between male and female tubules, although 
females have bigger size tubules. The main segment of the tubules is composed 
of two cell types; the large principal cells and the star-shaped stellate cells. 
The principal cells have deep basal infoldings and long apical microvilli and are 
more abundant than the stellate cells (Cabrero et al., 2014). The stellate cells 
are comparatively small and thin, with shallow basal infoldings and short apical 
microvilli (Wessing and Eichelberg, 1979). Enhancer trapping has been used to 
investigate the morphology of the tubule and cell-types in great detail, 
including the bar-shaped cells and tiny cells in the tubule (Singh et al., 2007, 
Sözen et al., 1997). 
1.6.3.3 Physiology 
The Malpighian tubules perform a multitude of physiological roles in 
Drosophila, from the normal renal and hepatic roles (detoxification) to a 
surprising role in immune response (McGettigan et al., 2005). Osmoregulation 
and ion homeostasis are arguably the defining functions of the tubules, as they 
are performed continually throughout the lifecycle of the fly. Active cation 
transport by the tubules is described by the Wieczorek model (Wieczorek et 
al., 1999, Wieczorek et al., 2009). The model suggests that the principal cells 
use the apical proton-pumping activity of the Vacuolar ATPase (V-ATPase) to 
build a favourable transport gradient (Wieczorek et al., 1991, Wieczorek et al., 
1999). Apical alkali metal-proton exchangers are then able to drive potassium 
into the tubule lumen, with water following the potassium due to the osmotic 
gradient. The Wieczorek model seems to fit the experimental tubule data in 
Drosophila, as V-ATPase inhibitors abolish fluid secretion (Dow et al., 1994), 
and the V-ATPase subunits are highly enriched and expressed in the principal 
cells (Wang et al., 2004). 
The principal cells are also involved in the active transport of cations 
(O'Donnell and Maddrell, 1995, Evans et al., 2005). These cells are 
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concentrated in the main segment of the tubule and contain basolateral ion 
cotransporters for Na+, K+ and Cl- as well as a Na+ dependent solute transporter 
and a Na+ dependent Cl-/HCO3- exchanger (Sözen et al., 1997). Ion transport at 
the apical cell membrane of the principal cell is accomplished via vacuolar-
type H+-ATPase (Dow et al., 1997), which pumps protons from the cell into the 
lumen, providing the gradient necessary for the secondary movement of Na+ 
and K+ into the lumen by the Na+/H+ and K+/H+ exchangers (Romero et al., 
2000) Figure 1.7. 
The stellate cells appear to be the site of transcellular chloride shunt and 
therefore, water movement (Dow et al., 1997). The stellate cells, which are 
more evenly distributed throughout the initial, transitional and main segments 
of the posterior Malpighian tubules, provide mainly chloride transport and 
water conductance (Dow and Romero, 2010). Chloride shunt is controlled by 
the hormone Drosokinin and the second messenger intracellular Ca2+, which 
increase transcellular conductance through chloride channels (Terhzaz et al., 
1999, Cabrero et al., 2014). 
 
Figure 1.7. Drosophila Malpighian tubule morphology. A. Spatial organisation 
of the Drosophila tubule as evidenced by scanning electron microscopy, with 
superimposed illustrations of principal and secondary cells. B. Classic two-cell-
type model: fluid transport is energised by a vacuolar H+-ATPase (V-ATPase) 
located in the apical membrane of PCs (grey), which through a K+/H+ 
exchanger, drives net secretion of K+ into the lumen. Reproduced with 
permission from (Halberg et al., 2015). 
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1.7 The aim of the study 
1.7.1 General Study Objective 
The prevalence of nephrolithiasis is increasing yearly; however, our 
understanding of the pathophysiology has not kept pace, and new therapeutic 
approaches have not emerged. Hence, the overall objective of this dissertation 
is to study the genetic and environmental cause of kidney stone formation 
using Drosophila as a model organism. Here, we establish a Drosophila 
melanogaster model for stones formation by using genetic, molecular, 
pharmacological and biochemical studies to open a novel perspective on the 
aetiology of urinary stones and related diseases, which may lead to the 
identification of new preventive and therapeutic approaches. 
1.7.2 Specific study Objectives 
There are four specific study objectives: 
1. Identification of the genes involved in nephrolithiasis. 
The ‘sensitised background’ in which stones form spontaneously at a low 
dose, will be used to screen RNAi and/or mutant panels for genes that 
increase or decrease the rate of oxalate stone formation, identify the 
genes responsible and seek homologous human candidate gene loci. This 
thesis will provide in detail description and validate the use of D. 
melanogaster as the model system for a screen of different genes in 
stones formation. 
2. In-depth study of selected genes involved in the renal stone 
accumulation 
By choosing candidate genes (objective 1), genetic and physiological 
experiments will be performed to determine their role in different types 
of stones accumulation. It is hypothesised that knockdown or 
overexpression of a gene will increase or decrease stone quantity. 
Further, it can be believed that under this objective, the results will 
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represent two distinct phenomena, a. Determination of the 
pathophysiological role of the gene in stone formation b. Mechanism of 
stone formation and accumulation.  
3. Identification of the role of temperature and age in the stone 
development 
To assess whether the risk of calcium phosphate deposition alters with 
environmental factors flies were reared at different temperature for a 
different time and the stone formation was quantified. It is hypothesised 
that the rate of the stone formation deviates with age and temperature 
of residence. This allows elucidating the complex interplay between 
proteins, minerals, genes and environmental exposures which are known 
to influence kidney stone formation. 
4. Identification of the role of Sip1 in kidney stones formation 
In humans, Sodium hydrogen Exchanger Regulatory Factor 1 (NHERF1), a 
homologue of Drosophila Sip1, is linked to nephrolithiasis. However, the 
function of Sip1 in Drosophila has not been previously investigated. 
Here, we have identified the role of Sip1 in uric acid stone formation 
and established a mechanism behind it.  
These research studies should improve our understanding of the genetic, 
physicochemical and physiological factors that may lead to the formation 
of a stone. 
1.8 Study Hypothesis 
1. Given the similarities in tubular structure, function and physiology; 
conservation of genes in the excretory system, and characteristics of 
stone formation between D. melanogaster and humans, and the 
availability of powerful genetic tools in the fly, we hypothesize that D. 
melanogaster can be utilized as a meaningful model to improve 
understanding of kidney stone disease and to identify novel 
therapeutics.  
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2. It is hypothesized that mutation of the gene causes formation or 
precipitation of kidney stones; while it is not revealed whether its 
monogenic or polygenic. This study will determine how mutation of gene 
causes calcium oxalate, uric acid and phosphate stones and how long the 
does it take to form the stones. If stone formation occurs due to 
mutation of the gene, it would be beneficial to determine the role of a 
gene in calcium oxalate or phosphate or uric acid precipitation. 
3. Heat and temperature are one of the risk factors for kidney stone 
formation. We hypothesise that change in temperature (from colder to 
warmer, low temperature to higher temperature) may have a more 
significant impact on the formation rate of nephrolithiasis. 
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Chapter 2 Materials and Methods 
 
2.1 Summary 
This chapter describes the protocols used during the experiments mentioned in 
this thesis. Further, it summarises the rearing conditions of Drosophila 
melanogaster and describes novel methods which play an essential role to 
validate Drosophila as a model for kidney stone formation studies. Relevant 
references were used for methods where applicable. 
2.2 Drosophila melanogaster 
2.2.1 Drosophila stocks 
The detailed description of all the Drosophila stocks used in this work can be 
found in Error! Reference source not found., including their fly ID, genotype, d
escription and the source of origin along with references. A full description of 
all mutations and balancer chromosomes used can be found in FlyBase 
(http://www.flybase.co.uk). 
Strain Genotype Description Origin 
Canton S w;+/+;+/+ Wildtype DD 
Actin-GAL4 
 
w;actin-GAL4/CyO; 
+/+ 
 
Ubiquitous GAL4 driver 
 
BDSC 
 
CapaR-GAL4 w-; +/+; CapaR-
GAL4/ 
CapaR-GAL4 
Expression of GAL4 to 
the 
tubule principal cells 
DD 
ClCa-Gal4 w-; +/+; CapaR-
GAL4/ 
C;Ca-GAL4 
Expression of GAL4 to 
the 
tubule Stellate cells 
DD 
Rosy ry 506  DD 
UAS-CG10939 RNAi  Knocks down CG10939 
expression by RNAi 
BDSC, 
VDRC 
Sip1 mutant Sip15a / CyO   
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NHE2 RNAi  Knocks down NHE2 
expression by RNAi 
BDSC 
UAS-Moe RNAi  Knocks down Moesin 
expression by RNAi 
BDRC 
Dihydropterin 
deaminase (DhpD); 
(CG18143) 
y-w-
;P{KK108461}VIE-
260B; +/+ 
 
Knocks down DhpD 
expression by RNAi 
VDRC 
w; 
CG18143/CyO;+/+ 
BDSC 
 
Water witch 
(Wtrw); (CG31284) 
y-w-
;P{attP,y+,w3'}VIE-
260B; +/+ 
Knocks down Wtrw 
expression by RNAi 
VDRC 
W-; +/+; 
CG31284/CG31284 
BDSC 
 
CG11374 y-w-
; P{GD5055}v15561; 
+/+ 
Knocks down CG11374 
expression by RNAi 
VDRC 
w-
;CG11374/CyO;+/+ 
BDSC 
 
Serine pyruvate 
aminotransferase 
(Spat);(CG3926) 
 
y-w-
;P{KK107941}VIE-
260B; +/+ 
Knocks down CG3926 
expression by RNAi 
VDRC 
y1 v1; 
CG3926/CG3926; 
+/+ 
BDSC 
 
Cinnamon (Cin); 
(CG2945) 
 
y-w-
;P{KK102795}VIE-
260B;+/+ 
Knocks down cin 
expression by RNAi 
VDRC 
y1 v1; +/+; 
CG2945/TM3 
BDSC 
 
Molybdenum 
cofactor synthesis 
1 (Mocs1); 
(CG33048) 
w; CG33048/CyO; 
+/+ 
Knocks down Mocs1 
expression by RNAi 
BDSC 
 
Carbonic 
anhydrase 1 
(CAH1); (CG7820) 
W;P{KK108727}VIE-
260B;+/+ 
Knocks down CAH1 
expression by RNAi 
VDRC 
Sarcoplasmic 
calcium-binding 
protein 2 (Scp2); 
(CG14904) 
 
w1118; 
P{GD7705}v31916;+
/+ 
Knocks down Scp2 
expression by RNAi 
VDRC 
Na+-dependent 
inorganic 
w;P{KK106711}VIE-
260B;+/+ 
Knocks down NaPi-T 
expression by RNAi 
VDRC 
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phosphate 
cotransporter 
(NaPi-T); 
(CG10207) 
W;+/+; 
CG10207/TM3, Sb1 
BDSC 
 
Secretory Pathway 
Calcium ATpase 
(SPoCk); 
(CG32451) 
y-w-
;P{KK101068}VIE-
260B; +/+ 
Knocks down SPoCk 
expression by RNAi 
VDRC 
y1 v1; +/+; 
CG32451/TM3 
BDSC 
 
 
Table 2.1. Drosophila melanogaster stocks used for the experiments in this 
thesis. VDRC: Vienna Drosophila Research Center, BDSC: Bloomington 
Drosophila Stock Center, DD: Dow/Davies lab (In house). 
 
 
 
2.2.2 Drosophila husbandry 
All the stocks of D. melanogaster (section 2.2.1) were maintained in standard 
conditions unless otherwise specified. An ideal fly husbandry room was tightly 
regulated with 22°C, 55% atmospheric humidity and a 12:12 h light: dark cycle. 
Flies were fed with the standard Drosophila diet (composition listed in Table 
2.2). 
Initially, 5-7 days old flies were transferred to vials containing freshly prepared 
food. The flies were transferred to another vial every two weeks to maintain 
the stock unless flies of specific age where required. For the collection of 
newly emerged flies, a laying population of around 15 females and 10 males 
were kept in a vial for 5 days and then transferred to next vial. When the new 
flies emerged from larvae and pupae stage after 10 days, the 1-day old progeny 
was collected in vials. This allowed us to determine the age of the flies and 
perform age-related experiments. All the flies referred to as adult flies 
throughout the thesis are 5-7 days old flies reared in the standard Drosophila 
diet unless otherwise mentioned.  
2.2.2.1 Rearing for age and temperature vs Kidney stones formation 
experiment 
1-day old flies (newly emerged) were subjected to 18°C, 22°C, 26°C and 28°C 
and they were maintained at that same temperature for 21 days unless 
mentioned. Furthermore, for the temperature switch experiment, flies were 
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transferred to another temperature every week, to observe an alteration in 
stones accumulation. Detailed rearing conditions are described in Chapter 4.  
2.2.3 Drosophila diet 
Flies were reared on standard Drosophila diet composed of yeast cornmeal, 
sucrose and agar medium. The recipe of standard diet is enlisted in Table 2.2. 
While preparing the food, all the recipes were mixed and boiled in 1 litre of 
water, and the mixture was let to simmer for 10 mins. Then the food was left 
to cool down at 70°C for about 20 minutes, before adding Nipagin and 
propionic acid. Finally, the food was kept in 50 ml vials and stored at 4°C.   
Per 1 litre of food recipe 
1. 10 g agar 
2. 15 g sucrose 
3. 30 g glucose 
4. 35 g dried yeast 
5. 15 g maize meal 
6. 10 g wheat germ 
7. 30 g treacle 
8. 10 g soy flour 
9. 10 ml Nipagin (25 g Nipagin M (Tegosept M, p-hydroxybenzoic 
acid methyl ester) in 250 ml Ethanol] 
10. 5 ml Propionic acid 
 
Table 2.2. The composition of fly food. Adapted from (Cabrero et al., 2014). 
 
2.2.3.1 Preparation of the diet containing Sodium oxalate 
For the induction of calcium oxalate stones within the MTs, we introduced 
Sodium Oxalate in the regular Drosophila diet. Different concentration of Na-
oxalate (0.1% low; 1% high) were dissolved in 100 ml of standard Drosophila 
diet. The food was kept at 100°C with continuous stirring for 20 minutes in 
order to mix thoroughly. Then the food was kept in the glass tubes, and the 
diet was left to set. Diet was freshly prepared to avoid any changes in the 
concentration of salts due to evaporation/precipitation.  
2.2.3.2 Preparation of the diet containing Allopurinol 
Allopurinol, containing food used was also freshly prepared before each 
experiment. Allopurinol [4-hydroxypyrazolo (3,4-d) pyrimidine; Sigma] was 
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dissolved in standard Drosophila diet to make final concentration 250 ng/ml 
(Zhou and Riddiford, 2008). At this concentration our flies can phenocopy rosy 
mutant flies. To prevent the irregular distribution of the drug and make the 
solution homogenous, drug was kept in the bottle with constant stirring for 
about 20 minutes. Then, 5 ml of the mixed solution was added to the vial and 
was kept at room temperature for 1 day in order to allow allopurinol to be 
completely absorbed. Flies were fed with allopurinol for 48 hours to observe 
the therapeutic effect. 
2.2.4 Drosophila crossing 
For the expression of the gene of interest in a particular tissue in Drosophila, 
the UAS-GAL4 binary system (section 1.6.2.1) was employed (Brand and 
Perrimon, 1993) Virgin female flies of UAS-RNAi lines were crossed to GAL4 
males. Flies were kept at 26°C for 4 days, and the parental lines were 
transferred to next vials to prevent mixing with the progeny. F1 progeny from 
the cross was used for experiments as a knockdown fly while UAS-RNAi/+ and 
UAS-Gal4/+ were regarded as parental controls . The presence of transgene or 
knockdown was evaluated by visual markers and validated by qPCR 
(quantitative PCR), respectively. 
In order to collect adult virgin female flies, an egg-laying population of around 
10 male and 20 females were transferred to the new vials every 3 days. The 
progeny which emerges from the vials were collected every hour, and virgin 
female flies were selected. The reciprocal crosses were also made, to test for 
sex-specificity of gene expression, though this was not observed in this project. 
Typical examples of GAL4-UAS crosses and selection of appropriate progeny as 
described below. After mating, flies laid sufficient eggs and adults were 
transferred into new vials leaving the first vial with larvae. The newly 
transferred flies were left for several days until sufficient eggs were laid. This 
process took approximately five to ten days. 
Example of a cross: 
ClC-a Gal4 is Drosophila Malpighian tubule SC specific Gal4 driver. 
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1. UAS and GAL4 driver lines on different chromosomes 
2. UAS and GAL4 driver on the same chromosome 
 
Flies with straight wings were selected from this cross and used for 
experimentation. 
2.2.5 Drosophila tissue dissection 
Adult flies were anaesthetised on ice and transferred to a Petri dish containing 
Drosophila Schneider’s medium (artificial hemolymph). Malpighian tubules 
were easily dissected by holding a fly firmly by forceps from the thorax region 
and with the other hand, pulling the very end part gently and slowly. At this 
point, the Malpighian tubules start to appear, attached in between midgut and 
Flies with long bristles were selected from this cross and used for 
experimentation. 
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hindgut. The tubules were then pulled out, and the joint between tubules and 
gut was cut with great care, gently hold the tubules from the ureter (Figure 
2.1). Importantly, the MTs should be intact for stone imaging experiments. The 
number of flies dissected for MT collection varied with each experiment. This 
method was adopted as per previous research articles (Dow et al., 1994, 
Sullivan and Sullivan, 1975). 
 
Figure 2.1. MTs dissection method.  
 
2.2.6 Slide preparation 
Following the dissection, tubules were mounted on glass slides and immediately 
transferred to Poly-L-lysine coated slides containing a drop of PBS (pH 7.4). The 
process of preparation of the slide is shown in Figure 2.2. Once the slide 
samples were prepared, they were imaged and analysed. 
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Figure 2.2. The process of preparation of glass slides and tubule samples. 
 
 
2.2.7 RNA interference kidney stone screen a candidate gene in 
vivo RNAi screen  
Candidate genes were screened for impact on oxalate stone deposition by using 
20 different RNAi lines (Error! Reference source not found.) driven by a t
ubule  principal cell-specific GAL4 line (CapaR-GAL4). Each transgenic fly strain 
containing inducible UAS-hairpin RNA elements on their chromosomes towards a 
single coding protein sequence was obtained from the Bloomington or Vienna 
Drosophila RNAi Center.  Knockdown flies were transferred to a fresh Sodium 
Oxalate containing diet and the tubules assessed for concretion formation. 
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2.3 RNA extraction 
Messenger RNAs (mRNAs) were extracted using the Qiagen RNeasy Mini 
extraction kit following the manufacturer’s instructions. RNA was extracted 
from Malpighian tubules as well as from whole flies, depending on experimental 
requirements and detailed below.  
2.3.1.1 RNA extraction from whole flies  
Adult flies were collected and then homogenised using a micropestle in an 
eppendorf containing 1 ml of Trizol (Life Technologies, UK). The homogenate 
was kept at the room temperature (RT) for 5 minutes, and 200 μl of Chloroform 
was added to the solution. The mixed solution was centrifuged at 12000 g at 
4°C for 15 min. The aqueous upper layer was transferred to a new 1.5ml 
eppendorf without touching the interface. Isopropyl alcohol (one half) was then 
added, followed by precipitation at RT for 10 min. The samples were then 
centrifuged at 12000 g and 4°C for 10 min. After removing the supernatant, the 
pellet was washed with 70% ice-cold ethanol and vortexed. Following 
centrifugation at 8000 g and 4°C for 5 min, the supernatant containing ethanol 
was discarded without disturbing the pellet. In order to remove any residual 
ethanol, the pellet was air-dried at RT for ∼5 min and then resuspended in 30 
μl of RNase-free water and gently mixed. Extracted RNA was immediately used 
for cDNA synthesis. Remaining RNA was stored at -80°C. 
 
2.3.1.2 RNA extraction using Malpighian Tubules 
Messenger RNA (mRNA) was extracted from 50-60 pairs of Malpighian tubules 
using the Qiagen RNA extraction kit according to the manufacturer’s 
instructions (Qiagen, UK). All the experiments were conducted in a nuclease-
free environment.  
After obtaining RNA, the total mRNA concentration and purity was analysed 
using Nanodrop TM 1000. The concentration was measured on the assumption 
that an OD of 1 at 260 nm corresponds to 50 μg/ml for DNA and 40 μg/ml for 
RNA. The same elution solution (used in the samples) was used as a control; 
hence, the value was balanced to zero. The purity was checked by the ratio of 
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A260/280. Values of 1.8 and above for DNA and 2.0 and above for RNA were 
considered as of acceptable purity. 
 
2.4 cDNA isolation 
First strand cDNA (complementary DNA) was synthesised from messenger RNA 
using the reverse transcription reaction protocol as described by manufacturers 
(Qiagen, UK). The reverse transcription reaction contained: 500 ng of total 
RNA, 0.2 mM of each dNTP (Promega), 40 U RNase OUT (Invitrogen), 10 mM 
dithiothreitol (DTT), 1X first strand buffer (Invitrogen), 1X oligo-dT (IDT, U.K.), 
final volume made up with nuclease-free water to 19 μl. The mixture was 
mixed by pipetting and incubated at 42˚C for 10 min, cooled on ice for 5 min 
and 1 μl of Superscript II RNase H- Reverse Transcriptase (Invitrogen) was 
added to each reaction tube. The reaction was incubated at 42˚C for 50 min 
and then incubated at 70˚C for 15 min to stop the reaction. The cDNA was 
subsequently quantified and stored at -20˚C. 
 
2.5 PCR 
Polymerase Chain Reaction (PCR) is used to amplify specific regions from a DNA 
template. The area of amplification was designated using specific DNA primers 
17 – 22 nucleotides in length. The DNA template was derived from gDNA, mRNA 
or plasmid DNA. The purpose of amplification was to assess the presence of a 
specific region in the template or to amplify a specific region of the template 
for future applications. 
2.5.1 Standard PCR 
This protocol was used to optimise the annealing temperature of primers used 
for quantitative real-time PCR. In brief, each 25 μl reaction contained 1 μl of 
cDNA mixed with left and right primers at a final concentration of 0.5 μM and 
pre-aliquoted ready-to-use DreamTaq Green PCR Master Mix (Thermo Scientific) 
that contained 2X DreamTaq Green buffer, dNTPs (0.4 mM each), and 4 mM 
MgCl2 and enhanced DNA polymerase. The cycling was carried out in 0.2 ml PCR 
tubes using the PCR Express-Gradient thermocycler for running a gradient of 
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annealing temperatures across the block at the same time. A typical cycling 
procedure is described in Table 2.3.  
Step Temperature, °C Time Number of cycles 
Initial 
Denaturation 
94˚C 2-5 min 1 
Denaturation 94˚C 30 s  
35 -40 cycles 
Annealing 55-65˚C 30 s 
Extension 72˚C 30 s 
Final Extension 72˚C 5 min 1 
 
Table 2.3. Taq DNA polymerase PCR cycling parameters. 
 
2.5.2 SYBR Green-based qRT-PCR  
For this method, gene-specific primers were designed according to the method 
described in section 2.5.5, that yielded a PCR product of 150-500 bp and 
wherever possible spanned intron/exon boundaries of each gene of interest in 
order to control for possible genomic contamination. Each reaction setup 
contained: 10 μl of 2X SYBR Green real-time PCR master mix (Agilent 
Technologies), 1 μl of each primer (0.3 μM final concentration) and 2 μl cDNA, 
made up to a final volume of 20 μl with sterile dH2O. The SYBR Green real-time 
PCR master mix which contains the mutant Taq DNA polymerase, dNTPs, Mg2+, 
a buffer specially formulated for fast cycling, and the double-stranded DNA-
binding dye SYBR Green I to detect PCR product as it accumulates during PCR. 
The cycling was performed used an Opticon 3 thermal cycler according to the 
protocol described in below Table 2.4.  
 
 
 
     30-40 X 
Denaturation  
Denaturation  
Annealing  
Extension  
Absorption reading  
Incubation  
Melting curve  
95 ºC 
95 ºC 
50-60 ºC 
72 ºC 
76 ºC 
72 ºC 
63 - 90 ºC 
10 min 
10s 
30s 
30s 
10s 
5 min 
Read every 0.2 ºC 
 
Table 2.4. SYBR Green-based qRT-PCR cycling parameters. 
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qRT-PCR reactions were set up in triplicates with primers of the gene of 
interest. A standard gene (house-keeping gene), Rpl32 that encodes for a 
ribosomal protein was used to quantify the relative amount of each target 
gene. 
Following amplification, each qRT-PCR reaction from a specific sample cDNA 
was analysed for its Ct (threshold cycle) value particular to the target gene and 
Rpl32 gene. Relative quantification for target gene in each sample cDNA was 
determined by normalising target gene Ct value to its Rpl32 Ct value. By 
calculating the ratio of the two compared samples’ Ct values and using the 2-
ΔΔCt (Schmittgen and Livak, 2008) method, the relative fold change data of 
target gene between two samples were obtained . It is assumed that during this 
comparative analysis, the PCR efficiency of the amplicon of interest was steady 
over all the cycles.  
The results were plotted as mean ± SEM using Graph Pad Prism 6.0 software. 
One-way ANOVA was used to determine the statistical significance of data 
where multiple samples were used, and a Student’s t-test was carried out for 
paired samples of two. qRT-PCR used throughout the thesis had 3 biological 
replicates, and the results were consistent in all the studies.  
2.5.3 Agarose gel electrophoresis 
Agarose gel electrophoresis was used to determine the quality and specificity 
of PCR products or DNA by running it on 1% TBE agarose gels made in 0.5 % TBE, 
containing 0.1 μg/ml EtBr using 0.5% TBE as the electrophoresis buffer. Before 
loading, 6x loading dye was added to samples. The size of the samples was 
compared with the 1 kb DNA ladder (Invitrogen). Typically, electrophoresis was 
carried out at 100 V, and the DNA was visualised using a high-performance 
ultraviolet transilluminator (UVP, UK). 
 
2.5.4 PCR/ Gel purification 
A DNA fragment of the desired size was excised using a scalpel blade under UV 
illumination on the transilluminator and transferred to an Eppendorf tube, 
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weighed, then processed according to the Qiagen Gel Extraction Kit 
manufacturer’s instructions. 
2.5.5 Primer sequences design  
Oligonucleotide primers were either designed using web source Primer3, NCBI; 
FlyPrimerBank, DRSC and/or using software MacVector 11.1.1 (MacVector, Inc. 
UK). The design of the primer pair wherever possible was either (1) extending 
across an intron, or (2) Some of the primers in the pair were designed across 
two exon boundaries.  
The lyophilised primers (Integrated DNA Technologies; IDT) were resuspended 
in nuclease-free water as a working concentration of 6.6μM prepared from the 
stock dilution of 100 μM. Primers were stored at -20 ˚C until further use. The 
table below (Table 2.5) shows the list of the oligonucleotide sequences 
(forward and reverse primers) used in this study. 
Primer  Forward Reverse 
Sip1  GCTGTTCGCTTTCGTTTCGTTTAG TGTCCTGGTTTCACCTTCTCCG 
Moe AACGCCAAGGATGAGGAGAC ACGCTTTGTGTTGCCCTTAC 
Rpl32 TGACCATCCGCCCAGCATAC ATCTCGCCGCAGTAAACGC 
Wtrw CTCGCAGGACCCCGTGAAC CGGATCTTGCCCCACTTGAT 
Cin CAATACGCTTTGCTGCTGGC TCGGCACCAACAATGCTCTG 
Spat ATGCGCAAGTACAGCGTTGA GATCCGTCTTGATCCCCAGC 
SCP2 CCGATTTCCGCAAAAAGAAGC TCCATCATCAGGTCGTAGGTCTCC 
SPoCK  TTTTCATTGAGGAACAGACGGG CACCAGAGCAGAACCAAGAAGC 
Picot TCAACCACTTGGACCTCACACC TGACGCACGACTACGGCTAATAC 
NHE2 CACAATGTCCTGGCTGACCTTTC CTCCACCACCGAGAGATAAAACC 
 
Table 2.5. List of Primers used for qPCR. 
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2.6 Microscopy 
2.6.1 Polarised light microscopy 
Polarising microscopy was used to visualise stones (oxalate, phosphate, 
xanthine and uric acid). Among all the different stones present in the tubule, 
oxalate and uric acid stones are bright and white under crossed polarising 
filters due to their birefringent property. Meanwhile, phosphate and xanthine 
stones are dull and not birefringent. In order to visualise birefringent 
specimens, the polarised microscope is equipped with two polarisers: one 
between the light source and the specimen (light path), and the other one 
(analyser) in the optical pathway between the objective and the observation 
tubes. The polariser can be rotated through 360 degrees, which enables 
regulation of the intensity of the polarisation light Figure 2.3. When minimum 
brightness was achieved, samples were visualised for birefringent stones and 
vice-versa for non- birefringent stones. All the samples were imaged as per the 
steps mentioned below: 
1. All the images were taken in the same microscope. 
2. The internal and external light intensity was made constant throughout 
the imaging. 
3. All the microscopic conditions were kept constant like the same 
objective magnification, exposure, gain, saturation, gamma, iris, 
transmitted light etc. 
4. The same volume of Drosophila medium was used for mounting the slides 
so that the focus of the microscope remains constant. 
All the tubules were accurately dissected in one set and images were taken 
approximately within a minute (since the amount of concretion might be 
dissolved if kept in the solution for a long time). Using this technique, 
Malpighian tubules were assessed for the presence or absence of stones. 
Tubules were dissected, and slides were prepared as described in section 2.2.5 
and quantified, as discussed in section 2.7. 
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Figure 2.3. Polarized Light Microscope Configuration.  
 
 
 
2.6.2 Confocal microscopy 
Fluorescent imaging of the MTs was carried out using the LSM 800 confocal 
microscope system (Zeiss Technologies UK) as described previously (Cabrero et 
al., 2014). HeNe1 543nm laser and a 561-625 nm bandpass filter were used for 
imaging the Alexafluor 568. An Argon 488 nm laser and a 505-530 nm bandpass 
filter were used for imaging the staining. The DAPI was excited using the 
standard UV source (mercury lamp) and the image captured using the confocal 
photomultipliers. Either 40x (oil immersion) or 63x objectives was used. All the 
images were processed with Zen software and Adobe Photoshop/Illustrator CS 
5.1. 
2.7 Photoshop 
Prior to the kidney stones quantification, images taken from the microscope 
were combined using Photoshop. Once the images were combined, the 
brightness and contrast of all-electron micrographs of an image was noted, and 
the same setting was used for all the pictures to make a consistent background 
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for the analysis. The images were adjusted using Photoshop CS3 version 
software. 
2.8 Quantification of the stones 
The samples prepared were viewed and imaged as per the protocol mentioned 
in section 2.6.1. The level of concretion accumulation was quantified using the 
public domain ImageJ software (http://rsb.info.nih.gov/ij). The process of 
quantification of the stones is described in detail below: 
2.8.1 Quantification of the stones using image J 
1. Open image using image J software 
 
2. Change image format by choosing Edit->Type->32 bit 
 
3. Make invert image by choosing Edit->Invert 
4. Using “Freehand selections” icons on the toolbar, outline the tubule 
5. Go to Analyze->Histogram 
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6. Make sure “use min/max” is marked. You do not have to change other 
parameters 
7. Click OK 
8. Write down Min and Max values (for example min:81, max:220) 
9. Close the window 
10. Go the Analyze->Histogram again 
11. Deselect “use min/max” box 
12. Enter min and max values obtained in (8) (for example min:81, max:220) 
13. Use the max-min value for Bins (for example 220-81=139) 
14. click OK 
15. Distribution with Bin width=1 achieved 
16. Write down “Count”, which means total tubule area, Mean=average 
intensity, Std Dev= standard deviation. However, the background 
intensity needs to be subtracted to get a real mean value. The 
background is the intensity obtained from an area without tubule on the 
image. 
17. Click “Copy” 
18. Open the excel file then “Past”, which will go past all the data on the 
excel file. The left column is intensity; the right column is the number of 
pixels corresponding to that intensity, which means an area. 
19. After subtracting background, the threshold intensity needs to be 
determined. We assume that if the intensity is above the threshold, it is 
concretion. The threshold is determined using a tubule obtained from a 
67 
 
wildtype fly tubule (CS) fed on a normal diet. We decided the threshold 
value to be “mean+3 x SD”. 
20. Sum the pixel number above the threshold 
21. Now the total area (From (16)) and the area above the threshold 
(=concretion) (From (20)) was obtained. 
22. Now the tubule area filled with concretion is calculated (%). 
Note: This technique was used for birefringent stones. However, in the case of 
non-birefringent stones, the images are not inverted (step 3); instead, follow 
all the same process except this step. All the images were taken in the white 
background instead of dark. 
2.8.2 Quantification of the stones using Fiji 
1. Open FIJI and Open the .CZI File for the tubule to be analysed (the 
computer will ask if you would like to Run FIJI; click Run). 
2. Go to Image → Type → 8-Bit (this will allow the image to be edited). 
 
3. Use the straight-line tool to measure the first 600 µm of the tubule.  
4. Mark off the regions that are not to be included in the crystal analysis 
using the Freehand selections tool and Ctrl + F to paint the selected 
area(s) black. 
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5. Go to Image → Adjust → Brightness/Contrast (or use Ctrl + Shift + C) 
and move the Minimum slider (the top slider) until most if not all of the 
tubule tissue disappears leaving only the birefringent crystals. If any of 
the tubule tissue is still visible select it with the Freehand selections 
tool and use Ctrl + F to paint the selected area black. 
 
6. Go to Image → Adjust → Threshold (or use Ctrl + Shift + T) and click 
Apply. If needed how many shades of white/grey are recognised as 
crystals can be adjusted using the top slider (this step is used to make 
the image binary so that there is only white and black). 
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7. Go to Analyse → Analyse Particles. 
 
 
8. Set the top blank to 2 µm (this is the minimum size partcle that will be 
analysed). Set the Show dropdown to Overlay Masks (this will mark the 
crystals/particles counted with a teal mask overlay). Check Display 
Results, Clear Results, Summarize and Include Holes checkboxes. Click 
OK. 
9. Check the teal overlays to make sure only the desired crystals were 
indeed analysed. Save both the Summary and the Results for further 
analysis. 
2.9 Biochemical assays 
2.9.1.1 Determination of concentration of uric acid 
The MTs concentration of uric acid was quantified using the Quantichrome 
Colorimetric Uric acid kit (DIUA-250, BioAssay Systems) according to the 
manufacturer’s instruction. Six adult MTs per sample were homogenised in 12 
μl of Tween-20 (Sigma-Aldrich), and 200 µl of working reagent was added to 5 
μl of each tubule sample in 96 well plates (3 replicates for each sample). 
Samples were incubated for 30 minutes at room temperature and the optical 
density measured at 590nm using a Mithras LB940 automated 96-well plate 
reader (Berthold Technologies). Data were analysed using the MikroWin 
software.  
Detailed method: 
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1. 5 flies were homogenised in 100 µl tween (or 6 tubules were suspended 
in 12 μl if measuring tubules) 
2. 10 volumes of reagent A and 1 Volume of reagent B and 1 Volume of 
reagent C was mixed as per the protocol (all the reagents are provided 
in the kit).  
3. All the standards were set up in the following concentration: (10-5-2.5-
1.25-.625 mg/dL). 
4. 5 μl of standards and samples were added to clear bottomed 96 well 
plates. (sample no. can be increased depending on the no. of replicates 
required). 
5. 200 μl of working reagent was added to the mixture, and the mix was 
tapped. 
6. The mixture was incubated for 30 minutes at RT and absorbance 
measured at 590 nm. 
CALCULATION:  
The uric acid concentration of the sample is calculated as 
 ODBLANK, ODSTANDARD and ODSAMPLE are OD590 nm values of Blank, Standard and 
Sample, respectively. It is not necessary to prepare a calibration curve, 
because the concentration of the provided standard lies within the linear 
range.  
Normal serum uric acid values: 1.0 to 7.0 mg/dL.  
Conversions: 1 mg/dL uric acid equals 59.5 µM, 0.001% or 10 ppm. 
 
= ODSAMPLE – ODBLANK         X 10 (mg/dL)   
   ODSTANDARD – ODBLANK  
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2.9.1.2 Determination of concentration of phosphate  
The MTs concentration of phosphate was quantified using the Quantichrome 
Colorimetric phosphate kit (DIPI-500, BioAssay Systems) according to the 
manufacturer’s instructions. Thirty adult fly MTs per sample were homogenised 
in 50 μl of nitric acid (Sigma-Aldrich), and 100 µl of working reagent was added 
to 50 μl of each tubule sample in 96 well plates (3 replicates for each sample). 
Samples were incubated for 30 minutes at room temperature and the optical 
density measured at 620 nm using a Mithras LB940 automated 96-well plate 
reader (Berthold Technologies). Data were analysed using the MikroWin 
software. 
Detailed method: 
1. 60 MTs were homogenised in 50 μl 30% HNO3. A range of HNO3 
concentrations was tried, and this was found to be the optimal 
concentration. 
2. Transfer 50 µL distilled water ("Blank"), Standard and samples in to 
duplicate wells of a clear bottom 96-well plate. All the standards were 
set up in the following concentration: (0.28, 0.14, 0.07, 0.035, 0.0175 
mg/dl). 
3. 100 μl of working reagent was added in the mixture, and the mix was 
tapped. 
4. The mixture was incubated for 30 minutes at RT and measure 
absorbance at 620nm. 
CALCULATION: 
The phosphate concentration of sample is calculated as 
= ODSAMPLE – ODBLANK         X 0.28 (mg/dL)   
   ODSTANDARD – ODBLANK  
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ODBLANK, ODSTANDARD and ODSAMPLE are OD620nm values of Blank, Standard and 
Sample, respectively.  
Conversions: 1 mg/dL Pi equals 105.3 µM, 0.001% or 10 ppm.  
2.10 Statistics 
Unpaired two-tailed Student’s t-test and ANOVA with Dunnett’s post hoc test 
were used for the statistical comparison between two independent groups and 
more than two independent groups, respectively. For the statistics assays, 
Prism 6 (Graphpad, CA, USA) was used for data analysis and statistical 
significance was tested. 
2.11 Solubility assay 
Adult flies were dissected in Phosphate Buffered Saline (PBS, pH 5), and intact 
MTs were mounted on glass-slide in PBS adjusted to pH 5 to 10, and 
immediately imaged using a microscope (Axioskop 2, Zeiss) under polarised 
light. Images were taken every minute for 30 min and were quantified once the 
time frame was completed. Imaging conditions were maintained as described 
previously in section 2.6.1. Total stones present within the tubule at 0 min 
were considered 100% and the stones accumulated after 1, 10, 20 and 30 min 
were quantified with respect to the initial quantity. 
2.12 Immunocytochemistry 
Immunocytochemistry (ICC) staining was performed to determine the cell-type 
localisation of the expressed protein within the Drosophila MTs. All the 
experimental protocol was followed as previously described in (MacPherson et 
al., 2001). Malpighian tubules were dissected in Schneider’s medium and 
transferred to a 1.5 ml Eppendorf containing 100 µl of PBS. This was aspirated 
with care taken not to disturb the tubules. 200 µl of fixation solution (4% (w/v) 
paraformaldehyde in PBS) was then added for 30 min. The fixation solution was 
removed, and the tubules were washed three times in PBS every 30 min. The 
tubules were then permeabilized for 30 min with PBS, 0.5% Triton (v/v), 0.15M 
NaH2PO4, 0.1% Sodium Azide (PBTA) (w/v), changing every 10 min. The tubules 
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were then incubated in PBS, 0.3% (v/v) Triton X-100, 0.5% (w/v) NGS (PAT) for 
3 h at RT. Incubation with the primary antibody was carried out overnight at 
4°C. Tubules were then washed 4 x in PAT for 2 h and then blocked with PAT 
for 3 h. Incubation with secondary antibody was performed in PAT overnight. 
The tubules were washed three times with PBTA for 30 min each wash. Tubule 
cell nuclei were stained with DAPI(500 ng/ml in PBS) for 2 min and washed 
three times with PBTA for 30 min each wash. Finally, the tubules were then 
washed 2 x 10 min in PBS, mounted in Vectashield (Vector labs, U.K.), and 
sealed with glycerol/gelatin (Sigma). The samples were viewed using confocal 
microscopy (details in section 2.6).  
2.13 Antibody purification 
2.13.1 Isolation of IgG fraction from immune serum 
The antibody was purified as detailed in (Day et al., 2008). A HiTrap Protein A 
HP‟ column (Amersham) was flushed with 5 ml 0.1 M glycine pH 2.5, passed 
through at ~2ml/min, then equilibrated with 30 ml of PBS. 5 ml of immune 
serum was filtered through a 0.45 µM filter and then syringed through the 
column to bind. The column was washed with 30 ml of PBS, and the IgG 
fraction was eluted with 17 ml of 0.1 M glycine, pH 3.0. The first 2 ml were 
discarded, and the subsequent 15 ml flow-through was collected in a 50 ml 
Falcon tube containing 1.5 ml 1 M Tris-HCl pH 8.0. The column was then 
washed with 5 ml 0.1 M glycine pH 2.5, and stored, sealed, containing ethanol, 
at 4˚C. The absorbance at 280nm was read to confirm IgG elution, and the IgG 
eluate was dialysed overnight against a large volume of PBS in a Slide-A-Lyzer 
dialysis cassette (Pierce). 
2.13.2 Preparation of affinity columns 
The bottom cap was fitted to a 10 ml polypropylene column (Pierce) and the 
column filled with deionised water. A frit was pushed to the bottom of the 
column using the plunger from a disposable syringe. The water was drained by 
removing the end cap, and 5 ml of Sulfolink slurry (Pierce) was added. When 
the slurry had sedimented, the slurry buffer was removed down to the surface 
of the gel and 2 x 25 ml of 50 mM Tris-HCl, 5 mM Na-EDTA pH 8.5 was run 
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through the column, with the end cap replaced when the buffer reached the 
slurry. 1 mg of the antibody-specific peptide was dissolved in 4 ml of 50 mM 
Tris- HCl, 5 mM Na-EDTA, and added to the column. The top cap was added, 
and the column subjected to the rotation for 15 min at 4˚C. The column was 
left upright for 45 min, following which the column was drained. 15 ml of 50 
mM cysteine in 50 mM Tris-HCl, 5 mM Na-EDTA was added to the column and 
rotated for 15 min at 4˚C. The column was set upright and allowed to settle for 
45 min. The top cap was removed, and the top frit fitted just above the level 
of the gel. The end cap was removed, and the column drained. 60 ml of 1 M 
NaCl was then run through the column, followed by 50 ml of PBS and then 40 
ml of 0.05 % (w/v) sodium azide in PBS keeping the level above the gel. The 
end caps were fitted and the column stored at 4˚C until use. 
2.13.3 Affinity purification of antibodies 
The affinity column was brought to room temperature, and the sodium azide in 
PBS was drained. The column was equilibrated by passing through 30 ml of PBS, 
and the IgG fraction was passed through in 5 ml batches. Next followed a wash 
with 30 ml of PBS and finally, the antibody was eluted with 0.1 M glycine, pH 
3.0. A volume of 12 x 1 ml fractions were collected into 12 x 1.5 ml Eppendorfs 
containing 100 µl Tris-HCl pH 8.0. To determine the yield the absorbance at 
280 nm of each fraction was measured and fractions with readings greater than 
0.05 were pooled and dialysed overnight against PBS with 0.01 % (w/v) sodium 
azide. The absorbance at 280 nm was again taken in order to ascertain the final 
yield using the equation: 
Antibody concentration (mg/ml) = OD 280 x 1.35 mg/ml 
Aliquots of the antibodies were made and frozen at -20 oC until use. 
2.14 Antibodies used in the study 
Tubules were incubated with markers such as 4’,6-diamidino-2-phenylindole 
(DAPI; Sigma-Aldrich, 1 µg/ml) and Rhodamine-Alexa-633-coupled phalloidin 
(Thermo Fisher Scientific, 1:100). The primary and secondary antibodies used 
are listed below. (Table 2.6). 
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Antibody and Source Concentration and Use 
Anti-NHE2 (long isoform), rabbit 1:300 (ICC) 
Anti-NHE2 (short isoform), rabbit 1:300 (ICC) 
Goat-Anti-Rabbit-Alexa Fluor 488 
(Thermo Fisher Scientific) 
1:1000 (ICC) 
Goat-Anti-Rabbit-Alexa Fluor 546 
(Thermo Fisher Scientific) 
1:1000 (ICC) 
Anti-Rabbit- Alexa Fluor 633 
(Sigma) 
1:600 (ICC) 
Anti-Sip1, Rabbit  1:200 (ICC) 
Anti-phosphorylated-Moesin, Rabbit  1:200 (ICC) 
Anti-Rabbit-HRP (Amersham)  1:2000 (Immunoblotting) 
Anti-Tubulin (Sigma) 1:2000 (Immunoblotting) 
 
Table 2.6. List of antibodies used in the experiment. 
 
2.15 Western blotting  
2.15.1 Preparation of sample 
2.15.1.1 Preparation of S2 cell lysates 
For S2 cell transfections, each transfection was viewed under 20x magnification 
to assess cell membrane integrity at every stage (as a measure of survival) and 
resuspended using a transfer pipette. Each transfection was split into two 1.5 
ml eppendorfs and spun down for 4 min at 2000 rpm in a Thermo Heraeus 
centrifuge. The supernatant was removed, and the cell pellets were frozen in a 
-80°C freezer. When needed, the pellets were resuspended in IGEPAL buffer 
(150 mM NaCl, 50 mM Tris, 1% IGEPAL) containing protease inhibitor cocktail 
(Sigma-Aldrich, UK). The lysate was then sonicated on ice. An equal volume of 
Laemmli 2x buffer (4% SDS, 5% β-Mercaptoethanol, 20% glycerol, 0.004% 
bromophenol blue, 0.125 M Tris-HCl) was then added, and the samples boiled in 
a boiling water bath for 3 min. 
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2.15.1.2 Preparation of sample from MTs 
Tissue sample (300 tubules) was transferred into 100 μl of Tris-Lysis buffer (2% 
(w/v) SDS, 70 mM Tris, pH 6.8) containing 1 μl of protease inhibitor cocktail 
(Sigma-Aldrich, UK), in a 1.5 ml Eppendorf tube. Next, the sample was 
homogenised using a hand-held pestle followed by 3 x 1-sec homogenisations 
with a Microson Ultrasonic Cell Disrupter. The sample was then centrifuged at 
14000 g for 10 min to remove debris and the supernatant transferred to a new 
tube. Samples were stored at -80ºC until the Bradford assay and Western blot 
were performed. 
2.15.2 Bradford assay 
The Bradford assay was performed on a 96 well plate. Standards from 0-5 μg 
(typically 0 μg, 0.5 μg, 1 μg, 1.5 μg, 2 μg, 3 μg, 4 μg, 5 μg) were generated in 
triplicate using Bovine Serum Albumin (BSA), Fraction V (Roche) in a volume of 
50 μl distilled H20. For each protein sample, 1 μl of the sample was added to 49 
μl H20 in triplicate. To each well, 200 μl of a well mixed 1 in 5 dilutions of Bio-
rad protein assay dye reaction concentrate (Biorad) in H20 was added. 
Absorbance at 590 nm was read using a plate reader; Quanta smart software 
was used to generate a standard curve, and from this ascertain the 
concentration of each protein sample. 
2.15.3 Sodium Dodecyl Sulfate Polyacrylamide Gel 
Electrophoresis 
10 or 15 well-resolving gels between 6-20% were prepared according to the size 
of the protein of interest, as according to (Joseph and David, 2001). 
Electrophoresis was performed in a Biorad Miniprotean 3 Cell electrophoresis 
system. Samples were run at 50 V until the dye front had settled at the bottom 
of the stacking gel, and then at 130 V for 1 hour. Prestained Benchmark Ladder 
(Invitrogen) was used to determine the exact size of proteins. 
2.15.4 Coomassie staining of PAGE gels 
PAGE gels were fixed by brief treatment with 40% distilled H20, 10% acetic 
acid, 50% methanol on a horizontal shaker. The gel was then added to the same 
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mix but with the addition of 0.25% by weight Coomassie Brilliant Blue R-250 
and incubated for 4 hours to overnight. The gel was then washed in 67.5% 
distilled H2O, 7.5% acetic acid, 25% methanol on a horizontal shaker, the 
solution changed until the excess dye was removed, and the protein bands 
were clear. 
2.15.5 Transfer 
Hybond P was incubated in methanol for 5 min and then rinsed in distilled H20. 
Western blotting was carried out according to Novex Xcell II Blot Module 
(Invitrogen) instructions. The transfer was carried out at 60 V for 1 hour, with 
ice packs to prevent overheating. 
2.15.6 Ponceau S Staining 
To visualise protein on the membrane, the membrane was rinsed in methanol, 
then washed in PBST. The membrane was then incubated for 5 min in PBST 
(PBS with Tween 20)-10% (v/v) Ponceau with rocking, scanned, rinsed in 
methanol to remove the stain, and then washed in PBST. 
2.15.7 Development 
The membrane was briefly rinsed with PBS with 0.1 % (v/v) Tween 20 (PBST), 
and blocking was performed with PBST containing 5% Marvel Milk (w/v), for 
three hours at RT, or overnight at 4°C. The membrane was then rinsed in PBST. 
Incubation with a primary antibody was performed in a block with a suitable 
amount of primary antibody for 1 hour. 
The membrane was then extensively washed for an hour with frequent changes 
of PBST. The membrane was then incubated with an HRP-conjugated secondary 
antibody in the block for 1 hour. The membrane was then extensively washed 
for an hour with frequent changes of PBST. All steps were performed on a 
flatbed shaker. 
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2.15.8 Signal detection 
Chemiluminescence detection was performed using the ECL Western Blotting 
analysis system (Amersham Pharmacia) following the manufacturer’s 
instructions. Equal volumes of reagent 1 and reagent 2 were mixed and added 
to a sheet of Saran wrap. The filter was added protein side down and incubated 
for 1 min. The membrane was then wrapped in Saran Wrap, added to a 
cassette, and exposed to ECL film (Amersham Pharmacia), before development 
in an X-OMAT film processor. 
2.16 Co-Immunoprecipitation  
For Co-IP experiments, 200 tubule tissues were dissected as described in 
section 2.2.5. The Dynabeads™ Co-Immunoprecipitation Kit (Invitrogen, UK) 
was used to carry out IPs. All the experiment was conducted according to the 
manufacturer's protocol. In brief, following immobilisation of a particular 
antibody, the coupled beads were used, and the buffers supplied in the kit for 
co-immunoprecipitation (co-IP) of proteins, intact protein complexes, or intact 
protein-nucleic acid complexes and to elute those complexes from the beads. 
In addition to Dynabeads®, all the buffers were supplied in the kit which was 
required for efficient antibody coupling, gentle washing, and elution of the co-
isolated protein complexes. Once eluted, the protein was loaded onto a 
standard SDS-PAGE gel and ran as described in section 2.15. The samples were 
developed using the western blot technique. 
2.17 Recipes of solutions used in the experiment 
2.17.1.1 Drosophila Schneider’s medium 
Commercially available Drosophila Schneider’s medium (Invitrogen, UK), which 
resemble the composition of the fly hemolymph, was used throughout the 
experiment to dissect the flies unless otherwise mentioned. The composition of 
the Schneider medium is: 
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Amino Acids (mM) 
• Beta-alanine:  5.6 
• L-arginine:  2.3 
• L-asparagine 0.3 
• L-aspartic acid: 4.0 
• L-cysteine: 0.5 
• L-glutamic acid: 5.4 
• L-glutamine: 12.3  
• Glutathione: 0.1 
• Glycine: 3.3  
• L-histidine: 2.6  
• L-isoleucine: 1.5 
• L-leucine: 1.1  
• L-lysine: 11.3  
• L-methionine: 5.4 
• L-phenylalanine: 1.5 
• L-proline: 14.8 
• L-serine: 2.5  
• L-threonine: 3.5 
• L-tryptophan: 1.0 
• L-valine: 2.6  
 
Inorganic Salts (mM) 
• Calcium Chloride (CaCl2-2H2O): 4.1 
• Magnesium Sulfate (MgSO4-7H2O):37 
• Potassium Chloride (KCl):21.5 
• Potassium Phosphate monobasic 
(KH2PO4):5.0 
• Sodium Bicarbonate (NaHCO3) 
• Sodium Chloride (NaCl):35.9 
• Sodium Phosphate monobasic 
(NaH2PO4-2H2O):2.8 
Other Components (mM) 
• Alpha-Ketoglutaric acid: 1.8 
• D-Glucose (Dextrose): 11.1 
• Fumaric acid: 0.9 
• Malic acid: 0.7 
• Succinic acid: 0.8 
• Trehalose: 5.3 
• Yeastolate: 2g 
• FCS 18% 
 
2.17.1.2 Buffers 
Phosphate Buffer Saline 
The PBS solution was prepared by mixing the recipes enlisted below. All the 
chemicals were mixed, and the final volume of 1 L of pH 7.4 was prepared.  
• 137 mM NaCl 
• 2.7 mM KCl 
• 10 mM Na2PO4 
• 2 mM KH2PO4 (pH 7.4) 
 
Lysis RIPA Buffer (in H2O) 
100 mM Tris-Cl (pH 7.4), 300 mM NaCl 
• 10% TritonX100 
• 10% Na deoxycholate 
• 200mM Phenylmethanesulfonyl fluoride (in isopropranol) 
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• 10% SDS 
• Pierce protease and phosphatase inhibitor (Thermo) 
• 0.01M EDTA (pH 7.4) 
 
Transfer Buffer (in 1 litre of H2O) 
• 20 % (v/v) Methanol 
• 14.4 g Glycine 
• 3 g Tris Base 
 
Tris/Borate/EDTA Buffer 
• 90 mM Tris 
• 90 mM boric acid (pH 8.3) 
• 2 mM EDTA 
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Chapter 3 Screening and identification of genes 
involved in kidney stone formation 
 
3.1 Summary 
This chapter describes identification and selection of genes which might be 
involved in kidney stone accumulation. Kidney stone disorder encompasses a 
wide range of clinical phenotypes and is genetically heterogeneous. It arises 
from mutations of the genes which might be effective targets for understanding 
the mechanisms involved in kidney stone formation. The introduction to this 
chapter describes the list of genes which are involved in different physiological 
functions and specifically for the transport of ions. Calcium, phosphate and 
urate co-transporters are conspicuous candidates among the hits. However, 
until now, there has been no study regarding a systematic screening of these 
genes for their involvement in oxalate stone formation. The results presented 
in this chapter confirms the list of hits and opens an idea to develop a 
molecular strategy to understand the role of those genes in mineralisation. 
Crucially, the role of the genes in calcium oxalate stone formation was 
demonstrated by feeding control and knocked down flies with different dose of 
sodium oxalate. The particular genes were knocked down using the UAS/GAL4 
system, and RNAi knocked down efficacy was confirmed by qPCR. Taken 
together, genetic interventions to inhibit the function of the genes and observe 
their decisive role in calcium oxalate stone formation confirm a critical role of 
the gene in driving the process of heterogeneous nucleation that eventually 
leads to stone formation. Our findings open a novel perspective on the 
aetiology of urinary stones and related diseases, which may lead to the 
identification of new preventive and therapeutic approaches. 
3.2 Introduction 
Calcium oxalate (CaOx) is the predominant type of kidney stone, occurring in 
the majority of the kidney stone population. Interestingly, the formation of 
calcium oxalate crystals is not limited to individuals who end up developing 
kidney stones, but several studies have confirmed the existence of calcium 
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oxalate crystals also in the urine of non-stone formers. Currently, the general 
consensus is that calcium oxalate crystals in urine appear through a 
heterogeneous, not homogeneous, nucleation, where the numerous 
components found in various concentrations in the kidney make heterogeneous 
nucleation more likely. The identity of materials acting as nidi for kidney stone 
growth remains unclear. Hence, researchers are searching for a model which 
can mimic the actual pathogenesis of the human stone disease and allow 
genetic manipulations with the convenient observation of results as well as 
being cost-effective and easy to breed (Kovshilovskaya et al., 2012, Miller et 
al., 2013, Tzou et al., 2016a). 
Previous studies have shown that, among different model organisms, oxalate 
metabolism of human is almost identical to rats (Khan, 1997, Liebow et al., 
2017). Kidney stones in humans and hyperoxaluric rats are located on renal 
papillary surfaces and consist of an organic matrix and crystals of calcium 
oxalate and/or calcium phosphate (Finlayson, 1978, Robertson and Peacock, 
1980). The disease is experimentally induced in rats, either by the 
administration of excess oxalate or exposure to the toxin ethylene glycol (EG), 
hydroxyl-L-proline (HLP), sodium oxalate (NaOx), or various nutritional 
manipulations (Khan, 1991, Khan and Hackett, 1987). A rat model of calcium 
oxalate nephrolithiasis can be used to investigate the mechanisms involved in 
human kidney stone formation. 
Medical treatment prevention strategies for calcium oxalate nephrolithiasis, in 
the last two decades, has remained stagnant based on an understanding of the 
underlying aetiology of the disease (Ali et al., 2018). Current studies show that 
various drugs like potassium citrate and thiazide diuretics are active agents in 
the prevention of calcium oxalate stone formation in hypocitraturia and 
hypercalciuria states (Qaseem et al., 2014, Reilly et al., 2010). However, the 
progress of the development of new drugs has been limited due to a lack of 
suitable pre-clinical models that reliably recapitulate the pathophysiology of 
this disorder. Recent work performed by Hirata and colleagues has shown that 
Drosophila fed with ‘moderate to strong’ (0.1% -1%) doses of sodium oxalate 
generate CaOx crystals in Malpighian tubules (Hirata et al., 2012, Tsai et al., 
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2008). Other studies have also shown that flies can be fed with ethylene glycol 
(EG) or hydroxyl-L-proline (HLP) to induce oxalate stones (Chen et al., 2011).  
3.2.1 Genes involved in stone formation 
Certain genes could be predicted to be involved in stone formation. Several  
genes have been implicated  in stone formation (Miller et al., 2013) for e.g., 
oxalate co-transporters (SLC26A6) (Hirata et al., 2012), xanthine 
dehydrogenase (xdh) (Chi et al., 2015, Wang et al., 2009), calcium transporters 
and zinc transporters (Chintapalli et al., 2012a). In order to assess the 
involvement of different genes in calcium oxalate stone formation, we 
screened different genes, via reverse genetic studies in an organotypic context, 
by visualising and quantifying calcium oxalate stone burden in the Drosophila 
model of calcium oxalate nephrolithiasis. This led to the identification of genes 
with a possible role in stone formation, allowing us to perform further in vivo, 
physiological and genetic assays. While the fly model may not fully recapitulate 
mammalian calculi formation processes, we successfully identified genes that, 
when knocked down, were highly effective in halting calculus formation. This 
approach indicates that other novel genes can be identified in a similar manner 
due to the primarily acellular development of kidney stones. 
In this study, it was initially planned to screen RNAi and/or mutant panels for 
genes that increase or decrease the rate of oxalate stones formation and to 
seek homologues human candidate gene loci. Genes were specifically searched 
based on three criteria: 
a. Genes that had not been previously studied in the context of stone 
formation, but which had predicted functions in kidney stone formation. 
b. Drosophila genes with human homologues that had been identified and 
their function characterised in mineralisation. 
c. Genes with enriched expression in Malpighian tubules (MTs). 
d. Drosophila RNAi, mutant stocks and resources that were already 
available. 
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The Drosophila homologues were investigated to determine the extent of gene 
characterisation, and any resources which could be utilised in this study. Based 
on previous gene characterisation and the availability of Drosophila resources, 
twenty different Drosophila RNAi lines corresponding to eleven homologues 
gene-pairs were selected, and the list of genes is summarised in Table 3.1.  
S.
N. 
Genes Tubule 
enrichment 
Functions 
Name Larvae Adult  
1 Carbonic anhydrase 
(CAH1); CG7820 
1082.7 978.6 zinc ion 
binding; carbonate 
dehydratase activity. 
2 Calcium Binding Protein 
(Scp2); CG14904 
3962.8 3687.3 GTPase activity 
Calcium ion binding 
3 Sodium Phosphate symport 
(NaPiT); CG10207 
1490.9 2613.8 Phosphate transporter 
4 Calcium Pump (SPoCK); 
CG32451 
28 33 Mg and Ca transporting 
ATPase activity 
5 Trp-like calcium channel 
(water witch); CG31284 
261.6 715.1 Cation channel activity 
Calcium channel activity 
6 UAT; urate transporter 
CG11374 
8.9 7.5 Galactoside binding, Urate 
transmembrane 
transporter activity 
7 Spat; CG3926 2567.9 1682.1 serine-pyruvate 
transaminase 
activity; alanine-
glyoxylate transaminase 
activity 
8 Cinnamon MOCS3; CG2945 NA NA Molybdenum Cofactor 
synthesis 
9 Dihydropterin deaminase; 
CG18143 
88.3 193.2 Guanine deaminase 
activity, Zinc ion binding 
10 MOCS1; CG33048 25 88 Molybdenum Cofactor 
synthesis 
11 Sry interacting protein 
(Sip1); CG10939 
171 369 scaffold and cytoskeletal 
linker proteins 
 
Table 3.1. List of genes selected for the initial screening. The expression 
level of the genes in MT was obtained from FlyAtlas (Chintapalli et al., 2007, 
Leader et al., 2017). 
 
 
These candidates are described more fully in the following paragraphs. 
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3.2.1.1 Carbonic anhydrase (CAH1); CG7820 
The carbonic anhydrase (or carbonate dehydratases) are a group of enzymes 
that catalyses the interconversion between carbon dioxide and water and the 
dissociated ions of carbonic acid (i.e. bicarbonate and hydrogen ions) (Supuran 
et al., 2003). Carbonic acid dissociates spontaneously to release protons, which 
are essential for creating the acidic environment required for the dissolution of 
bone minerals in the resorption lacunae (Sly et al., 1983). There are 14 known 
human carbonic anhydrase isoenzymes (CAs), and they differ in tissue 
distribution, subcellular localisation, kinetics and sensitivity to various carbonic 
anhydrase inhibitors (Shah et al., 2004). Carbonic anhydrase is an essential 
enzyme for brain, kidney and bone physiology.  
Carbonic anhydrase II (CA II) is one of the most widespread of the CA isozymes 
and one with the highest catalytic activity. It is a cytoplasmic isozyme 
expressed in a variety of cell types in different tissues. The physiological 
functions of CA II include pH regulation, CO2 and HCO3- transport, and 
production of aqueous humor, cerebrospinal fluid, gastric acidity and 
pancreatic secretions (Pushkin et al., 2004). The only known inherited 
deficiency of a carbonic anhydrase of clinical significance is the CA II deficiency 
syndrome, which is inherited as an autosomal recessive trait. It also assists in 
metabolic pathways such as gluconeogenesis, lipogenesis, ureagenesis and bone 
resorption and calcification (Mboge et al., 2018). The clinical manifestations 
include osteopetrosis, renal tubular acidosis, and cerebral calcification. 
Additional clinical features of the disease include developmental delay, short 
stature, a history of multiple skeletal fractures by adolescence, and cognitive 
defects varying from mild learning disabilities to severe mental retardation 
(Alhuzaim et al., 2015). 
Further patients with CA deficiency are found to have mixed-type renal tubular 
acidosis with other features of carbonic anhydrase deficiency. Hence, we 
knocked down CG7820 in PCs of Drosophila MTs to observe its impact on stone 
accumulation. 
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3.2.1.2 SCPs (CG14904) 
Sarcoplasmic calcium-binding proteins (SCPs) are proteins that participate in 
calcium cell signalling pathways and play essential roles in many cellular 
processes (Hermann and Cox, 1995). SCPs have specific domains that bind to 
calcium and are known to be heterogeneous. Since Ca2+ is an important 
secondary messenger, it can act as an activator or inhibitor in gene 
transcription (Ikura et al., 2002). SCPs are found exclusively in invertebrates 
and have been identified in crustaceans, insects, annelids, molluscs, 
cephalochordates and other groups (Hermann and Cox, 1995). 
SCPs have been selected evolutionarily with a range of affinities, kinetics and 
capacities to intervene in cell-specific Ca2+ signals (Fernández‐Boo et al., 
2016). A transient rise of the intracellular Ca2+ concentration is achieved by the 
entrance of Ca2+ ions either through the plasma membrane from the external 
compartment via voltage, ligand or stretch-activated ion channels or by being 
released from various internal stores (endoplasmic/sarcoplasmic reticulum, 
mitochondria, etc.) (Gees et al., 2010). The rise and fall of the cellular Ca2+ 
concentration or in localised areas within the cytoplasm play a key role in the 
activation of membrane conductance, secretion, contraction, regulation of 
enzymes.  
Renal calcium-binding proteins have been identified in several biological 
systems. Previous studies have reported excess excretion of calcium-binding 
proteins in the kidney leads to the accumulation of the stone formers 
(Ratkalkar and Kleinman, 2011, Alelign and Petros, 2018). Calcium-binding 
proteins, as well as molecules like sialic acid, carboxy glutamic acid and 
phosphatidic acid, allow high local concentrations of calcium inside the cell in 
hyperoxaluric conditions (Aggarwal et al., 2013). Using calcium oxalate, the 
existence of CaOx binding protein has been demonstrated in several rat tissues 
(Selvam and Kalaiselvi, 2003), and the kidney showed the maximum binding 
activity among the various tissues studied. Renal medulla exhibited higher 
CaOx binding activity than papilla or cortex. All the above-mentioned calcium 
oxalate binding proteins are located in different membranes of renal cells 
which may serve the function of carrier proteins for the transport system. 
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Purified mitochondrial oxalate binding proteins derived from rat and human 
kidney showed a promoter effect on CaOx crystallisation (Selvam and Devaraj, 
1997). Among them, rat protein showed higher promoter activity, and CaOx 
binding protein antibody inhibited both oxalate binding activity and crystal 
growth in vitro, suggesting that the oxalate binding site plays a vital role in 
crystal growth. Hence, we knocked down CG14904 in Drosophila MTs to observe 
its impact on stone accumulation. 
3.2.1.3 NaPi-T (CG10207) 
Human has three types of membrane-bound phosphate transporters: type I: 
SLC17A1–9, type II: NPT2a, NPT2b, and NPT2c, and type III: Pit1 and Pit2; 
which are thought to be exclusively transporting phosphate across the 
membrane (Levi and Bruesegem, 2008). In humans (Blaine et al., 2015, Virkki 
et al., 2007) and rat studies (Villa-Bellosta et al., 2009), it has been shown that 
the sodium phosphate cotransporters are positioned in the apical membrane of 
renal proximal tubule cells, to move phosphate from lumen to the cell interior 
(Curthoys and Moe, 2014b). In Drosophila MTs, NaPi-T is known as a major 
player to be involved in elevating intraluminal phosphate concentration that 
contributes to the kidney disease (Villa-Bellosta et al., 2009, Chintapalli et al., 
2012). However, a detailed study has not been conducted. Hence, to better 
understand the role of NaPi-T in kidney stone formation, I selectively knocked 
down NaPi-T in Drosophila MTs to observe its impact in stone formation. The 
detailed characterisation of NaPi-T, for its involvement in kidney stone 
formation, is explained in Chapter 4 and Chapter 6. 
3.2.1.4 SPOCK (CG32451) 
Secretory pathway Ca2+/Mn2+-ATPases (SPCAs) represent a new group of ion-
motive ATPases consisting of single subunit integral membrane enzymes 
specifically mediating the ATP-powered uphill transport of either Ca2+ or 
Mn2+ from the cytosol into the Golgi lumen. The lumens of the Golgi apparatus 
(GA), store a high amount of free Ca2+, in the order of 1.0 mM and 0.3–0.4 mM, 
respectively, compared with those in the external fluids. The [Ca2+] in all these 
compartments is finely regulated, and the correct Ca2+ homeostasis is essential 
for the majority of intracellular pathways, including the protein trafficking and 
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secretion (Micaroni, 2010). The mammalian Ca2+-transporting ATPases are 
encoded by ATP2C1-2 genes, sarco(endo)plasmic reticulum Ca2+-ATPases 
(SERCAs; encoded by ATP2A1–3 genes) and plasma membrane Ca2+-ATPases 
(PMCAs; encoded by ATP2B1–4 genes). The biochemical, cell biological, and 
physiological functions of SERCA and plasma membrane Ca2+-ATPases have been 
intensively studied (Okunade et al., 2007). Only limited information is available 
for the SPCAs, which are firmly related to PMR1, a P-type Ca2+-ATPase in yeast 
that is expressed in Golgi membranes and transports both Ca2+ and Mn2+ (Shull 
et al., 2011, Okunade et al., 2007). 
The focus here is on the SPCA family of Golgi Ca2+ pumps, with particular 
emphasis on disease phenotypes resulting from null mutations in 
the ATP2C1 (SPCA1) gene in mice and humans and their similarities to disease 
phenotypes resulting from null mutations in the ATP2A2 gene (Shull et al., 
2011), which encodes SERCA2, the major endoplasmic reticulum (ER) Ca2+ pump 
(Liao and Zhang, 2008). Drosophila homologue of SPCA genes is SPoCK, the 
gene encoding a secretory pathway Ca2+/Mn2+-ATPase  that has been mainly 
characterised in our lab (Southall et al., 2006). However, its role in kidney 
stone formation is not known. Hence in this chapter, we focus on the impact of 
SPoCK in calcium oxalate stone formation. 
3.2.1.5 Waterwitch (Wtrw; CG31284) 
Renal and intestinal transcellular calcium absorption plays a crucial role in 
calcium homeostasis (Blaine et al., 2015). The rate-limiting step in 
transcellular calcium transport across the apical membrane of the epithelial 
cell is tightly controlled by 2 members of the transient receptor potential (TRP) 
superfamily, TRPV5 and TRPV6 (Bonvini et al., 2016), which controls renal 
epithelial, and  the small intestine calcium transport respectively, Figure 3.1 
(Sakhaee, 2009). 
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Figure 3.1. TRPV5 function and regulation in active renal Ca2+ reabsorption. 
Adapted from (Peng et al., 2018). 
 
TRPV5 is the main channel responsible for apical Ca2+ entry. It is expressed in 
the distal convoluted tubule and connecting tubule that acts as cellular sensors 
and regulates a variety of cell functions (Loffing et al., 2001, Suzuki et al., 
2008). TRPV5 channels mediate calcium reabsorption in the kidneys, and their 
expression is regulated by parathyroid hormone, 1,25 di-hydroxyvitamin D3, 
estrogen and dietary calcium (Hoenderop et al., 2003). Interestingly, TRPV5 -/- 
mice have impaired Ca2+ reabsorption and high plasma 1,25 di-hydroxyvitamin 
D3 with compensatory hyperabsorption of dietary calcium and severe calcium 
wasting (Renkema et al., 2005). Additionally, a reduced trabecular and cortical 
bone thickness indicated disturbed bone morphology. Hence, it is interesting to 
investigate associations of the gene TRPV5 in kidney stone formation. In our 
study, we knocked down Wtrw, Drosophila homologue of human TRPV5 and 
observed its impact in oxalate MTs stone accumulation. 
3.2.1.6 CG11374  
Galectins are an ancient, ubiquitous family of lectins characterised by an 
evolutionally conserved, approximately 130-amino acid-long carbohydrate 
recognition domain that binds ß-galactosides. Galectins include 15 members, 
among which Galectin-1 is the family prototype, containing one carbohydrate 
recognition domain and forming homodimers. Galectin-1 binds to the TRPV5 N-
glycan (Nie et al., 2016).  
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Among all the members of Galectins, Galectin-9 (UAT; urate transporter) has 
also been proposed to be involved in renal urate transport (Lipkowitz et al., 
2002). UAT was identified by screening a rat kidney cDNA library with a 
polyclonal antibody to pig liver uricase, and its function was examined using a 
reconstitution assay (Knorr et al., 1994). UAT is expressed ubiquitously and 
localises to the apical side of the proximal tubule in the kidney. It consists of 
322 amino acid residues and contains 4 transmembrane-spanning domains, with 
a predicted urate binding site on the intracellular loop between 
transmembrane domains 2 and 3 (Lipkowitz et al., 2002, Hediger et al., 2005). 
Consequently, UAT is supposed to be a multimeric protein related to various 
functions which are still required to be discovered. Hence, further studies are 
needed to determine the precise role of UAT/galectin 9 in urate metabolism. In 
this study, we knocked down UAT in Drosophila MTs to observe its impact in 
oxalate stone formation. 
3.2.1.7 Alanine: Glyoxylate Aminotransferase (AGT) – homologue of 
Drosophila spat 
Primary Hyperoxaluria Type 1 (PH1) is a severe autosomal recessive kidney 
stone disease (~1:120,000 live births per year in Europe), caused by loss or 
dysfunction of the enzyme alanine: glyoxylate aminotransferase (AGT; the 
AGXT gene product) and characterised by oxalate overproduction and elevated 
excretion (Adam et al.). AGT is a hepatic peroxisomal enzyme involved in 
glyoxylate metabolism that detoxifies glyoxylate in the peroxisomes of cells by 
converting it to glycine. If not degraded, excess glyoxylate results in a build-up 
of oxalate in all tissues, which is also deposited in the kidneys in the form of 
calcium oxalate, resulting in nephrocalcinosis, urolithiasis, and renal failure 
(Danpure, 2005). Since calcium oxalate is poorly soluble in urine, patients with 
PH1 usually present with symptoms related to the urinary tract. The risk of 
stone formation is increased when urine oxalate exceeds 0.4 mmol/l, especially 
if urine calcium concentration is elevated (i.e. more than 4 mmol/l), leading to 
the formation of monohydrated calcium oxalate (whewellite) crystals (Cochat 
et al., 1995). 
Current knowledge on the role of AGXT for PH1 is not fully understood. 
Enzymes that can significantly degrade oxalate have not been discovered. Over 
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75 different missense mutations in AGT have been found associated with PH1. 
While some of the mutations are affecting enzyme activity, stability, and/or 
localisation, approximately half of these mutations are completely 
uncharacterized (Lage et al., 2014). The Drosophila homologue of AGXT is spat 
(CG3926) which functions in catalysing the conversion of glyoxylate to glycine 
using L-alanine as the amino donor. Hence, we sought to systematically 
knocked down spat in Drosophila MTs to observe its effect in the accumulation 
of oxalate stones.  
 
3.2.1.8 Molybdenum cofactors MOCS 
Molybdenum cofactor deficiency (MoCD) is a rare autosomal recessive inborn 
error of metabolism of sulfur-containing amino acid with an overlapping clinical 
phenotype and severe neurodegeneration in new-borns. All molybdenum‐
containing enzymes are other than the bacterial nitrogenase share an identical 
molybdenum cofactor (MoCo), which is synthesised via a conserved pathway in 
all organisms and therefore also is called “universal molybdenum cofactor”.  
In humans, four different molybdenum enzymes are expressed, known as 
sulfite oxidase (SO), xanthine oxidoreductase (XOR), aldehyde oxidase (AO) 
and the mitochondrial amidoxime-reducing component, in the form of two 
isoforms (mARC1 and mARC2) (Reiss and Hahnewald, 2011). Mutations in the 
genes encoding the biosynthetic MoCo pathway enzymes abrogate the activities 
of all molybdoenzymes and result in the “combined” form of MoCo deficiency, 
which is clinically very similar to isolated sulfite oxidase deficiency, caused by 
mutations in the gene for the corresponding apoenzyme (Reiss and Hahnewald, 
2011). Both deficiencies are inherited as an autosomal recessive disease and 
result in progressive neurological damage and early childhood death in most 
cases. The majority of mutations leading to MoCo deficiency have been 
identified in the genes MOCS1 (type A deficiency), MOCS2 (type B deficiency), 
with one reported in GPHN (Reiss, 2000). This is summarised in (Figure 3.2 and 
Figure 3.3).  
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a. MOCS1 
The MOCS1 gene was the first gene identified in human in this conserved 
pathway (Figure 3.2), leading from GTP to active MoCo (Reiss et al., 1998). 
Approximately two-thirds of all MoCo-deficient patients are homozygous or 
compound heterozygous for mutations in the MOCS1 gene. Mutation in MOCS1 
causes synthesis of all the four MoCo‐dependent enzymes; aldehyde oxidase, 
mARC, xanthine oxidoreductase, and sulfite oxidase. Classical xanthinuria type 
I is the result of an isolated xanthine oxidoreductase deficiency, while 
traditional xanthinuria type II is caused by a defect in the molybdenum 
cofactor sulfuration by HMCS before incorporation into xanthine oxidoreductase 
and aldehyde oxidase (Ichida et al., 2006). In the asymptomatic patient, 
xanthine stones have prominent effects due to elevated levels of xanthine, 
although they are not life-threatening. Isolated sulphite oxidase deficiency is 
also an autosomal‐recessive genetic disease even rarer than the “combined” 
MoCo deficiency (Ichida et al., 2001). Furthermore, Isolated sulfite oxidase 
deficiency and the combined deficiency of all MoCo‐dependent enzymes due to 
MoCo deficiency are clinically indistinguishable and can be differentiated only 
by biochemical parameters like high xanthine and lowered uric acid as a result 
of the simultaneous loss of xanthine oxidoreductase deficiency in the combined 
form. 
Similarly, CG33048 is the Drosophila homologue of human MOCS1. We knocked 
down CG33048 in MTs to observe its impact in oxalate stone formation. 
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Figure 3.2. Biosynthesis of MoCo via an ancient pathway common to all free‐
living species and types of diseases as a consequence of mutations in the 
different genes. Reproduced with permission from (Reiss and Hahnewald, 
2011). 
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Figure 3.3. MoCo containing enzymes in Drosophila. GTP; Guanosine 
triphosphate, MPT; molybdopterin, MoCo; molybdenum cofactor, SO; sulphite 
oxidase, XDH; xanthine dehydrogenase, AO; aldehyde oxidase, cin; cinnamon, 
ry; rosy, mal; maroon-like. Adapted from (Hobani, 2012). 
 
 
b. MOCS3 
MOCS3 is one of the essential genes which encodes a protein believed to 
catalyse both the adenyl transfer and subsequent thiocarboxylation at the C‐
terminus of the small subunit of molybdopterin synthase (Matthies et al., 
2004), thus providing the sulfur to be incorporated into cPMP. This gene is 
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located on chromosome 20 and contains no introns. A pseudogene (MOCS3P1) is 
located on chromosome 14 (Reiss and Hahnewald, 2011). Mutations in the genes 
encoding the biosynthetic MoCo pathway enzymes abrogate the activities of all 
molybdoenzymes and result in the "combined" form of MoCo deficiency, which 
is clinically very similar to isolated sulfite oxidase deficiency, caused by 
mutations in the gene for the corresponding apoenzyme (Reiss and Hahnewald, 
2011). Hence, in this study, we knocked down Cinnamon, Drosophila 
homologue of human MOCS3 in Drosophila MTs and observed its impact in 
oxalate stone formation Figure 3.3. 
3.2.1.9 Guanine Deaminase - homologue of Drosophila dihydropterin 
deaminase (CG18143) 
Guanine deaminase (GDA) is a metalloenzyme that catalyses the first step in 
purine catabolism by converting guanine to xanthine by hydrolytic deamination. 
GDA also regulates the total cellular purine-derived nucleotide pool by 
converting adenylic derivatives to guanine (Figure 3.4) (Saint‐Marc and 
Daignan‐Fornier, 2004, Nygaard et al., 2000). Since GDA activity is involved in 
guanine metabolism, this enzyme is essential for the regulation of intracellular 
levels of guanylic derivatives (Akum et al., 2004). Furthermore, in higher 
eukaryotes, GDA (also known as cypin) plays an essential role in the 
development of neuronal morphology where the dendrite growth/ branch 
formation by GDA is dependent on the breakdown of guanine as substrate 
(Chen et al., 2005, Chen and Firestein, 2007). 
Recent studies have shown that abnormally high levels of GDA activity occur in 
serum from patients suffering from liver diseases as compared to levels in 
healthy adults. A strong correlation is observed between high GDA activity and 
patients with chronic hepatitis, biliary obstruction, and liver cirrhosis (Kuzmits 
et al., 1980, Shiota et al., 1989). Although GDA serves as an attractive drug 
target for the prospective treatment of purine metabolism deficiency, liver 
diseases, and cognitive disorders; novel ligands, which may act as clinically 
significant inhibitors and/or activators of the enzyme, have not been intensely 
investigated. 
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Figure 3.4. Pathway for the enzymatic degradation of purines in humans. 
Reproduced with permission from (Berry and Hare, 2004). 
 
GDA, a homologue of Drosophila dihydropterin deaminase (CG18143) which 
encodes an enzyme responsible for the hydrolytic deamination of guanine, i.e. 
conversion of guanine to xanthine (Kim et al., 2009, Takikawa et al., 1983). 
Xanthine is again oxidised by xanthine oxidase to form the final product, uric 
acid. Therefore, we knocked down CG18143 in Drosophila MTs to determine its 
involvement in oxalate stone formation. 
3.2.1.10 Na+/H+ exchanger regulatory factor (NHERF1)- homologue of 
Drosophila Sip1 (CG10939) 
NHERF1 was first characterised in rabbit border membrane as an essential 
cofactor for cyclic AMP inhibition of Na+/H+ exchanger (Weinman et al., 1989, 
Murtazina et al., 2007). Mutation of NHERF1 is associated with different 
diseases such as imbalance in renal phosphate absorption (Giral et al., 2012), 
hypercalciuria (Levi and Bruesegem, 2008), osteoporosis tumour growth (Pan et 
al., 2006) and uric acid stones formation (Cunningham et al., 2007). 
Intriguingly, targeted deletion of NHERF1 in mouse elevates intestinal 
deposition of calcium and also triggers calcium oxalate and uric acid crystal 
formation (Shenolikar, 2002). Hence, to better understand the role of NHERF1 
in Drosophila kidney, I selectively knocked down Sip1(Drosophila homologue of 
human NHERF1) in stellate cells to observe the impact on stones formation. 
The detailed characterisation of Sip1 gene is presented in Chapter 5. 
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3.3 Results 
3.3.1 Determination of the dose of NaOx 
A preliminary study was performed to determine the minimum dose of NaOx to 
induce CaOx crystals in Drosophila MTs. Different dosage of NaOx (0.1%, 0.2%. 
0.5% and 1%) were fed to Canton-S (wild-type strain of D. melanogaster) and 
the total stones accumulated within MTs were quantified at day 1, day 2 and 
day 4. For this MTs were dissected and imaged using a polarised light 
microscope to visualise the birefringent crystals of CaOx.  
Astonishingly, CaOx crystals appear as early as within 2 hours when viewed 
under the microscope. Monohydrate CaOx crystals (clear or jewel-like gloss; 
six-sided prisms or various forms) are more common than the typical dihydrate 
CaOx crystals. Various forms of monohydrate CaOx crystals shapes were also 
identified. Free crystals were extensive, with many incorporated in casts. Their 
size is estimated to vary approximately between 5 and 20µm. Most crystals 
were identified within the ‘enlarged initial (distal) segment’ of the anterior 
MTs of flies of either sex, where the calcium is stored in concretions. Figure 
3.5 indicates a representative image of CaOx crystal deposition in the MTs. 
  
98 
 
 
Figure 3.5. Oxalate nephrolithiasis in Drosophila renal tubules. A. tubules 
dissected from adult fly fed in a normal diet. B. tubules from the adult fly fed 
with NaOx. Scale: 500 µm. 
 
To optimise NaOx concentration, crystal-inducing period, and the quantity of 
crystal formation in anterior and posterior tubules, male flies were fed with 
different concentrations of NaOx for 1,2 and 4 days. The details are shown in 
Figure 3.6. The mean stone formation time in anterior tubules is high as 
compared to posterior tubules at days 1, 2 and 4. Interestingly in anterior 
tubules, the accumulation of stones increased with feeding time, e.g. 0.2% 
NaOx fed flies at day 1 had 13.09±2.61% stones; on day 2, 19.46±0.85% and on 
day 4 23.84±5.29.  Similarly, at a particular day (either day 1, day 2 or day 4), 
the quantity of stones accumulated increased with the concentration of NaOx, 
i.e. 1% fed flies have a higher quantity of stones compared to 0.5% NaOx fed 
flies followed by 0.2% and 0.1% NaOx fed flies. However, we did not observe 
consistent results in posterior tubules. For example, the total quantity of 
stones accumulated in day 1 is significantly higher compared to flies dissected 
in day 2, fed with the same dose (0.2%) of NaOx. Hence, the quantity of stones 
formed by feeding male flies with 0.2% for 2 days was found to be sensitised 
background in which only impact (positive or negative) on stone formation 
would be readily detectable. Hence, this dose was used throughout the 
experiment. 
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Day 1 Day 2 Day 4 
Anterior Posterior Anterior Posterior Anterior Posterior 
 
Control 0.0±0.0 0.0±0.0 0.65±0.62 0.087±1.73 0.19±0.09 0.62±0.45 
NaOx  
0.1% 0.09±0.08 1.24±1.52 2.11±0.92 0.47±0.31 18.78±3.32 15.49±2.26 
0.2% 13.09±2.61 8.65±1.03 19.46±0.85 2.34±1.04 23.84±5.29 16.45±4.29 
0.5% 18.49±4.74 11.41±3.18 23.64±2.91 18.33±8.25 24.47±6.07 11.54±2.57 
1% 32.40±4.43 12.75±2.62 26.91±2.89 8.82±1.90 41.59±6.67 6.12±2.58 
 
 
Figure 3.6. The extent  of crystals formation in male adult Drosophila MTs 
fed on NaOx. A. The total quantity of stones accumulated in anterior and 
posterior tubules after feeding with different doses of NaOx for different days 
represented in table and graphs. (B-C) Line graph representing the total stones 
accumulated in the anterior and posterior tubules after feeding flies with 0.2% 
NaoX for 2 days. Values were expressed as mean ± SEM, N = 10 tubules for each 
condition.  
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3.3.2 Genes knockdown results in an alteration in the 
accumulation of oxalate stones within the Drosophila 
Malpighian tubules 
Seeking a Drosophila model for the urinary stone disease, we examined the 
consequences of knockdown of homologues of human genes (Error! Reference s
ource not found.) implicated in kidney stone formation. All parental lines 
(Capa-R-GAL4/+ and UAS- GeneX RNAi/+) and knockdown lines (CapaR-
GAL4>UAS-RNAi) were fed with 0.2% NaOx and the mineralised concretion in 
adult Drosophila MTs after 48 hours quantified. The Representative images of 
the parental lines and knockdown conditions are shown in Figure 3.7.  
 
 
Figure 3.7. Representative images of tubules from control flies (CapaR 
GAL4/+ and UAS-RNAi/+) and gene knockdown flies (CapaR GAL4>UAS-
RNAi/+) fed with 0.2% NaOx for 2 days. White concretions are birefringent 
crystals accumulated intraluminally.  
 
Under light microscopy examination, concretions were birefringent intraluminal 
contents within the MTs and had the appearance of small stones. Upon 
dissection, they also looked like small stones, given their physical appearance, 
we refer to these as fly stones composed of oxalate. Throughout the 
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experiment, UAS-RNAi> Capa R GAL4 was regarded as a knockdown group and 
UAS-RNAi/+ and  CapaR-GAL4/+ were regarded as control groups.  From a 
screen of twenty independent RNAi lines, we did not observe the significant 
change in the quantity of stone accumulation in twelve RNAi lines, as compared 
to the parental controls. The list of the genes is enlisted in Figure 3.8. 
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Gene ID Source UAS-
RNAi/+ 
CapaR-
GAL4/+ 
UAS-RNAi> 
Capa R GAL4 
Statistics 
CAH1 (CG7820) VDRC 69.17±3.447 21.20±3.479 24.04±4.584 NS 
SPoCK (CG32451) VDRC 52.91±2.863 21.20±3.479 44.26±3.232 NS 
Wtrw (CG31284) VDRC 55.08±3.049 21.91±4.680 35.07±1.887 NS 
UAT (CG11374) BDSC 62.07±2.137 21.91±4.680 35.60±3.302 NS 
Cin (CG2945) VDRC 28.74±3.275 21.91±4.680 23.16±3.176 NS 
Dihydropterin 
deaminsase 
(CG18143) 
BDSC 49.69±4.226 21.91±4.680 51.10±2.177 NS 
Dihydropterin 
deaminsase 
(CG18143) 
VDRC 55.07±2.835 21.20±3.479 29.82±3.366 NS 
MOCS1 
(CG33048) 
BDSC 50.09±3.337 21.91±4.680 55.20±2.354 NS 
 
 
Figure 3.8. List of RNAi lines which on knockdown did not show significant 
aggregation or decrease in stone quantity.. A. Table enlisting a list of genes 
which on knockdown did not have a significant effect in the quantity of stones 
accumulation compared to parental control conditions.  B.  The data shown in 
103 
 
the table are represented in the bar graph. Data are presented as mean ± SEM. 
N=10 MTs. One-way ANOVA followed by Dunnett’s test. N.S. stands for non-
significant. BDSC: Bloomington Drosophila Stock Centre, VDRS: Vienna 
Drosophila research centre.  
 
 
However, in the remaining eight RNAis, I observed a significant high/low 
quantity of stones upon knockdown as compared to parental controls. The list 
of genes are Waterwitch (Wtrw), Serine Pyruvate Amino Transferase (Spat), 
Cinnamon (Cin), Na+-dependent inorganic Phosphate Co-transporter (NaPi-T), 
Sarcoplasmic Calcium-binding Protein 2 (Scp2) and Secretory Pathway 
Ca2+/Mn2+-ATPase (SPoCK) and is enlisted in Figure 3.9.  Remaining two are 
described in  Chapter 4, Chapter 5 and Chapter 6. Further, gene silencing 
efficiency for all the shortlisted genes  was quantified by qPCR and represented 
in Figure 3.10. Among all the genes enlisted in Figure 3.9, Spat (CG3926 from 
VDRC) did not show any significant knockdown compared to parental controls; 
hence, the result is not mentioned in Figure 3.10. 
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A 
Gene ID Source UAS-
RNAi/+ 
CapaR-
GAL4/+ 
UAS-RNAi> 
Capa R 
GAL4 
Statistics 
Cin (CG2945) BDSC 25.22±3.429 21.91±4.680 43.53±1.614 *** 
Spat (CG3926) BDSC 45.20±4.464 21.20±3.479 67.44±2.385 *** 
Wtrw (CG31284) BDSC 38.51±1.915 22.71±4.824 64.11±2.348 *** 
SPoCK (CG32451) BDSC 32.12±3.208 21.20±3.479 50.82±3.389 *** 
Spat (CG3926) VDRC 61.68±7.778 21.91±4.680 13.38±1.942 *** 
Scp2 (CG14904) VDRC 26.47±3.447 22.71±4.824 40.90±4.715 *** 
 
 
Figure 3.9. Silencing/Downregulating candidate genes expression 
alters/impacts the concretion formation in a fly model for oxalate kidney 
stone formation. A. Table enlisting the list of a gene which on knockdown 
resulted in a significant alteration in stone accumulation compared to parental 
controls. B. Measuring the areas of the tubule lumen occupied by mineralised 
concretions in control flies (CapaR GAL4/+, UAS-RNAi/+) and  knockdown flies 
(CapaR GAL4>UAS-RNAi)fed with 0.2% NaOx for 2 days. Data are presented as 
mean ± SEM. ***p<0.05, **p<0.01, *p<0.001 one-way ANOVA with Dunnett’s test, 
N = 10.  
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Figure 3.10. Validation of gene expression in principal cells of MTs in Gene 
knockdown MTs.  The expression of Gene X was significantly reduced in CapaR 
GAL4>UAS-Gene RNAi compared to parental lines (CapaR GAL4/+, UAS-RNAi/+). 
Data are presented as fold change, N=3, ***p <0.05, ** p <0.01, *** p <0.001 
one-way ANOVA followed by Dunnett’s test . 
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3.3.2.1 Discussion 
Despite possible limitations of D. melanogaster as a pre-clinical model for 
nephrolithiasis, we hypothesised that it could have value as a screening 
platform for identifying genes which could increase or decrease calcium 
oxalate calculus formation. Previous studies have validated the use of 
Drosophila for the screening of the genes and the compounds for the treatment 
of the diseases (Chi et al., 2015, Hirata et al., 2012). Hence we used flies as an 
amenable genetic model for the study. However, it is important to consider the 
physiological nature of concretion accumulated within the tubules. Dube et al. 
demonstrated that flies mainly formed concretions in the anterior MTs and 
postulated that this was meant to regulate calcium; tubular calcium excretion 
was thought to be a normal homeostatic function in the wild-type fly (Cabrero 
et al., 2014, Dube et al., 2000). These concretions were visible as small 
calcium-containing spherules/spherites (Hirata et al., 2012, Miller et al., 2013). 
In our model, similarly, appearing concretions are induced by feeding flies with 
stones inducing lithogenic agent (NaOx).  
This screening platform relies on the dietary administration of sodium oxalate 
in parental control and knockdown RNAi flies (candidate genes knockdown) to 
observe changes in intraluminal calculus quantity via imaging and 
quantification (Hirata et al., 2012). The assay performed in D. melanogaster 
provides a highly promising in vivo screening platform for the identification of 
the genes involved in stone formation. The results of our study were consistent 
with data from rats and humans. It is flexible and scalable to screen hundreds 
of candidate genes at a minimal cost. However, it might take too much time if 
crosses are not maintained regularly. The use of birefringent signals to 
quantitate stone accumulation is a validated and innovative system that is cost-
effective and does not require any additional processing or staining. It also 
suggests that other birefringent calculi, such as uric acid calculi are also 
amenable to this type of screen.  
This screening platform provides several avenues of opportunity to narrow 
down large numbers of potentially overlooked candidate genes with possible 
clinical applications for further evaluation. This permitted us to select the 
genes which had human homologues and might have some impact on kidney 
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stone formation. Another key point for the selection of the genes was the use 
of the RNAi lines which were efficiently knocked down in Drosophila MTs 
principal cells. Screening of 20 different RNAi lines led to the identification of 
eight major genes that have a significant impact in stone formation and were 
referred to as candidate “hits”. The list of hits is; Waterwitch (Wtrw), Serine 
Pyruvate Amino Transferase (Spat), Cinnamon (Cin), Na+-dependent inorganic 
Phosphate Co-transporter (NaPi-T), Sarcoplasmic Calcium-binding Protein 2 
(Scp2) and Secretory Pathway Ca2+/Mn2+-ATPase (SPoCK). Two genes from this 
initial screen were further studied for their impact on stone formation. Still, 
we cannot exclude the genes which were not hits, because although no change 
in stone formation was seen in the RNAi lines, I had not performed qPCR on 
genes that had not shown an effect. Hence, the effect may be due to poor RNAi 
lines. However, positives resulting from the screen and with confirmed qPCR 
knockdown are likely to be genuine positives. 
The observed effects of hits in these experiments raise intriguing questions 
about the potential for these genes to be used as a strategy to prevent and or 
treat pre-existing human calcium oxalate stone disease. In patients at risk for 
calcium oxalate stone formation, these genes could through competitive 
inhibition, prevent calcium oxalate binding. In humans, it has been noted that 
PH1 occurs due to the mutation and polymorphism of the AGXT gene (Cochat et 
al., 2010). The Drosophila homologue of AGXT is spat, which functions in 
catalysing the conversion of glyoxylate to glycine using L-alanine as the amino 
donor (Lüneburg et al., 2014). It might play a distinct role in the determination 
of oxalate concentration. In addition to this, it has been noted that rosy and 
maroon like mutants (homologues to XDH genes) suffer from the whole-body 
accumulation of xanthine and the formation of xanthine concretion within the 
Malpighian tubules (Dow and Romero, 2010, Miller et al., 2013). Defects of XDH 
causes Xanthinuria. In nonneuronal tissues, the encoded protein is also required 
for molybdenum cofactor (Moco) biosynthesis. Moco contains the element 
molybdenum, which is essential for the function of several enzymes, including 
XDH. Another gene cinnamon, a homologue of human gephyrin, is a conserved 
evolutionary gene in mammals and multicellular fungi. Recent work (Wittle AE 
et al.) in Drosophila Moco gene cinnamon (cin), which encodes a multidomain 
protein, CIN, shows significant similarity to different proteins encoded by 
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prokaryotic Moco genes (Wittle et al., 1999). Lack of Moco biosynthesis results 
in the loss of all Moco dependent enzyme activities, finally leading to death in 
affected patients. Hence gephyrin might have a vital role in nephrolithiasis.  
Furthermore, a recent study has shown that other genes namely, Calcium 
Binding protein (Scp2; CG14904), Sodium Phosphate symport (NaPi-T; 
CG10207), Calcium pump (SPoCK) and Trp like calcium channel water witch 
(CG31284), which are expressed in the initial segment of tubules might play an 
important role in nephrolithiasis (Chintapalli et al., 2012b). SPoCK has the 
major role in Ca2+ /Mn2+ ATPase in the tubules along with the peroxisomal 
biogenesis. Ca2+ can enter to the specialised peroxisome through Trp like 
plasma membrane channel along with SPoCK (Southall et al., 2006); phosphate 
is supplied through Na+/phosphate cotransporter; Napi-T, the membrane is 
polarised by V-ATPase (with protons provided by a highly enriched isoform of 
carbonic anhydrase). Calcium is enriched by Scp2, a specialised calcium-binding 
protein (Gao et al., 2006). This screening platform provides several avenues of 
opportunity to narrow down large numbers of potentially overlooked candidate 
genes with possible clinical applications for further evaluation. 
Our study has several advantages yet is not without limitations. We have 
applied a novel animal model, which readily provided a large number of test 
subjects. In addition, the results of our study were consistent with data from 
rats and humans. The translation of our obtained results using the proposed 
model to  humans is difficult because human stones are composed of different 
stones causing agents like phosphate, oxalate or uric acid. There are two main 
concerns. One is that the absorption, metabolism, and excretion of a given 
substance using an invertebrate model can be different from those of 
mammals, and consequently, the results may not be comparable. The second 
aspect is related to the composition of fluids in MTs of flies and the urine 
composition of mammals.  
The percentage of candidate hits (40 %) that resulted in significantly alteration 
in stone accumulation compared to the control conditions was unexpected. 
Similarly, the total stones accumulated in UAS-RNAi/+ were significantly high 
compared to the UAS-Gal4/+ hence, further investigation is required to address 
this question. That means these RNAi lines might have some other factors 
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silenced which might be the major influencing factor of kidney stones. 
However, re-screening was not performed using different approaches. This is a 
flaw in the study design; it would have prompted more screens of the library 
with no true termination point. Further, the stones accumulated in the 
knockdown lines of CG3926 (Spat) is opposite between two lines of different 
origins, i.e. BDSC and VDRC. However, on verification with qPCR, I did not 
observe any significant knockdown in VDRC origin RNAi lines. Hence further 
investigation would be important to determine the reason behind it. Upon 
completion of the first pass of the genes screen, the set of genes discovered 
led to focused studies on a single gene. Discovery of a gene with an essential 
role in stone formation validated the capacity of the screen, which was the 
main goal of the study. 
3.4 Conclusion 
The reverse genetic screening provides a useful insight into the function of 
genes which modulate oxalate stone formation in the MTs. We examined the 
role of phosphate, urate and calcium transporters in initiating fly stone 
formation using a genetic approach to knock down genes expressed in MTs 
principal cells. Ion transporters and channels are particularly prevalent in 
having an impact/effect on oxalate stone formation in Drosophila MTs. 
Knockdown of four homologues genes resulted in upregulation in stone 
formation while downregulation of one of the genes resulted in a decrease in 
stone accumulation. Thus, this finding suggests that characterisation of the 
candidate genes identified in our screen will help to reveal molecular 
mechanisms that modulate stone formation in many different organisms. 
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Chapter 4 Characterisation of the role of 
temperature and age in kidney stone formation  
 
4.1 Summary 
In Chapter 3, I discussed different factors (such as genetics, environmental, 
socio-economic, dietary intake, lifestyle) as the key contributors promoting 
renal stones. In this chapter, the impact of environmental factors on 
mineralisation is characterised. Although many studies have been conducted in 
the human/mouse model to understand the impact of temperature and age in 
renal stone development, the stage of and nature of the stones developed 
remains predominantly unknown. The frequent association of renal stones with 
temperature and age highlights their role in the occurrence and relapse of the 
disease, which is the critical focus of this investigation. The introduction to this 
chapter describes current understanding regarding the role of environmental 
factors in initiating the mineralisation process. The results presented in this 
chapter help to establish Drosophila melanogaster as a model for phosphate 
stone studies. For this, flies were reared at a different temperature, altering 
the temperature weekly and quantifying stones over an extended time frame. 
To further test the role of phosphate transporters, NaPi-T and Picot, in driving 
the creation of stones, flies were reared for 21 days, and the alteration in 
expression with age was observed. Colorimetric analysis of the stones in 21 
days old Drosophila Malpighian tubules (MTs) revealed high enrichment of 
phosphate, which is also one of the major constituents in human kidney stones. 
Additionally, when the expression of NaPi-T was silenced, surprisingly 
significant growth of stones was observed. Taken together, investigation based 
on physiological, genetic, biochemical and pharmacological assays validate a 
critical role of temperature and age in the process of nucleation, which 
eventually leads to the stone deposition. In conclusion, the findings of the 
present study potentially suggest a novel mechanism for renal stone growth 
involving temperature and age.  
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4.2 Introduction 
Kidney stone deposition is a multi-faceted process often associated with 
genetics, environmental and physiological behaviours (Hirata et al., 2012, 
Miller et al., 2013); such as human feeding behaviour, age, the altitude of 
residence, hydration levels, urinary volume and the urine pH (Worcester and 
Coe, 2010, Dow and Romero, 2010). Ageing and geographical variation are 
significant risk factors contributing to the development of kidney stones. 
Ageing is the outcome of the interaction of the plethora of genetic and 
environmental factors and biochemical pathways. As we age, we accumulate 
cellular damage at the molecular levels, accompanied by a decrease in the 
efficiency of our body, causing various metabolic and physiological disorders 
(Ortega and Farley, 2015). Furthermore, environmental factors like region of 
residence, seasonal variance and global climate change also increase the rate 
of kidney stone disease. In the broad consensus, the average global 
temperature has been increasing over the past few decades and also is 
mirrored by the rate of hospitalised patients due to stones. Hence, an in-depth 
study of the involvement of the demographic and regional variations in the 
incidence of kidney stones may provide clues to their aetiology and prevention. 
4.2.1 Kidney stone prevalence with age  
Recent investigations suggest that ageing is one of the main factors initiating 
kidney stones (Taylor et al., 2004, Scales Jr et al., 2012). Although little is 
known about the effect, it is identified that the rate of stone creation varies 
among different age groups mainly depending on the composition of the stones. 
For example, cystine stones initiate in the first and second decades of life; 
calcium stones form in between the third and fifth decades of life; while uric 
acid stones usually start after the age of 50 (Lancina Martin et al., 2004). 
However, children and adolescents show a low incidence of stones of all 
compositions (Knoll et al., 2011). 
Kidney stones cause a higher rate of morbidity in older adults as compared to 
the younger population because older adults have are high risk to other 
multiple comorbidities including hypertension, diabetes mellitus and metabolic 
syndrome (MeS), coronary artery disease, obesity, and excessive meat 
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consumption (Kaur, 2014). Recent studies have shown that 10.6% of men and 
18.4% of women develop their first calculus before they turn the age of 20 
(Lancina et al., 2004) and these outcomes are believed to be the consequences 
of changes in lifestyle and diet (Krambeck et al., 2013).  
Further, the elderly population over 60 years of age are most prone to stone 
disease associated with complications of infection due to the increased 
frequency of urinary tract infection and concomitant urological diseases. It is 
estimated that, in this age group, the risk of attaining the disease is 20% in men 
and 5–10% in women (Knoll et al., 2011). A cross-sectional study conducted 
across different states in the United States of America (USA) has pointed out 
that the incidence of mineralisation increases with age until the age of 70 and 
then decreases after that (Soucie et al., 1994, Cramer and Forrest, 2006). 
Another study conducted in Iran, Japan and USA has reported that the 
incidence rate among different age group alters with age of the population. 
The peak age of occurrence was similar among these three countries, ranging 
from 40 to 49 years, except for Japanese women for whom the peak incidence 
occurred between the age of 50 to 59 years (Romero et al., 2010).   
Studies have shown that the prevalence rate increased with age in Germany, 
Iceland, Iran, Italy, Greece, Turkey, and the USA, although there is a sharp 
decrease in prevalence in Italians, age > 60 years, living in Milan (Stamatelou et 
al., 2003, Amato et al., 2004, Hesse et al., 2003, Trinchieri, 2008). In South-
Korea, prevalence rate declines with an increase in the age of men; however 
the result is opposite in  women (hoe Kim et al., 2002). In the USA, a study 
during 1976 through 1980 showed that frequency decreases in women over age 
59 and men over age 69, but by 1991 prevalence rates continued increasing as 
the population got older among all age groups (Stamatelou et al., 2003). 
4.2.2 Kidney stone prevalence with gender 
Gender specifically, males are more susceptible to suffer from kidney stone as 
compared to women (Parmar, 2004), with lifetime occurrence rate up to 50%. 
According to the USA National Health and Nutrition Examination Survey 
(NHANES), the susceptibility ratio of men to women is 3:1, prevalence was 7.1% 
in women and 10.6% in men, however, in other western countries is 4.3% in 
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women and 6.9% in men (Lin et al., 2014). Similarly, the sex ratio ranges from 
2.5:1 in Japan to 1.15:1 in Iran (Safarinejad, 2007, Fujita, 1979). Nevertheless, 
there is an age range in some countries where this ratio is reversed. Studies 
suggest that women have lower urinary calcium, oxalate and uric acid 
concentrations, but have higher concentrations of citrate than men, which 
might be the cause for reduced frequency of stone formation (Vega Carbó et 
al., 2009). However, over the years this rate has increased for females, which 
could be due to other risk factors associated with a lifestyle such as a diet 
intake and obesity (Lancina et al., 2004) Figure 4.1. 
 
Figure 4.1. Kidney stone prevalence by age group. (A) Rise-and-fall pattern is 
observed for reported incidence rates in Iran during 2005. (B) Prevalence of 
stones increases with age in Germans. (C) Prevalence rate increases along with 
age among those living in Milan, but a prevalence decreases after 60 years of 
age. (D) Prevalence in men and women demonstrates a rise-and-fall pattern as 
the population ages in the USA. Adapted from (Romero et al., 2010). 
 
4.2.3  Kidney stone prevalence with geographical location  
Geographical variation is another influential factor responsible for alteration in 
the accumulation of renal stones. The prevalence in a given population not only 
depends on the geographical area but also differs depending on the racial 
composition and socioeconomic status of the community (Trinchieri, 2008). 
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Evidence attained from different geographical regions in the USA, Europe and 
Asia demonstrates that people residing in warmer areas have a high prevalence 
of renal stones as compared to people residing in colder areas Figure 4.2 (Dirks 
et al., 2006, Soucie et al., 1994, Brikowski et al., 2008). 
Figure 4.2. The predicted kidney stone risk areas around the globe. The 
stone belt (red) extends all the way around the world and is characterised by 
the urinary stone prevalence of 10 to 15%. Climate simulations for the USA 
indicate that the stone belt will move northwards in the coming decades. 
Adapted from (Fisang et al., 2015). 
 
The probability of conceiving stones varies considerably in different parts of 
the world. It affects 10–15% of the population in parts of Asia, 5–9% in Europe, 
and 12-15% in North America (Silva et al., 2011). The risk of developing kidney 
stone among adults is more significant in the western hemisphere (9.5% in 
Europe, 12% in Canada, 13–15% in the USA) as compared to the adults living in 
the eastern hemisphere (5.1%) (López and Hoppe, 2010). South western Asia 
represents a high-risk environment for stones (5 times higher) (Evans and 
Costabile, 2005) as compared to other regions of the world. The highest risk 
has been reported in the United Arab Emirates (UAE), Kuwait and Saudi Arabia 
(20.1%) (Robertson, 2012). 
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4.2.4 Kidney stone prevalence with temperature 
There is an increasing incidence of nephrolithiasis in the tropics, especially 
during the summer, where the risk is aggravated by low urine volume 
(Trinchieri, 2008). It is known that elevated temperature causes increase in 
heat-induced sweating which further, leads to a state of dehydration causing 
reduced urine volume and increase in diuretic concentrations, which thereby 
facilitates the crystallisation of the urinary compositions, thus triggering the 
accumulation of stones (Silva et al., 2011).  
Previous studies hypothesise that dry climate increases the development of 
renal calculi, mainly due to dehydration (Khan et al., 2016, Clark et al., 2016). 
Further, it is known that the incidence of nephrolithiasis is higher in countries 
with a warm climate, mainly the North American and Afro-Asian stone belts, 
probably due to low urinary output and low fluid intake (López and Hoppe, 
2010). In the United Kingdom, a similar study was conducted to find the 
relation between seasonal variation in temperature with mineralisation 
process, where researchers analysed urine samples for 24-hours from 246 male 
patients with a history of kidney stones (Fakheri and Goldfarb, 2011). Further 
analysis demonstrated statistically significant changes in the quantity of stones 
in summer as compared to winter. However, no change was observed in urine 
pH or volume in this UK study.  
A similar study was conducted in Finland throughout a year, and the results 
were analysed by measuring the serum level of 25-hydroxyvitamin D, urinary 
calcium, and urinary oxalate (Juuti and Heinonen, 1979). It is known that 
sunshine activates vitamin D and therefore increases the concentration of 
serum 25-hydroxyvitamin D, thereby elevating urinary calcium levels in summer 
(Lin et al., 2014). Moreover, the levels of 25-hydroxyvitamin D were higher 
throughout the year in hypercalciuric stone-formers than normocalciuric stone-
formers. All the changes observed correlated temporally with an increase in 
sunlight measured by units of ultraviolet light. Further, seasonal variation was 
also evaluated in Kuwait by quantifying the number of patients visiting in the 
hospitals due to renal colic; the authors found 980 cases of colic in the summer 
versus only 524 cases in the winter (Fakheri and Goldfarb, 2011). 
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Studies conducted across the USA found that the rate of stone prevalence 
increased from north to south and west to east (Figure 4.3). The north-to-
south trend correlates well with temperature variation, but the role of climate 
in the west-to-east trend is much more ambiguous (Brikowski et al., 2008). 
These reports were further supported by other researches across the USA. In 
addition to that, another study has shown/examined the relation between 
stone prevalence and specific risk factors such as mean temperature, sunlight 
index, and beverage consumption. For males, sunlight exposure caused more 
stones as compared to variation in mean annual temperature or beverage 
consumption. For women, beverage consumption, average temperature, and 
sunlight index explained regional variation more or less equally (Soucie et al., 
1996).  
Figure 4.3. Predicted growth in the high-risk stone area (stone belt; risk 
ratio ≥1.2) vs time, for 2000 (yellow), 2050 (orange), and 2095 (red); linear 
model. At 2000, 41% of the population is within a high-risk zone, 56% in 2050, 
and 70% in 2095, based on the year 2000 population distribution. Reproduced 
with permission from (Brikowski et al., 2008) 
 
 
Subsequently, the first prospective study in healthy human population showed 
that the mean time to develop symptomatic urinary calculi was 93 days after 
continuous exposure to hot temperature (Evans and Costabile, 2005). 
Furthermore, consistent results were attained analysing the duration of 
symptoms (stones) occurrence in the European immigrants moving to Israel 
(Frank et al., 1959) and also with military desert deployments (Blacklock, 
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1965).  Similarly, professional cooks exposed to intense heat for a long time 
have a high prevalence of renal stones; and likewise, the workers exposed to 
the extensive heat in the glass industry (Atan et al., 2005). 
Overall, these data provide a comprehensive picture to forecast the 
relationship between geographic variability and weather in the creation and 
development of renal stones. Based on these observations, we derive two 
primary outcomes:  
a. Kidney stone growth increases with a rise in environmental 
temperature.  
b. The incidence of mineralisation increases with age. 
  
4.3 Aims: 
Evidence shows that many factors may influence nephrolithiasis, either as 
protective or risk factors (Scales Jr et al., 2012). To further elucidate the 
possible mechanisms behind temperature and age-induced nephrolithiasis, we 
undertook a study to observe the trend of the mineralisation process using 
Drosophila as a model organism. Besides all the benefits of using Drosophila in 
molecular research as enumerated in section 1.6. Drosophila can be readily 
switched from one temperature to another, which allows researchers to make a 
rapid observation of the effect of environmental alteration in stone production. 
Specifically, we studied variation by rearing and switching flies between high 
and low temperature or vice versa. Further, we altered the temperature every 
week to observe the change in the pattern of stone formation. Through 
quantification and analysis of the data, we provide clear evidence that 
temperature variation correlates with renal stones accumulation. Thus, 
Drosophila can be used to model the impact of the environment on stone 
formation. 
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4.4 Results: 
4.4.1 Rise in temperature accelerates Drosophila stone 
development 
To investigate the functional role of temperature in stone development newly 
emerged wild-type flies (Canton S) were collected from stock tubes and reared 
at different temperatures: 18°C, 22°C, 26°C and 29°C. All the experimental 
flies reared at temperatures as mentioned earlier were dissected on day 7, day 
14 and day 21 and the total stones accumulated within MTs were quantified. 
Under light microscopic examination, the intraluminally accumulated dark 
content had the physical and visual appearance of small stones (hardness of 
stones could be felt by touching with fingers), suggesting the presence of 
stones within the MTs. Given their characteristics, these abundant concretions 
were referred as fly stones Figure 4.4.  
 
Figure 4.4. Representative tubule from control flies reared at 29°C, for (A) 
day 7 and (B) day 21. Stones are dark intraluminal contents. Scale bars: 500 
μm.  
 
 
Interestingly in mammals, sexual dimorphism is evident in kidney stone growth 
(Ling et al., 1998, Stamatelou et al., 2003). Hence, in this study, the stones in 
flies of either sex were quantified to observe the difference in stone 
accumulation in between male and female flies. The amount of concretions 
accumulated in MTs of female flies at 18°C, 22°C, 26°C and 29°C on day 7, day 
14 and day 21, was quantified using a comparative analysis method. At day 7 
and day 14 there was no significant difference in the quantity of stones 
accumulated among all the groups (flies reared at 18°C, 22°C, 26°C and 29°C). 
On day 21, flies reared at 18°C, 22°C, 26°C and 29°C exhibited 13.33 ± 0.81 %, 
23.45 ± 2.61 %, 24.86 ± 1.92 %, 27.04 ± 1.08 %  stones respectively which was 
significantly higher as compared to stones accumulated at day 14 (Table 4.1, 
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A) (flies reared at 18°C, 22°C, 26°C and 29°C exhibited 0.86 ± 0.13 %, 0.96 ± 
0.29%, 1.52 ± 0.17% and 2.01 ± 0.1% respectively).  However, there was no 
significant difference in the quantity of stones between flies reared at 22°C, 
26°C and 29°C. Furthermore, male flies also showed a similar response to that 
of female flies (Table 4.1, B).  
A. Female Anterior 
 
 
Temp 18°C 22°C 26°C  29°C 
Days Mean ± SEM Mean ± SEM Mean ± SEM Mean ± SEM 
7 0.867 ± 0.304 0.901 ± 0.130 1.733 ± 0.225 2.354 ± 0.203 
14 0.866 ± 0.136 0.962 ± 0.296 1.529 ± 0.178 2.015 ± 0.513 
21 13.337 ± 0.812 24.866 ± 1.923 23.456 ± 2.614 27.040 ± 1.077 
28 21.444 ± 1.450 21.408 ± 1.025 25.020 ± 1.803 25.860 ± 1.268 
B. Male Anterior 
 
 
Temp 18°C 22°C 26°C  29°C 
Days Mean ± SEM Mean ± SEM Mean ± SEM Mean ± SEM 
7 1.646 ± 0.456 0.876 ± 0.085 1.355 ± 0.418 0.370 ± 0.158 
14 1.677 ± 0.302 1.329 ± 0.167 0.880 ± 0.131 0.901 ± 0.105 
21 15.632 ± 1.368 20.127 ± 2.284 20.793 ± 1.655 21.553 ± 0.999 
28 20.995 ± 1.489 20.115 ± 1.070 20.733 ± 2.178 20.234 ± 1.654 
 
Table 4.1. Temperature and age-specific occurrence of kidney stones among 
female and male flies. The total luminal area occupied by mineralised 
concretions in (A) female and (B) male flies. At day 21, flies reared at 29°C 
produce significantly more concretions compared to flies reared at 18°C in 
both the cases. However, at day 7 and day 14, there was no significant 
difference in the quantity of accumulated stones in between 18°C, 22°C, 26°C 
and 29°C reared flies. Both female and male flies show a similar response to 
the temperature). Data shown are the mean ± SEM, N=10. 
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In summary, the results indicate a clear positive correlation between 
temperature and renal stone accumulation in flies of either sex. Thus, these 
data are consistent with a similar study conducted in a human model (Fakheri 
and Goldfarb, 2011, Romero et al., 2010), thereby validating Drosophila as a 
useful model for such studies. 
4.4.2 The incidence of kidney stone increases with age 
Next, the influence of age in kidney stone accumulation was examined. For 
this, all the flies were reared for 21 days, and accumulated stones were 
quantified every week. It was observed that the stone formation increased with 
age, irrespective of the gender and temperature they were reared (Figure 
4.5). Among all the groups, 21-day old female flies reared at 29°C, has 27.04 ± 
1.07% stones which are 12-fold high as compared to the stones accumulated in 
14-day old flies. A similar result was also observed between 21 days and 14 
days old female flies, reared at 18°C, 22°C and 26°C. Interestingly, the impact 
of age on stone formation was similar in male flies, thereby confirming that 
stones formation increases with age.  
 
Figure 4.5. Data are replotted from Error! Reference source not found. to d
raw attention to the effect of age on kidney stone formation. In both (A) 
Female and (B) male flies, development of kidney stone increases with age, 21 
days old flies have a significantly higher amount of stones accumulate as 
compared to day 7 or day 14 old flies. Data are presented as mean± SEM, N=10. 
*p <0.05, two-way ANOVA.  
 
In summary, based on the observations above, we can conclude that the rate of 
renal stone accumulation is directly proportional to the age.  
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4.4.3 Alteration in the stone formation rate in response to 
changing of temperature  
In our previous results, temperature specific alteration in stones development 
was demonstrated, where the maximum effect was observed in flies reared at 
29°C, and the minimum in flies reared at 18°C. Hence, to further determine an 
impact of alteration in temperature and exposure time in stone production, 
flies were reared at 18°C and 29°C and then switched to an alternate 
temperature weekly (day 7, day 14 and day 21). The quantity of accumulated 
amount of stones measured for each temperature and age combinations. The 
experimental procedure is shown in Figure 4.6.  
 
Figure 4.6. Workflow for fly maintenance and temperature switching 
 
 
Wild-type flies were reared at 18°C and 29°C, and at age 1, 2 and 3-week they 
were switched from one temperature to other. First, it was confirmed that 
flies, aged 21 days, have an increased amount of stones compared to 7- and 14-
days old flies. Interestingly, it was also shown that at day 21, female flies kept 
at 18°C have significantly fewer stones as compared to flies switched from 
18°C to 29°C at day 7 and day 14 (Figure 4.7 A). Similarly, flies raised at 18°C 
and changed to 29°C, at day 7 exhibited significantly higher levels of renal 
stones than flies switched from 18°C to 29°C at day 14. This was expected as 
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rearing flies at higher temperature should accelerate the rate of stone 
formation. 
The relation of the temperature switching with accumulated stones was further 
analysed by reverse-switching flies from 29°C to 18°C, at day 7 and day 14. By 
contrast, flies reared at 29°C for 21 days accumulated significantly more stones 
as compared to flies switched from 29°C to 18°C, at day 7 and day (Figure 4.7, 
B). 
 
Figure 4.7. Disproportion in renal stone formation in response to switching 
of temperature in female flies. A. Quantification of the total stones 
accumulated in female flies reared at (A) 18°C and switched to 29°C, at day 7 
and 14 and (B) at 29°C and switched to 18°C, at day 7 and 14. Data shown are 
the mean ± SEM, N=8, tubules. For 18°C reared and switched flies 18°C was 
regarded as a control and 29°C reared and switched flies 29°C was regarded as 
control. ***p <0.001, two-way ANOVA.  
 
 
Further, the same analysis was concurrently performed in male flies to observe 
a potential variation in stone accumulation. Surprisingly, 21-days-old males 
reared at 18°C did not show any significant stones compared to males switched 
from 18°C to 29°C, at day 7 or 14. By contrast, 21-day-old males kept at 29°C 
showed a higher quantity of stones compared to males switched from 29 °C to 
18°C, at days 7 or 14, Figure 4.8. 
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Figure 4.8. Renal stone formation in male flies in response to a temperature 
switch. (A) Quantification of stone in flies reared at 18°C and then switched to 
29°C, at day 7 and 14, or (B) reared at 29°C and then switched to 18°C, at day 
7 and 14. Data shown are the mean ± SEM, N=8. For 18°C reared and switched 
flies 18°C was regarded as control and 29°C reared and switched flies 29°C was 
regarded as control. *p <0.05, two-way ANOVA .  
 
 
Taken together, these results demonstrate that the incidence of a renal stone 
depends upon the age of flies and the temperature of their current habitation, 
with past exposed temperature having no detectable effect. Hence, it can be 
proposed that flies reared at low temperature has reduced the quantity of 
stones entirely as a consequence of less accumulation of ageing related 
damage. In reciprocal switches from 29°C to 18°C, the stones were 
significantly higher in flies reared at 29°C for a more extended period. 
Throughout the experiments, female flies subjected to temperature switching 
analysis showed consistent results as compared to male flies. Further, it is 
known that female flies have higher tubule calcium content compared to male 
flies (Chintapalli et al., 2012, Dube et al., 2000), which is required for egg 
production. Hence, a significantly enhanced accumulation was observed in 
female as compared to male flies.  
4.4.4 Intraluminally accumulated stones are composed of 
Phosphate 
Next, the chemical composition of the intraluminally accumulated stones was 
analysed using a colorometric assay. The intensity of the colour of the tubule 
sample was plotted based on the absorbance at 620  nm as a function of 
phosphate concentration in the sample (Figure 4.9). The resultant linear 
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regression equation for the male flies was: Abs=0.1133+0.001754 (R2=0.9424) 
and for female was Abs=0.1103+0.001701 (R2=0.9084). 
 
Figure 4.9. Calibration curves corresponding to phosphate concentration in 
MTs of 21 days old female and male flies. The blue colour intensity in the 
control and samples can be observed directly by naked eyes.; dark blue=high 
concentration. 
 
To examine the selectivity of this system towards the phosphate detection in 
MTs of 7- and 21-days old flies, the phosphate concentration was quantified in 
MTs of both age group flies. The results are displayed in Figure 4.10. As 
expected, the total concentrations of phosphate in MTs of 21 days old flies 
were significantly higher compared to 7 days old flies, independently of the 
gender (~3-fold increase in both males and females).  
 
Figure 4.10. Intraluminal phosphate concentration increases with age. The 
total phosphate concentration in anterior MTs was quantified at day 7 and day 
21. 21 days old flies have significantly higher phosphate quantity as compared 
to 7-day old flies. Data are expressed as mean ± SEM (n = 60). ***p<0.001, 
students t-test. 
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Taken together, these results unambiguously demonstrate the presence of 
phosphate stones within MTs and elevation in the quantity of phosphate stones 
along with age. 
4.4.5 Age-dependent variation in expression of NaPi-T and Picot 
On the basis of the above-mentioned colorimetric result, it is hypothesised that 
phosphate stones might be formed due to high transport of phosphate 
intraluminally in MTs. Hence to better understand the phenomena, the 
alteration in the expression of genes involved in the transport of the phosphate 
across the membrane in MTs was observed in 7- and 21-day old flies. In 
Drosophila, two essential phosphate transporter genes (NaPi-T and Picot) have 
been reported to be highly expressed in MTs (section 4.6), whose function is to 
regulate phosphate movement across the cell membrane (Chintapalli et al., 
2012a, Overend, 2010).  
In this model, the expression level of NaPi-T and Picot was compared with age 
(7 and 21-days old flies) using qRT-PCR. Observations indicate significant 
downregulation (55%) in the expression of NaPi-T in 21-day-old flies as 
compared to 7-day-old flies. Additionally, modest upregulation in the 
expression levels of Picot was observed in 21-days-old MTs as compared to 7-
day-old MTs (Figure 4.11).  
 
Figure 4.11. Effect of age in NaPi-T and Picot genes expression in MTs.  A. 
NaPi-T B. Picot. The experiment was conducted in three biological replicates. 
Data are expressed as the mean of mRNA relative expression ± SEM, N=3. 
**p<0.01, ***p<0.001, students t-test. 
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4.4.6 Knockdown of NaPi-T increases phosphate concentration 
within the MTs 
NaPi-T is the Drosophila orthologue of human sodium phosphate specific 
Transporter-II predominantly expressed in MTs. It is located on the apical 
membrane of the tubular cells and facilitates the excretion of phosphate across 
the cell membrane into the lumen (detail Chapter 6). Based on previously 
published data in other organisms, it can be postulated that by inhibiting 
transport genes function using RNA interference technology, phosphate should 
be sequestered away from the tubule lumen where it would otherwise be 
excreted and should, therefore, be accumulated in higher levels. So, in order 
to verify the effect of NaPi-T in the modulation of the quantity of phosphate, 
genetic and biochemical assays were performed.  
For this, initially, an expression of NaPi-T was silenced in the MTs principal 
cells using CapaR-GAL4. It is found that the expression of mRNA levels of NaPi-
T was reduced by 75% (Figure 4.12).  
 
Figure 4.12. Validation of knockdown of NaPi-T expression in principal cells 
of MTs. The relative expression shows a significant downregulation of Capa-R-
GAL4>UAS-NaPi-T RNAi compared to parental control lines. Data are expressed 
as mean ± SEM, n=3. *p<0.05, one-way ANOVA followed by Dunnett’s test. 
 
 
As shown in Chapter 3 it is observed that RNAi inhibition of NaPi-T resulted in 
increased tubular phosphate concentration as compared to the controls. In 
addition to that, the stones in this model were physically and visually alike to 
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phosphate stones. Hence it is assured that the stones accumulated within the 
MTs are composed of phosphate. Further, the chemical composition of the 
stones was determined using the colorimetric assay kit. We found that 
ubiquitous knockdown of NaPi-T in principal cells (CapaR-GAL4>UAS-NaPi-T 
RNAi) induces significantly higher (~200-fold increase) phosphate concentration 
compared to controls, in both males and females (Figure 4.13). 
 
 
Figure 4.13. Downregulation of NaPi-T expression elevates tubule 
phosphate concentration. CapaR>NaPi-T RNAi exhibits a significant increase in 
the phosphate levels in MTs in both female and male flies compared to 
controls. Data are expressed as the mean ± SEM, N = 60). ***p<0.001, one-way 
ANOVA followed by Dunnett’s test. 
 
Our results demonstrate the importance of NaPi-T in the maintenance of 
intraluminal phosphate concentration. Taken together, these results chemically 
validate the previous findings assuring that inhibition of the function of NaPi-T 
causes formation of phosphate stones. 
4.5 Discussion 
Understanding the diverse causes that give rise to renal stones and the 
development of effective medical management to cure the disease is a long-
standing challenge (Moe, 2006). A significant barrier for such management 
includes a rudimentary understanding of the detailed mechanisms initiating 
stones accumulation (detail in section 1.4.4).  
In this study, the time and duration of stone accumulation concerning gender 
and temperature are well documented, which allows calculating the pattern of 
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stones formation. Previous human studies in the US have shown that locations 
with high temperature have a high prevalence of renal stones (Soucie et al., 
1994). A consistent result was obtained in the European immigrants to Israel 
(Frank et al., 1959) as well with the military desert deployments (Blacklock, 
1965). Similarly, professional cooks exposed to intense heat for a long time 
have a high prevalence of renal stones, and similar results have been observed 
with workers exposed to the intense heat of the glass industry (Atan et al., 
2005).  
The temperature switch experiment revealed that accumulation of stone surges 
at high temperature and decreases with lowering temperature. However, once 
the stones are generated, they reside forever without disintegration. We 
present strong evidence that stone formation was elevated when flies were 
switched from 18°C to 29°C compared to flies permanently reared at 18°C. In 
reciprocal switches from 29°C to 18°C conditions, stones level remained 
unaffected in switched flies. Long-term 18°C reared flies; therefore, either 
impeded the female’s ability to respond to 29°C or ageing related damage 
could not accumulate (Mair et al., 2003). 
Additionally, previous studies have observed that flies reared at 29°C age 
earlier and accumulate ageing-related damage compared to flies reared at 
18°C, 22°C or 26°C. It is generally accepted that anterior tubule of Drosophila 
store a high amount of calcium as a phosphate-rich mineral concentration in 
large initial segments (Dube et al., 2000). Furthermore, anterior tubules are 
enriched with genes implicated in calcium and phosphate transport (Chintapalli 
et al., 2012, Wessing and Eichelberg, 1979). Hence; all the studies were carried 
out using anterior tubules of D. melanogaster. 
However, the primary aim of our experiment was to determine the change in 
the stone accumulation with age. Hence, to be consistent throughout the 
experiment (among all the age groups and temperature reared flies), the 
stones within MTs were quantified every week. Overall, these results extend 
the findings that the process is dependent on the duration of the current 
exposure temperature, and once the stones start accumulating they remain 
accumulated for more time. Further, this observation was validated by 
biochemical assays which revealed that the stones within MTs were indeed 
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composed of phosphate and the phosphate concentration increases with age, 
which thereby might bind with calcium forming the calcium phosphate crystals 
(Ratkalkar and Kleinman, 2011). The details about the formation mechanism of 
calcium phosphate and calcium oxalate crystals are well documented in section 
1.4.5.1. 
Our physiological and biochemical experiments revealed that there are two 
alternative scenarios to explain the elevation of intraluminal phosphate; a. 
Role of phosphate transporters, b. Phosphate storage in the form of concretions 
within the tubule (Chintapalli et al., 2012a, Bergwitz et al., 2012). H. Sapiens 
has three types of membrane-bound phosphate transporters: type I: SLC17A1–9, 
type II: NPT2a, NPT2b, and NPT2c, and type III: Pit1 and Pit2; which are 
thought to be exclusively transporting phosphate across the membrane (Levi 
and Bruesegem, 2008). However, in Drosophila MTs, NaPi-T and Picot are the 
knows major players involved in elevating intraluminal concentration that 
contributes to the kidney disease (Villa-Bellosta et al., 2009, Chintapalli et al., 
2012). In humans (Blaine et al., 2015, Virkki et al., 2007) and rat studies (Villa-
Bellosta et al., 2009), it has been shown that the sodium phosphate 
cotransporters are positioned in the apical membrane of renal proximal tubule 
cells, to move phosphate from lumen to the cell interior (Curthoys and Moe, 
2014b). The qPCR results described suggest that NaPi-T and Picot act as 
contributors to the accumulation of phosphate stones. However, the 
mechanism behind an influence of temperature in the change of body 
physiological function to contribute stones accumulation remains unclear and 
requires further study. 
In humans, the primary driving force is a transporter, Na+/K+-ATPase generating 
an electrochemical gradient for apical phosphate entry (Virkki et al., 2007). 
Mutation of the phosphate transporters causes high accumulation of sodium and 
phosphate intraluminally. Hence, it is hypothesised that a similar mechanism is 
also conserved in the flies resulting in aggregation of renal stones. However, 
Picot is present in the basolateral membrane in Drosophila tubules (Overend et 
al., 2015) and is required to transport sodium inside the vesicles to maintain 
phosphate concentration inside the cell interior (unpublished results; 
Dow/Davies lab). It is hypothesised that, with age, Picot expression increases, 
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thereby elevating the concentration of inward flow of phosphate within the 
tubule.  
In conclusion, our analysis demonstrates that high temperature and age causes 
accumulation of phosphate crystals due to change in expression of phosphate 
transporters. Furthermore, these data complement previous work (Hirata et 
al., 2012, Chi et al., 2015) to establish Drosophila melanogaster as one of the 
best models to study the renal stone formation and highlights its importance in 
the field of biomedicine. Further research focused on the relationship between 
age, temperature, and renal stone formation may reveal new possibilities for 
the management of renal and unrevealing possible new efficient therapies and 
cures for this condition. 
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4.6 Supplementary data 
NaPi-T 
 
Adult Male Adult Female Larval 
Tissue FPKM Enrichment FPKM Enrichment FPKM Enrichment 
Head 0.2 0.0 0.1 0.0 
  
Eye 0.2 0.0 0.1 0.0 
  
Brain / CNS 0.2 0.0 0.3 0.0 0.5 0.0 
Thoracico 
abdominal ganglion 
0.9 0.0 0.8 0.1 
  
Crop 0.5 0.0 1.0 0.1 
  
Midgut 1.9 0.1 0.4 0.1 0.5 0.0 
Hindgut 0.9 0.0 1.0 0.1 2.4 0.1 
Malpighian Tubules 1004 35 917 115 615 28 
Fat body 
 
   3.3 0.2 
Salivary gland 2.1 0.1 0.3 0.0 0.2 0.0 
Heart       
Trachea 
    
1.4 0.1 
Ovary 
  
0.3 0.0 
  
Virgin 
Spermatheca 
  
0.0 0.0 
  
Mated 
Spermatheca 
  
0.2 0.0 
  
Testis 1.3 0.0 
    
Accessory glands 0.1 0.0 
    
Carcass 7.9 0.3 6.2 0.8 0.7 0.0 
Rectal pad 0.2 0.0 0.4 0.1 
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Picot 
 
Adult Male Adult Female Larval 
Tissue FPKM Enrichment FPKM Enrichment FPKM Enrichment 
Head 42 1.0 40 1.5 
  
Eye 33 0.8 29 1.1 
  
Brain / CNS 24 0.6 26 1.0 19 0.9 
Thoracico 
abdominal ganglion 
40 1.0 44 1.6 
  
Crop 4.9 0.1 7.5 0.3 
  
Midgut 125 3.0 107 3.9 18 0.9 
Hindgut 677 16 656 24 112 5.4 
Malpighian 
Tubules 
215 5.2 261 9.6 154 7.4 
Fat body     2.0 0.1 
Salivary gland 18 0.4 28 1.0 7.7 0.4 
Heart       
Trachea 
    
20 1.0 
Ovary 
  
10 0.4 
  
Virgin 
Spermatheca 
  
94 3.4 
  
Mated 
Spermatheca 
  
113 4.2 
  
Testis 20 0.5 
    
Accessory glands 18 0.4 
    
Carcass 20 0.5 19 0.7 6.3 0.3 
Rectal pad 24 0.6 56 2.1 
  
 
Supplementary Tables. Expression of NaPi-T and Picot in Drosophila adult 
(male and female) and larval MTs. Data is obtained from RNA-seq analysis, 
FPKM (Fragments Per Kilobase Million). Adapted from FlyAtlas2 (Leader et al., 
2017).  
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Chapter 5 Role of Sip1 in Uric acid stones 
formation in Drosophila MTs 
 
5.1 Summary 
In Chapter 3, different genes expressed in MTs that are putatively involved in 
renal stone formation were identified. In this chapter, the role of Sip1 (SRY-
interacting protein 1) gene, a homologue of human NHERF1 (Sodium-Hydrogen 
Exchanger Regulatory Factor-1) in Drosophila MTs, and its impact on 
nephrolithiasis were determined. The introduction of this chapter describes the 
uric acid stones formation pathway. Further, we emphasise the 
characterisation of mammalian NHERF1 and its importance in uric acid stones 
formation. Previous studies have demonstrated that targeted deletion of 
NHERF1 augmented intestinal deposition of calcium, thereby elevating calcium 
oxalate and uric acid stone formation. Drosophila Sip1 is strongly expressed in 
MTs and is the primary focus of this study. Mutation or tubule knockdown of the 
Sip1 gene led to abundant uric acid stone formation in MTs, which was 
validated by physical, chemical and pharmacological studies. Further, the 
localisation of SIP1 protein and its partner proteins Moesin and NHE2 were 
demonstrated in stellate cells. In MTs, exchange of Na+/H+ is mediated by NHE2 
and has a specialised role in ion transport in MTs. It is proposed that NHEs 
transport H+ into the lumen using the inward Na+ chemical gradient, thereby 
decreasing luminal [Na+] and increasing luminal [H+] resulting in a lower pH 
that favours precipitation of urate as uric acid crystals. Taken together, our 
results further increase the understanding of the molecular mechanisms of 
kidney stone formation in Drosophila, which may be beneficial for mammalian 
studies leading to the identification of novel approaches to human renal stone 
treatment. 
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5.2 Introduction 
Urate, the anionic form of uric acid (Nuki, 2012), plays an essential role in 
many biological functions, including maintenance of vascular endothelial cell 
integrity and defence against neurological and autoimmune diseases through 
various physiological and biochemical pathways (El Ridi and Tallima, 2017). In 
the normal physiological condition of the human body, uric acid predominates 
at neutral pH and is present both intracellularly in all the body fluids 
(Bobulescu and Moe, 2012). The enzyme urate oxidase (UO or uricase) has been 
lost with evolution in higher primates like humans, suggesting the importance 
of uric acid in survival and reproductive functions of the normal body (Álvarez-
Lario and Macarrón-Vicente, 2010, Riches et al., 2009). However, in mammals, 
uric acid is excreted in the urine, as an end product of purine metabolism. 
Continuous accumulation of uric acid in the body causes various noxious effects 
like gout and kidney stone (Moe, 2006).  
Uric acid stones are the third most common class of kidney stones, accounting 
for around 10% prevalence among the total global population (Curhan, 2007). 
Uric acid stones were first isolated in 1776 from urinary calculi by Karl Wilhelm 
Scheele. He initially called the substance lithic acid and later proved it to be 
one of the major components present in human urine (Fink et al., 2003). 
Similarly, in 1798 George Pearson isolated uric acid from 200 urinary calculi 
specimens and characterised them physically and chemically as uric acid 
(Pearson, 1798). In 1875 Ludwig Medicus proposed the first structure of uric 
acid, without definitive evidence. The first total synthesis of uric acid was 
performed in 1895 by the 1902 Nobel laureate Emil Fischer (Hall et al., 2016), 
proving the accuracy of Medicus’ proposed structure. It has a molecular 
formula of C5H4N4O3 (168.112 g/mol). Since then, different forms of uric acid 
crystals have been recognized as noticeable components in these pathological 
deposits (Atsmon, 1963, Mandel and Mandel, 1989), including anhydrous uric 
acid (UA) (Ringertz, 1965, Ringertz, 1966), uric acid dihydrate (UAD), uric acid 
monohydrate (UAM), the structure of which was only recently reported, as well 
as the ionized forms monosodium urate monohydrate (MSU) and ammonium 
acid urate.  
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5.2.1 Physiology of purines and Uric acid 
In human, uric acid is a necessary product in the purine metabolism pathway. 
Xanthine oxidase (XO), the mediator enzyme, converts hypoxanthine to 
xanthine and xanthine to uric acid, Figure 5.1. In most mammals, uric acid is 
an intermediate product, as it undergoes oxidation by hepatic uricase to the 
more soluble allantoin. However, multiple cumulative mutations result in non-
functional uricase in higher primates, including humans. Thus urate is an end 
product of purine metabolism in humans (Riches et al., 2009). Allantoin is a 
highly soluble compound without any known adverse effects on health (Maiuolo 
et al., 2016). XO inhibitors are effective in reducing new/de novo uric acid 
formation, but the accumulation of xanthine may result in acute xanthine 
nephropathy (LaRosa et al., 2007). 
The sources of purines in the human body are (a) de novo synthesis, (b) cellular 
RNA from the normal turnover of cells, and (c) exogenous, i.e., from external 
sources like dietary intake (Maiuolo et al., 2016, Lane and Fan, 2015). Under 
standard conditions, endogenous uric acid production is about 300–400 mg per 
day. The role of exogenous purines is variable though it usually contributes less 
than 50% of total uric acid production. Elimination of uric acid is achieved via 
the gastrointestinal tract (30%) and the kidneys (70%). About 90% of uric acid is 
freely filtered; the remaining 10% is protein-bound urates. The filtered load 
undergoes several cycles of absorption and secretion by the kidney for a final 
fractional excretion rate of about 10% (Kamel et al., 2005).  
Alkaline supplementation is one of the most effective treatments for existing 
uric acid stone. If the urine pH is upheld at 6.5 or higher (which often requires 
90 to 120 mEq of supplemental alkali per day), uric acid stones dissolve within 
the human body. Slightly lower doses may be used to avoid new uric acid stone 
formation (Kanbara et al., 2010). An XO inhibitor is a second-line choice if the 
patient has noticeable hyperuricosuria or is unable to maintain a urine pH 
higher than 6.5. Several drugs such as benzbromarone, losartan, probenecid 
and salicylic acid have a uricosuric property and thus increase the risk of renal 
stones formation by influencing the renal handling of uric acid. Recent 
molecular identification and functional analysis of urate-specific transporters 
have provided important new insights (Enomoto et al., 2002, Lipkowitz et al., 
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2001, Leal-Pinto et al., 2002). This is of interest not just to better elucidate 
the complex renal handling of uric acid, but also for understanding the genetic 
mechanism behind uric acid stone formation using Drosophila renal tubules 
(Sorensen and Chandhoke, 2002, Johri et al., 2010). 
 
 
 
Figure 5.1. Uric acid biosynthesis pathway. Uric acid is the end product of 
purine metabolism catalysed by different enzymes, including Xanthine Oxidase. 
Adapted from (Berry and Hare, 2004). 
 
5.2.2 Pathophysiology of uric acid stone formation 
The pathogenesis of uric acid stone formation is only moderately understood, 
therefore limiting the prevention and therapeutic approach of the disease. 
Persistent acidic urine, hyperuricosuria and excretion of low urinary volume, 
are the most prevalent risk factors of uric acid nephrolithiasis in humans (Moe, 
2006). Among all, urinary pH is the main determining factor of uric acid 
manifestation and precipitation. If the acidic pH level in urine gets too high, 
then the uric acid crystals may not dissolve, resulting in accumulation of a high 
quantity of uric acid stones (Coe and Coe, 1983). Alternatively, if urinary pH 
becomes alkaline, uric acid stones solubilise and do not precipitate.  
Despite recent findings suggesting that defects in renal tubular ammonia 
production and secretion can at least partially explain low urinary pH, the 
pathophysiology of the disease has not been entirely explained (Gianfrancesco 
et al., 2003, Weiner and Verlander, 2017). Hence, this is of interest not just to 
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better elucidate the complex renal handling of uric acid, but also for our 
understanding of some rare forms of familiar nephrolithiasis associated with 
hypouricemia due to a high fractional excretion of uric acid.  
5.2.3 NHERF1 in mammals 
The cause of uric acid stone development has been the subject to several 
recent investigations, and attention has centred on genetic approaches for 
determination of causative factor of the disease (Riches et al., 2009, 
Vasudevan et al., 2017). Despite the accessibility of various precursor pathways 
and genes proposed to have an essential role in nephrolithiasis, very few genes 
have been characterised and linked with kidney stone formation. In mammals, 
targeted deletion of Na+/H+ Exchanger Regulatory Factor (NHERF1) results in 
uric acid stone formation (Cunningham et al., 2007). Additionally, NHERF1(-/-) 
mutant mice (male and female) have increased urinary excretion of phosphate, 
calcium, and uric acid associated with interstitial deposition of calcium in the 
papilla of the kidney (Weinman et al., 2006).  
The sodium-hydrogen exchanger regulatory factor 1 (NHERF1) is one of the four 
related scaffolding proteins (NHERF1- NHERF4), which regulates sodium 
hydrogen exchanger NHE3 in rabbit kidney epithelial and mainly in the apical 
surface of epithelial cells (Weinman et al., 2006, Ardura and Friedman, 2011, 
Voltz et al., 2001). Scaffold proteins allow the formation of protein complexes, 
interacting with a wide variety of cellular targets. The association of multiple 
target proteins is facilitated by the presence of postsynaptic density protein; 
Drosophila disc large tumour suppressor zonulaoccludens1 protein (PDZ) 
modular protein-protein interaction modules (Cortese et al., 2008). These 
domains interact with specific carboxyl-terminal motifs on target proteins. 
Moreover, the scaffolding function can be enhanced by oligomerisation with 
other PDZ domains.  
NHERF1 is encoded by the SLC9A3R1 gene, which contains six exons and is 
localised in human chromosome 17q25.1. It contains 358 amino acids and is 
characterised by the presence of two PDZ domains, PDZ1 (11-97 amino acids) 
and PDZ2 (150-237 amino acids); these two domains resemble 74% to each 
other and carboxyterminal Ezrin–Radixin–Moesin (ERM) binding region, Figure 
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5.2 (Morales et al., 2004). Human NHERF1 presents 84% similar identity to 
rabbit protein co-factor Na+/H+ exchanger regulatory factor (NHERF) and 48% 
identity to human Tyrosine Kinase Activator Protein 1(TKA-1). NHERF is 
involved in the regulation of rabbit renal brush border Na+/H+ ion exchanger 
(Weinman et al., 1995). NHERF1 align very well over their entire lengths, while 
the sequence of TKA-1 diverges after G261 in NHERF1, and PDZ1 together with 
PDZ2 are found in nearly identical versions in both protein cofactor and TKA-1 
(Fouassier et al., 2001, Kreimann et al., 2007, Weinman et al., 2006). Studies 
have shown that loss of heterozygosity for NHERF1 results in breast cancer, 
suggesting its potential role as a tumour suppressor (Le Dai et al., 2004, Pan et 
al., 2006). Additionally, there is evidence from breast tumour cell lines that 
overexpression or mislocalization of ezrin is correlated with invasiveness (Sarrió 
et al., 2006). 
NHERF1 is enriched in epithelial cells microvilli in various organs of the human 
body such as kidney, intestine, liver and placenta. Microvilli are specialised cell 
surface structures present in polarised epithelial cells and are enriched in 
members of the ERM family protein (Berryman et al., 1993, Amieva et al., 
1994). ERM proteins organise protein complexes that link the membrane to the 
cytoskeleton. The structure of ERM proteins comprises an amino (N)-terminal 
FERM (band 4.1, ERM) domain and a short carboxy (C)-terminal domain. ERM 
proteins bind to transmembrane or membrane-associated proteins with the 
FERM domain and interact, with their C-terminal domains, with actin of the 
cytoskeleton (Morales et al., 2007). 
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Figure 5.2. Domain structure of human NHERF1. (A) Intramolecular structure 
of NHERF1 conformation; (B) The amino acid positions of differently truncated 
domains, including phosphorylation sites: phosphorylation is on Thr156, and Ser 
339-340 disturb self-association, favouring PDZ-ligands interaction. Adapted 
from (Centonze et al., 2018). 
 
 
An observation in the Dow lab (Southall and Giannakou, unpublished) suggested 
that stones were abundant in a P-element insertional mutant for NHERF. In 
Chapter 3, I confirmed this finding; here I established that these stones are of 
uric acid and these findings can be further studied in the context of 
mammalian studies. 
5.2.4 NHERF1 and kidney stones 
Recent studies have shown that mutations in NHERF1 resulted in phosphaturia 
in human (Vaquero et al., 2017, Karim et al., 2008), where three out of seven 
patients who had lower TMP/GFR (tubular maximal reabsorption of phosphate/ 
glomerular filtration rate) values, lower serum phosphate concentrations, and 
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higher serum 1,25-dihydroxy vitamin D concentrations than controls were 
identified with the NHERF1 mutation. Although the NHERF1 mutation causes 
stones, the mechanism behind it is not precise.  Furthermore, NHERF1 mutant 
mice or inhibition of the activity of NHERF1 in cells have impaired transport 
activity and expression of NPT2a in the apical membrane. Phosphorylation of 
NHERF1 by PTH is important in the internalisation of sodium-phosphate 
cotransporter-IIa (NPT2a) (Weinman et al., 2007). However, the actual 
mechanism behind the abnormalities of phosphate transport in humans due to 
NHERF1 mutations is not known because the expression of the mutant NHERF1 
cDNA does not affect phosphate transport. In addition, it will be important to 
determine whether these mutations directly modulate the transport activity 
and expression of NPT2c as well as NPT2a and whether there are secondary 
effects on sodium-potassium–ATPase, which is also regulated by PTH through an 
NHERF1-dependent pathway and may regulate sodium phosphate cotransport 
by means of decreased generation of the sodium gradient. 
Recent studies indicate that NHERF1 also interacts with mouse urate 
transporter 1 to regulate uric acid transport in the proximal renal tubule and 
that NHERF1-knockout mice have increased uric acid excretion (Cunningham et 
al., 2007). A further study has also indicated a potential interaction between 
NHERF1 and the renal-proximal-tubule sodium sulfate transporter NaSi-1, but it 
is not known whether NHERF1-knockout mice have increased urinary sulfate 
excretion (Gisler et al., 2008). It is important to know whether the subjects 
with NHERF1 mutations also abnormalities in uric acid or sulphate excretion 
since these are highly relevant to nephrolithiasis. 
To overcome this issue and to know much about the role of NHERF1 in the 
kidney stones formation, we proposed to use Drosophila as a model organism in 
advancing the understanding of the mechanism by which mineralisation occurs 
by mutation and knockdown of the NHERF1 homologue, Drosophila Sip1. 
 
5.2.5 Drosophila homologue of NHERF1 
A Blast search of the human protein RefSeq database using Drosophila SIP1 
sequence reported that the closest homologue of SIP1 is human EBP50/NHERF1 
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and NHERF2 (Altschul et al., 1990). Drosophila SIP1 is more identical to NHERF1 
as it has 57% resemblance and 81 % similarity to NHERF1 PDZ domain1, 
however, NHERF2 is only 45% identical and 60% similar. Moreover, a reciprocal 
blast search was performed using human NHERF1/EBP50 against Drosophila 
protein database, which showed a similar alignment. Furthermore, a sequence 
alignment of Drosophila SIP1 PDZ domains was compared to PDZ1 and PDZ2 
domains of human, rat mouse and C. elegans. Additionally, it is found that the 
EB domain or C-terminal end of NHERF1, which binds with mammalian ERM 
protein is also conserved in Drosophila SIP1. Similarly, EB domain of Drosophila 
SIP1 and human NHERF1 has 23% identity (61% similarity) and 28% identity (67% 
similarity) with NHERF2 (Figure 5.3) (Hughes et al., 2010). The high degree of 
similarity in PDZ domains and EB domains strongly suggests that Sip1 is a 
Drosophila orthologue to human EBP50/NHERF1 and that they adopt similar 
structures. Further, RNA-seq analysis obtained from FlyAtlas2 has shown that 
Sip1 is up-regulated in male and female adult tubules, midgut and hindgut. 
Further, it is also highly enriched in male accessory glands and rectal pads 
Table 5.1.  
 
 
Figure 5.3. A comparative analysis of the composition of Drosophila SIP1 
(NP_524712) protein with human EBP50/NHERF1 (NP_004243) and NHERF2 
(NP_001123484) proteins. Drosophila N-terminal contains only a single PDZ 
domain which is more similar to NHERF1 as compared to NHERF2. The 
percentage identity and percentage similarity are indicated by vertical arrows. 
The C-terminal FERM-binding domain also appears to be conserved in 
Drosophila. The interacting domain as determined by overlapping clones from 
the two-hybrid interaction of SIP1 and Moesin is indicated by the dark 
horizontal line (Y2H). Adapted from (Hughes et al., 2010). 
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Table 5.1. Expression of Sip1 in Drosophila adult male and female and larval tissues obtained from RNA-Seq analysis. FPKM 
(Fragments Per Kilobase Million). Adapted from Fly Atlas2 (Leader et al., 2017). 
 Adult Male Adult Female Larval 
Tissue FPKM Enrichment FPKM Enrichment FPKM Enrichment 
Head 18 1.3 16 1.4 
  
Eye 6.7 0.5 6.6 0.6 
  
Brain / CNS 0.5 0.0 0.7 0.1 13 0.6 
Thoracicoabdominal ganglion 1.9 0.1 2.7 0.2 
  
Crop 26 1.9 29 2.6 
  
Midgut 12 0.9 4.8 0.4 19 0.8 
Hindgut 34 2.5 37 3.3 24 1.1 
Malpighian Tubules 26 1.9 27 2.4 10 0.4 
Fat body 
    
3.6 0.2 
Salivary gland 46 3.3 34 3.0 43 1.8 
Heart 
      
Trachea 
    
35 1.5 
Ovary 
  
16 1.4 
  
Virgin Spermatheca 
  
37 3.3 
  
Mated Spermatheca 
  
46 4.0 
  
Testis 9.0 0.7 
    
Accessory glands 145 11 
    
Carcass 15 1.1 14 1.3 42 1.8 
Rectal pad 85 6.2 79 7.0 
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5.3 Results 
5.3.1 Mutation of Sip1 induces stones accumulation   
Mutation of Sip1 results in the formation of a very high number of small 
birefringent stones in both male and female MTs compared to wild-type tubules 
of either sex (Figure 5.4, A-F). Quantification of the mineralised area covered 
between 70-80% of both anterior and posterior tubule area of male and female 
flies (Figure 5.4, G-H). The anterior tubules have an enlarged initial segment 
(Wessing and Eichelberg, 1978, Sözen et al., 1997), which handles most of the 
organism’s excess calcium (Dube et al., 2000); however, this region did not 
develop birefringent stones in Sip1 mutants, and the stone burden was similar in 
anterior and posterior tubules (Figure 5.4), suggesting that these calculi were 
not calcium-based. 
  
144 
 
 
Figure 5.4. Quantification of intraluminal stones in Sip1 mutant flies. (A-F) 
Representative polarised microscopy images of wildtype (+/+) and Sip1 mutant (-/-
). MTs are showing intraluminal accumulation of birefringent stones.  Bars 
represent the percentage of total stones in the anterior and posterior MTs of 
male (G) and female (H) Sip1 mutant flies compared to wildtype MTs are 
represented in bar graphs. Data are presented as mean ± SEM, N=5. ***p<0.001, 
one-way ANOVA followed by Dunnett’s test. In panels A-F, scale bars represent 
500 μm. 
 
5.3.2 Cell-specific knockdown of Sip1 promotes lithiasis 
We next investigated whether renal, cell-specific knockdown of Sip1 in tubule 
specific cells (Principal and Stellate cells) under control of the appropriate GAL4 
driver lines resulted in the same phenotype. The Bloomington UAS-Sip1 RNAi line 
produced a significant knockdown (>70%) in overall tubule expression of Sip1 
when driven in stellate cells (Figure 5.5, A), but no knockdown when driven in 
principal cells (data not shown), suggesting that Sip1 is expressed uniquely in the 
stellate cells. Accordingly, specific knockdown of the Sip1 gene in tubule 
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principal cells using CapaR-GAL4 driver line did not result in an increase in stone 
burden (Figure 5.5, B), while stellate cells specific knockdown of the Sip1 gene 
(ClCa-GAL4>UAS-Sip1 RNAi) showed, as expected, marked increase of 
birefringent stones compared to parental control lines (ClC-a-GAL4/+, UAS-Sip1 
RNAi/+) (Figure 5.5, C), indicating a novel role of Sip1 in tubule stellate cells in 
mediating stone formation. Taken together, these results suggest that RNAi 
knockdown of Sip1 in SCs promoted the accumulation of stones.  
 
 
Figure 5.5. Quantification of stones accumulated in Sip1 knockdown MTs. (A-
B) The expression of Sip1 was significantly decreased in ClCa-GAL4>UAS-Sip1 
flies as compared to parental lines. (C) Representative polarised microscopy 
images of ClCa-GAL4>UAS-Sip1 RNAi knockdown flies compared to parental 
controls, ClC-a-GAL4/+ and UAS-Sip1 RNAi/+. (D) Quantification of stones 
accumulated in knockdown and control conditions. Bar diagrams were 
constructed by considering the accumulated stones at time 0 as 100%. Data are 
presented as mean ± SEM, N=5, *p<0.05, one-way ANOVA followed by Dunnet's 
test. In panels C, scale bars represent 500 μm. 
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5.3.3 Modulation of pH affects stone solubility 
To determine the chemical nature of the observed stones, we incubated Sip1 
mutant tubules under acidic or alkaline load by altering pH by 1 pH unit from 5 
to 10. At pH 5 and pH 6, no change in the quantity of stones after 30 minutes 
was noted. However, we found that at pH 7 the total accumulated stones 
started to dissolve significantly within 20 min and this process occurred faster 
with increased pH of the bathing solution, where 90% of the stones were 
dissolved within 10 min at pH 10 (Figure 5.6, A).  
To precisely determine at which pH stones start dissolving, the pH of the bathing 
solution was altered by 0.1 pH unit ranging between pH 6 and pH 7. So, placing 
tubules under acidic or basic load, we found that intraluminal stones start 
dissolving significantly at pH 6.7 and above (Figure 5.6, B-C). Chemically, the 
dissociation constant (pKa) for uric acid is 5.35 to 5.5 (Sakhaee and Maalouf, 
2008, Martillo et al., 2014), where uric acid precipitates out of acidic solution. 
Thus, at a normal Drosophila physiologic pH of 7.4 (Schneider medium), most 
uric acid is in de-protonated form. However, in the urine, the pH of the solution 
might vary dependent on the concentration of uric acid in the sample. The risk 
of uric acid crystallisation increases with a progressive fall in urine pH and 
decreases with an increase of pH. Therefore, these results provide strong 
evidence that the stones accumulated in Sip1 mutant MTs share similar chemical 
behaviour with uric acid stones. 
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Figure 5.6. pH modulates solubility of tubule stones. (A) Graph represents the 
percentage of undissolved stones corresponding to the pH change of the bathing 
solution. (B-C) Bar diagram represents the pH (pH 6.6 to 6.7) at which stones 
start dissolving over a 30 min period. Data are expressed as mean ± SEM, N=5. 
*p<0.05, which one-way ANOVA followed by Dunnett’s test, N.S. stands for non-
significant. 
 
 
5.3.4 Inhibition of the function of Xanthine Oxidase leads to the 
disappearance of the stones of Sip1 mutant tubules 
The biochemical pathway of uric acid formation shows that uric acid is the end 
product of purine metabolism, Figure 5.1. The pathway includes Xanthine 
Oxidase (XO) which is responsible for converting hypoxanthine to xanthine; and 
xanthine to uric acid. Allopurinol inhibits the function of XO, thereby blocking 
the biosynthesis of uric acid (Parks and Granger, 1986) resulting in a 
concomitant increase of hypoxanthine and xanthine concentration (Pacher et 
al., 2006). Similarly, XO gene mutant fly, rosy (ry) mutant (Dow and Romero, 
2010), has an elevated the level of hypoxanthine and xanthine due to inhibition 
of the formation of uric acid. 
To confirm the presence of uric acid in MTs of Sip1 mutant flies, flies were fed 
with allopurinol. Feeding allopurinol allows us to assess the presence of uric acid 
stones in the Sip1 mutant. On a normal diet, Sip1 mutant flies accumulate 
stones throughout the lumen of MTs. However, wild-type and rosy mutant flies 
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(with no XO enzyme activity) do not produce uric acid stones (Figure 5.7, 
A;C;E;G). Wild-type, Sip1 mutant and rosy mutant flies were fed with allopurinol 
containing diet which led to the disappearance of birefringent crystals in the 
tubules (Figure 5.7, B;D;F;H). The allopurinol fed flies phenocopy xanthine 
oxidase mutants (ry flies), in which they show a complete absence of 
birefringent urate stones (Figure 5.7, H). Thus, pharmacological inhibition of XO 
by feeding with allopurinol leads to the disappearance of stones, confirming that 
the intraluminally accumulated stones are uric acid stones. 
Figure 5.7. Pharmacological evidence and quantification of uric acid stones. 
Representative images of MTs from different genotypes (wildtype, Sip1(-/-), 
Sip1(+/-) and rosy (-/-)) in normal or allopurinol diet. In all cases, flies fed with 
allopurinol did not accumulate stones. In panels B-G, scale bars represent 500 
μm. 
 
 
5.3.5 Uric acid is accumulated in Sip1 knockdown tubules 
I next quantified the concentration of the uric acid in the MTs of wild-type, Sip1 
mutant and Stellate cell-specific Sip1 knockdown flies. The total concentration of 
uric acid in the MTs of Sip1 mutant flies was 8.5-fold higher compared to wild-
type flies (Figure 5.8, A). Similarly, in Sip1 RNAi lines (ClC-a-GAL4>UAS-Sip1 RNAi) 
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a 3-fold increase in the quantity of uric acid compared to the parental controls 
was measured (ClC-a-GAL4/+ and UAS-Sip1 RNAi/+) (Figure 5.8, B). Taken 
altogether, these results unambiguously demonstrate the presence of uric acid 
stones within MTs of Sip1 mutant and Sip1 knockdown flies, and that Sip1 gene 
expression in the stellate cells mediates proper tubular lumen pH. 
 
 
 
Figure 5.8. Concentration of Uric acid in Sip1 mutant and knockdown flies. 
(A) Uric acid level in Sip1 mutant MTs is significantly higher compared to control 
tubules. (B) Uric acid concentration is high in Sip1 knockdown flies (ClCa-
GAL4>UAS-Sip1 RNAi) compared to parental lines. Data are presented as mean ± 
SEM, N=5. ***p<0.001, student t-test (A), one-way ANOVA followed by Dunnett’s 
test (B). 
 
5.3.6 Sip1 and Moesin localise to the apical membrane of tubule 
stellate cells 
SIP1 encodes a protein that functions as a scaffold linking the plasma membrane 
and cytoskeletal linker proteins encoded by Moesin (Hughes et al., 2010) where 
SIP1 and Moesin interact with each other to maintain epithelial integrity via 
phosphorylation (Hughes et al., 2010, Ponuwei, 2016). We tested the co-
localisation of these proteins in MTs using polyclonal antibodies raised against 
both SIP1 and Moesin. Immunocytochemistry showed specific labelling of SIP1 
(Figure 5.9, A) and Moesin (Figure 5.9, B) of only stellate cells within the 
tubule of wild-type flies. Thus, confocal microscopy revealed that the location 
was on the apical membrane as showed by immunostaining apical to the DAPI-
150 
 
stained nuclei. As expected, no immunostaining was observed in tubules from 
Sip1 and Moesin mutant flies (Figure 5.9), confirming the specificity of their 
respective antibodies and the clear expression of SIP1 and Moesin to the same 
tubule cell type. 
Figure 5.9. Expression of SIP1 and Moesin proteins in MT stellate cells. (A) 
Sip1 (B) Moesin. Both proteins are specifically expressed in MT SCs of wild-type 
fly while no expression was seen in Sip1 and Moesin mutant flies respectively. 
DAPI (blue), Sip1/Moesin (Green), Merged (yellow); Scale bar represents 10 μm. 
 
 
5.3.7 SIP1 colocalises with Na+/H+ Exchanger NHE2 and Moesin in 
stellate cells 
The function of NHEs was first characterised in isolated cortical brush-border 
membrane vesicles showing Na+-driven H+ movement and H+-driven Na+ 
movement across the membrane (Murer et al., 1998). Further, computational 
modelling of the hydrophobic-hydrophilic nature and predicted structure of NHEs 
has also shown an interaction between NHEs with NHERF1 (Orlowski and 
Grinstein, 2004). It is known that SIP1 is a scaffold protein required for the 
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regulation of several transmembrane receptors and ion transporters (Vaquero et 
al., 2017, Hughes et al., 2010), so we hypothesised that SIP1 could regulate the 
activity of alkali-metal/proton exchanger (NHE) protein family in Drosophila 
tubules. 
NHEs play an important role in the transport of Na+ and H+ across the membrane 
(Giannakou and Dow, 2001) as well as maintenance of cellular and epithelial 
integrity. D. melanogaster has three NHE genes - NHE1, NHE2, and NHE3, which 
are expressed in multiple tissues, Figure 5.10 (Giannakou and Dow, 2001) but 
NHE2 seems to be tubule SCs specific, Figure 5.11 (Day et al., 2008).  
 
 
Figure 5.10. Expression pattern of NHE2-long and NHE2-short in different 
tissues of adult Drosophila melanogaster. Expression of NHE2-long and NHE2-
short isoforms in Midgut (MG), Hindgut (HG), Ureter (UR). DAPI (blue), NHE2-long 
and -short (Green), Phalloidin (Red) and Merged (yellow). Scale bar represents 
10 μm. 
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Figure 5.11. Expression of NHE2 (Long and Short isoform). (A) NHE2-long is 
expressed in MT stellate cells, scale bar: 500 μm. DAPI (blue), NHE2-long 
(Green). (C) Expression of NHE2-Short isoform in the apical membrane of the 
tubule, scale bar: 500 μm. DAPI (blue), NHE2-short (Green). 
 
Interestingly, we found that the NHE2-long isoform also has clear localisation in 
stellate cells of wild-type MTs; whilst the NHE2-short antibody labels the apical 
membrane of tubule principal cells (Figure 5.12, A-B). Further, when Moesin 
was specifically knocked down by Moesin RNAi in MT SCs, no birefringent crystals 
were observed in Moesin RNAi lines (ClC-a-GAL4>UAS-Moesin RNAi) compared to 
parental controls (ClC-a-GAL4/+ and UAS-Moesin RNAi/+) suggesting the absence 
of the role of Moesin alone in the formation of uric acid stones (data not shown). 
Consistent with the co-localisation of SIP1, Moesin and NHE2 proteins, we 
investigated a putative functional relationship between these proteins. To 
achieve this, we use an immunocytochemistry approach using anti-NHE2 long and 
anti-NHE2 short rabbit polyclonal antibodies to stain tubules of Sip1 and Moesin 
mutant flies. Interestingly, no immunostaining using both NHE antibodies were 
observed in tubules from Sip1 and Moesin mutant flies, suggesting that both SIP1 
and Moesin and NHE proteins are part of a scaffold linking the plasma membrane 
and cytoskeletal of tubule stellate cells (Figure 5.12, A-B).  
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Figure 5.12. Expression of NHE2-long and NHE2-short isoforms of wild-type, 
Sip1 mutant and Moesin mutant flies. (A) NHE2-long isoform is expressed in the 
MT stellate cells of wildType fly. DAPI (blue), NHE2-long (Green) and merged 
image (Yellow). (B) NHE2-short isoform has clear localisation in the apical 
membrane of MT PCs. DAPI (blue), NHE2-short (Green) and merged image 
(Yellow). Scale bar represents 20 μm. 
 
 
 
5.4 Interaction between SIP1, Moesin and NHE2 
Consistent with the co-localisation of SIP1, Moesin and NHE2 proteins to the 
stellate cells, we investigated a putative functional relationship between these 
proteins. To achieve this, we use an immunocytochemistry approach using anti-
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NHE2 long and anti-NHE2 short rabbit polyclonal antibodies to stain tubules of 
Sip1 and Moesin mutant flies. Interestingly, no immunostaining using both NHE 
antibodies were observed in tubules from Sip1 and Moesin mutant flies, 
suggesting that both SIP1 and Moesin and NHE proteins are part of a scaffold 
linking the plasma membrane and cytoskeletal of tubule stellate cells. 
Interestingly, co-immunoprecipitation (co-IP) studies between SIP1 and Moesin in 
pupae and in Drosophila S2 cells suggested that SIP1 regulates Moesin activity, 
possibly by acting as a scaffold that links these proteins together, leading to 
phosphorylation of Moesin thereby forming a SIP1-Moesin complex. Therefore, to 
investigate the potential physical interaction between these three proteins SIP1, 
Moesin and NHE2, we performed co-IP experiments using Drosophila S2 cells 
transfected with a Sip1 construct or MTs overexpressing the Sip1 gene 
specifically to the stellate cells (ClC-a-GAL4>UAS-Sip1). Essentially, we 
immobilised Sip1 antibody to the support in order to precipitate SIP1 target 
protein along with the binding partners/protein complex, which we detected by 
SDS-PAGE and western blot analysis. Unfortunately, we were unable to 
demonstrate a direct interaction between SIP1, Moesin and NHE2 proteins from 
both S2 cells or tubules lysate using the Co-IP technique . 
5.5 Discussion  
Mammalian NHERF1 was first characterised in rabbit border membrane as an 
essential cofactor for cyclic AMP inhibition of Na+/H+ exchanger (Weinman et al., 
1989, Murtazina et al., 2007). Here, the role of the Drosophila orthologue 
NHERF1, Sip1, in mediating uric acid stone formation in Drosophila MTs was 
characterised by biochemical, pharmacological and genetic assays. Insects, like 
birds, are considered to have uricotelic excretory systems, in which waste 
nitrogen is dumped as uric acid, in order to conserve water, and so uric acid 
calculi are constitutive in most terrestrial insects (Dow, 2012). However, adult 
Drosophila tubules express very high levels of urate oxidase (uricase) (Wallrath 
et al., 1990), and so urate crystals are not normally abundant. In this context, 
the extreme accumulations observed here in Sip1 mutants are remarkable. 
Mutation and specific knockdown of Sip1 in MT SCs resulted in the significant 
deposition of birefringent stones in the lumen of the tubule. Our experiments 
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provide evidence that these stones are uric acid stones based on the results 
obtained from physical appearance and biochemical experiments (Dow and 
Romero, 2010). To analyse the chemical nature of the stones, we performed pH-
based solubility experiments which is the traditional method to determine the 
solubility of the stones and threshold pH value of 6.7 was determined. The 
results demonstrate similarity in characteristic between the accumulated stones 
and uric acid stones. Previous experiments have demonstrated that uric acid 
crystallisation and precipitation mainly depends on two major factors; uric acid 
concentration and uric acid solubility. However, the solubility of uric acid is 
more dependent on pH because of hyperuricosuria and low urinary volume (Pak 
et al., 2005, Pak et al., 2001). Uric acid is a weak organic acid with a first pKa of 
5.5, resulting in the loss of 1 proton from uric acid and formation of anionic 
urate (Finlayson and Smith, 1974). The second pKa value is 10.3, but it has no 
physiological significance in human stones formation (Shekarriz and Stoller, 
2002). Hence, at the normal body physiological pH, i.e. 7.4 uric acid is in de-
protonated and more soluble form. In urine, however, the pH can vary over a 
wide range, which determines the concentration of uric acid. The risk of uric 
acid supersaturation increases with a progressive fall in urine pH. At a pH 5.3, 
50% of uric acid will be in its poorly soluble form (Sakhaee et al., 1983). This 
scenario is much less likely then crystallisation due to an acid urine pH. The 
solubility of de-protonated urate also depends on its cation. Our results also 
show that increment of pH of the bathing solution leads to an increase in the 
solubility of the stones confirming the stones accumulated intraluminally are 
indeed uric acid stones. 
Xanthine oxidase catalyses the final step of purine degradation resulting in the 
formation of uric acid. Allopurinol, a Xanthine oxidase inhibitor, is used as a 
drug for the treatment of gout by inhibition of uric acid synthesis. Allopurinol, 
when fed to wild-type Drosophila, phenocopied the rosy mutant by inhibiting XO 
and caused accumulation of xanthine and hypoxanthine stones. Allopurinol is a 
prodrug which is converted to oxypurinol by the enzymatic reaction of XO. 
Oxypurinol is an inhibitor of XO which replaces the hydroxyl ligand of the 
molybdenum ion at the active site of XO and thus very effectively prevents the 
conversion of hypoxanthine to xanthine and xanthine to uric acid. Accordingly, 
Sip1 mutant flies fed with allopurinol did not develop stones within the MTs, 
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which further illustrates that the stones accumulated within the MTs of the Sip1 
mutant flies are uric acid stones.   
What mediates precipitation of uric acid stones in the tubule? In mammals, 
interaction between SIP1 and urate transporters has been suggested 
(Cunningham et al., 2007); our results suggest SIP1 connects plasma membrane 
proteins such as NHE2, with members of the ERM (Ezrin, Radixin, Moesin) family, 
thereby regulating lumen acidification (Vaquero et al., 2017, Hughes et al., 
2010). In mammals, ERM protein complex interacts with the plasma membrane 
and actin cytoskeleton (Hirao et al., 1996, Weinman et al., 1995) within specific 
domains to systematise the plasma membrane (Hanzel et al., 1991) and thereby 
providing a regulated linkage between the plasma membrane and the actin 
cytoskeleton. Recent genetic and biochemical studies have shown that 
NHERF1/SIP1 plays an essential role in the activation of ERM proteins in 
mammals (Brône and Eggermont, 2005) and also in D. melanogaster (Hughes et 
al., 2010). Intriguingly, targeted deletion of NHERF1 in mouse elevates intestinal 
deposition of calcium and also triggers calcium oxalate and uric acid crystal 
formation (Shenolikar, 2002). However, loss of ERM proteins results in 
mislocalization of NHERF1 in mouse (Saotome et al., 2004). In D. melanogaster, 
Moesin is the sole representative of the ERM family (Roch et al., 2010). SIP1 
promotes Moesin function by affecting interaction with Slik Kinase; genetic and 
functional interactions between SIP1, Moesin and Slik kinase has been shown in 
Drosophila pupae and cultured S2 cells (Hughes et al., 2010). We demonstrated 
the expression of SIP1 and Moesin in the MT SCs, potentially suggesting an 
interaction in SCs. 
 
Na+/H+ exchangers (NHEs) are a part of integral membrane proteins which 
comprises multiple transmembrane domains and a large cytosolic carboxyl-
terminal domain (Yoshida et al., 2016). Studies in the mammalian model have 
shown that NHERF1 phosphorylates NHEs, thereby affecting their activity and 
microenvironment acidification (Centonze et al., 2018). Interestingly, rabbit 
NHERF1 is involved in the regulation of the renal brush border NHEs (Giral et al., 
2012). Also, the computational modelling of the hydrophobic-hydrophilic nature 
and predicted structure of NHEs has also shown the interaction between NHEs 
with NHERF1 (Orlowski and Grinstein, 2004). Previous studies have shown that 
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the null allele of NHE2 catalyses the influx of Na+ and efflux of intracellular H+ 
(Ulmschneider et al., 2016). Mutation of NHE2 decreases pH but does not change 
larval tissue morphology (Grillo-Hill et al., 2015). Previous findings augmented 
by our Immunocytochemistry experiments reveal that NHE2-long is localised to 
MT SCs but are not expressed in Sip1 and Moesin mutant MTs. Thus, as all three 
proteins SIP1, Moesin, and NHEs are localised explicitly in MT SCs, there may be 
a functional interaction in the SCs.  
Collectively, our experimental results allow a model for the formation of uric 
acid stones in the MTs of D. melanogaster with the support of other studies 
which have shown the genetic interaction between Sip1 and Moesin as well as 
co-immunoprecipitation experiments in mammals and S2 cells (Hughes et al., 
2010, Giral et al., 2012). Additionally, Reczek et al. have shown the interaction 
between NHERF1 and ERM proteins in the mammalian model (Reczek et al., 
1997) by co-immunoprecipitation experiments with extracts of purified placental 
microvilli. Previous studies have also shown the interaction between NHERF1 
with NHEs by co-immunoprecipitation experiments, Figure 5.13, (Weinman et 
al., 2000, Bhattacharya et al., 2012). It is proposed that NHEs bind multiple 
members of the NHERF family of multiple PDZ domain proteins, potentially via 
the physical linkage of NHE (Donowitz et al., 2013, Orlowski and Grinstein, 
2004). Support for this model comes from the co-localisation of SIP1, Moesin, 
and NHE2.  
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Figure 5.13. Model illustrating the role of SIP1 protein in uric acid stone 
formation in Drosophila tubules. (A) Hydrogen ion transport across the 
membrane in Drosophila MTs. Moesin-Sip1 complex interacts with NHE2 and 
activates the transport of Na+ and H+ (B) Mutation of Sip1 disrupts the 
interaction between SIP1 and NHE2 thereby inactivating the function of NHE2 
and leading to high accumulation of H+ ions intraluminally and tubular lumen 
acidification, mediating uric acid stones formation. 
 
5.6 Conclusion 
In summary, the results presented in chapter 5 indicate that Drosophila Sip1, an 
ortholog of human NHERF1, plays an essential role in the prevention of uric acid 
stone formation. Our study further reflects the conservation of the function of a 
homologous gene pair, NHERF1 from mammals to Drosophila. Mutation of Sip1 
results in a decrease of intraluminal pH (acidic) resulting in high accumulation of 
birefringent crystals in MTs. The physical, chemical and pharmacological assays 
unambiguously suggest that the accumulated stones were uric acid stones. We 
hypothesise that the Sip1 mutants display such a phenotype by interacting with 
proton pump transporter thereby amplifying accumulation of intraluminal H+ ion. 
We further exhibited that the increase of uric acid is deleterious and also 
showed involvement of proton exchangers NHEs, particularly NHE2 for the 
increment of acidic environment intraluminally. Our results also highlight the 
importance of Moesin, which plays a crucial role in interaction with NHE2, 
specifically in the stellate cells. A critical question that remains to be answered 
regarding the interaction between SIP1, Moesin and NHE2 and how their 
activities are regulated in MTs. Results from the previous studies and our 
localisation assays help us to predict that SIP1-Moesin forms a complex which 
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bind with NHE2 for a normal physiological function.  However, mutation of Sip1 
potentially alters the phenomena resulting in high accumulation of H+ thereby 
increasing luminal H+ ion, and making lumen of the tubule acidic, favourable for 
the precipitation of uric acid. 
  
160 
 
Chapter 6 Role of Napi-T in Phosphate stones 
formation 
 
6.1 Summary 
Recent genetic studies in different model organisms have successfully identified 
the role of physio-chemical factors and significant heritability of the genes in 
renal stone formation. Genetic screening in Drosophila melanogaster, as 
described in Chapter 3, has successfully identified a list of genes which might be 
involved in renal stone formation. Mutation of renal phosphate transporters has 
been characterised to be associated with several pathological states, including 
the renal stone formation and recurrence. In the introduction of this chapter, 
we explain about the phosphate transporter families in mammals and our 
current understandings of their physiological role. Further, we explain the 
function of phosphate transporters and their involvement in renal tubular 
handling of lithogenic substrates such as calcium, oxalate and phosphate. In the 
results section, we describe the impact of silencing of the sodium-phosphate co-
transporter, NaPi-T in Drosophila Malpighian tubules, which is the focus of the 
study. Additionally, we analysed the physiological and chemical properties of the 
stones, which suggested that knockdown of NaPi-T results in accumulation of 
phosphate stones. There is no clear human homologue of Drosophila NaPi-T; 
hence, further experiments to elucidate how NaPi-T regulates the transport of 
phosphate across the membrane and identification of the human homologue of 
NaPi-T is required. Finally, in the discussion section, our results are linked with 
previous findings to demonstrate the influential role of sodium-phosphate 
transporters in phosphate stone formation. Taken together, in this chapter I 
discuss the role of physiological, genetic and pharmacological interventions to 
alter phosphate concentration within MTs to confirm a critical role of NaPi-T in 
the process of nucleation which eventually leads to stone formation. In 
conclusion, the findings of the present study open a novel perspective in the 
identification of the role of NaPi-T in the formation of renal phosphate stones. 
161 
 
6.2 Introduction 
Over the past few decades, considerable research advancement has been 
achieved in understanding the vital role of various minerals in the human 
physiological and metabolic process (Tomlekova et al., 2017). Among them, 
phosphorus is one of the essential elements. In the human body, it is absorbed in 
the form of inorganic phosphate (H2PO4− or HPO42−); abbreviated as Pi,  through 
the small intestine; and is expended for normal human physiological function, 
cell metabolism (energetics and signalling) and maintenance of the body 
structural integrity (phospholipid membrane and skeletal tissue) (Takeda et al., 
2004a). It is known to be involved in fuel storage and critical energy 
transformations in the body (Bonora et al., 2012). In addition to this, it is 
required for other essential functions like maintenance of nucleic acid and 
nucleoprotein complexes, signal transduction pathways, delivery of oxygen to 
tissues (Krebs and Beavo, 1979, Hubbard and Till, 2000), muscle contraction, 
lipid metabolism, neuronal function and integrity of the bones (Crook and 
Swaminathan, 1996, Takeda et al., 2004b). All the functions mentioned above 
are achieved by maintaining a balance between dietary phosphate intake and 
phosphate excretion in the form of sweat, urine and faeces. 
6.2.1 Phosphate balance in the human body 
Phosphorus is transported intracellularly from the extracellular environment via 
secondary transporters (Virkki et al., 2007), in the form of negatively charged 
inorganic phosphates. In the healthy person under a normal dietary condition, 
around 80-90% of Pi is present in bone (approximately 10 g/100 g dry fat-free 
tissue), mainly complexed with calcium, in the form of hydroxyapatite (Hansen 
et al., 1976). The remaining 10-20 % is present in skeletal muscles and 
extracellular fluids, where the phosphate comprises about 0.1- 0.3 % of wet 
weight. The average serum Pi changes with age, i.e. highest during the neonatal 
period (1.88-2.4 mM) and gradually decreases with age reaching 0.85-1.44 mM 
during the adult age (Pettifor, 2008). 
In the human body, intracellular Pi level is widely distributed with significant 
functions in vital cellular processes, cell metabolism, growth and pathological 
changes. In mammals, it is also involved in the regulation of extracellular 
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mineralisation processes (formation of complexes of phosphate with calcium). To 
maintain balance and control between mineralisation and cellular delivery, the 
extracellular phosphate levels and the total body phosphate content are firmly 
regulated by some hormones, including parathyroid hormone (PTH), 1,25-
dihydroxy vitamin D (1,25(OH)2D), and fibroblast growth factor 23 (FGF23) 
(Sterling and Nemere, 2005). When phosphate concentration increases (as a 
result of high phosphate intake or a reduced glomerular filtration rate [GFR]), it 
inhibits secretion of parathyroid hormone (PTH) (which also decreases renal 
phosphate reabsorption) and increases secretion of FGF-23 (Prasad and 
Bhadauria, 2013). However, when phosphate concentration decreases, it 
stimulates the synthesis of 1,25(OH)2D, the active form of vitamin D Figure 6.1. 
 
Figure 6.1: Phosphate Homeostasis in the human body. Phosphate homeostasis 
involving different organs and various regulators such as PTH and 1, 25 D. 
Adapted from:(Forster et al., 2013). 
 
 
Reabsorption of phosphate filtered by the glomerulus occurs almost exclusively 
in the proximal renal tubule by an active hormonally regulated process. The 
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amount of reabsorbed phosphate is a crucial determining factor of the total 
plasma phosphate concentration. Mis-regulation of phosphate homeostasis or 
phosphate deficiency results in clinical symptoms like muscle weakness, 
impaired leukocyte function, central nervous system dysfunction, and abnormal 
bone mineralisation resulting in osteomalacia (Solanki, 2013). Considering these 
diverse pathological conditions, tight regulatory control over Pi concentration 
and maintenance of metabolic and endocrine phosphate effects is therefore very 
pivotal for the routine maintenance of human health. 
 
6.2.2 Renal phosphate co-transporters 
Sodium phosphate co-transporters are expressed in various parts of the human 
body (Figure 6.2) and are identified for their functions in human clinical 
physiology and disease processes (Prié et al., 2009). Under normal 
circumstances, the negative electrochemical potential across the cell membrane 
prevents the entry of anionic phosphate into the cell cytosol by simple diffusion. 
Hence, the availability of phosphate being the rate-limiting factor, an efficient 
phosphate transport system across the prevailing electrochemical gradient is 
vital for the maintenance of various normal physiological functions (Werner and 
Kinne, 2001). Transport of phosphate across the apical membrane of the 
proximal tubule epithelia requires Na+, i.e. inward phosphate transport across 
the apical membrane depends on the outward electrochemical gradient of Na+ 
(Hammerman, 1986).  
Previous studies have demonstrated that phosphate concentration in the human 
body is mediated by at least three different sodium-dependent phosphate 
transporters; type-I (SLC17 family), type-II (SLC34 family) and type-III (SLC20 
family) (Miyaji et al., 2013, Crouthamel et al., 2013). All three types of Pi 
transporters are multispanning membrane proteins, assigned to the solute 
carrier series (SLC) or proteins. Despite having similarity in the basic structure, 
these phosphate transporters differ in their affinity to the phosphate distribution 
in the tissues and physiological regulations. Their specific role in human health 
and disease has not been defined clearly; hence in this chapter, we discuss the 
importance of phosphate transporters in the maintenance of human physiology 
and pathophysiology (Figure 6.2). 
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Figure 6.2. Distribution of Phosphate transporters in the body and diseases 
associated with its dysfunction. The figure shows the locations of sodium 
phosphate cotransporters and the transporters represented underlined. Proposed 
but unidentified associations are represented by a question mark. Reproduced 
with permission from (Lederer and Miyamoto, 2012). 
 
6.2.3 Phosphate co-transporters and stone formation 
The role of sodium phosphate co-transporters in the deterioration of the human 
physiology and the occurrence of kidney stone formation has been poorly 
studied. To bring new insight into the understanding of the formation of the 
disease due to the substantial contribution of phosphate co-transporters studies 
are conducted in different animal models to overcome, at least in part, the vast 
knowledge gap on the genetics of phosphate stone formation. 
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Studies in mice and human models have indicated that impaired expression of 
phosphate transporters led to renal stones (Han et al., 2015, Vasudevan et al., 
2017). It has been known that hypercalciuric rats, fed with a low phosphate diet, 
form fewer kidney stones due to a decrease in urinary phosphate excretion. 
Similarly, studies in humans have emphasised that subjects with renal phosphate 
loss, develop kidney stones composed of calcium phosphate and calcium oxalate 
(Letavernier and Daudon, 2018, Ratkalkar and Kleinman, 2011). 
Furthermore, deficiency in renal phosphate reabsorption could trigger the 
formation of renal stones thereby increasing the concentration of calcium and 
phosphate ions in the loop of Henle. In this segment, water retrieval from the 
lumen increases phosphate and calcium concentrations which thereby favours 
initiation of the stone’s formation. Examination of renal-biopsy specimens 
obtained from different human samples suffering from renal stones suggests that 
calcium phosphate crystals form on the basement membrane of the thin loop of 
Henle and migrate through the epithelium to the papilla, where they form 
calcium phosphate stones (Evan et al., 2014, Yu et al., 2018).  
Several studies in human have shown that total phosphate concentrations in 
serum and urine can be used to calculate the maximum tubular reabsorption of 
phosphate (TMP) normalised for the GFR (the TMP/GFR value). The TMP/GFR 
value less than <0.70 mmol per litre value shows impaired renal phosphate 
reabsorption (Bech et al., 2013). In the study conducted in 207 subjects with the 
case of calcium oxalate stones, it was reported that 20% of the subjects with 
normal parathyroid function had decreased TMP/GFR value (Wang et al., 2013). 
The associated mild hypophosphatemia results in increased 1,25-dihydroxy 
vitamin D production, which increases intestinal phosphate and calcium 
absorption. The combination of hypercalciuria from the increased intestinal 
calcium absorption and the hyperphosphaturia favours the formation of calcium 
phosphate complex resulting in kidney stone formation. 
Therefore, these studies show the potential role of mutations in the renal 
sodium phosphate transporters and with the mutations of proteins interacting 
with sodium phosphate may also play a vital role in renal phosphate stone 
formation.  
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6.2.4 Inorganic phosphate stones in Drosophila Malpighian 
Tubules 
Compared to mice and human models, little is known about the mutational 
effects of phosphate cotransporters in invertebrates like Drosophila. Over the 
past decade, various studies have shown that some human sodium phosphate 
cotransporters have homologues/analogues in Drosophila melanogaster 
(Bergwitz et al., 2013). Presence of homologues makes Drosophila an attractive 
model to understand the impact of sodium phosphate cotransporters in human 
physiology and metabolic disorders. In Drosophila two types of concretions have 
been identified, a. Type I concretions: they are composed of calcium, 
magnesium, Pi and bicarbonate, and are present in the initial segment of the 
anterior tubule. The number of types I concretions in the initial segment 
increases in parallel with the increase in calcium in the Drosophila diet. b. Type 
II concretions: they are composed of potassium, calcium and magnesium, and 
are found in the transitional segment of the anterior tubule (Wessing and 
Eichelberg, 1979, Wessing and Zierold, 1999, Wessing et al., 1992). It has been 
suggested that excess ions such as iron may be stored in the concretions as a 
storage/deposit. The concretions would, therefore, be a way of isolating 
materials which are toxic in excess, by confining them to the tubules (Figure 
6.3). Alternatively, the concretions may be a useful store centre of ions, which 
can then be re-directed as needed to sustain biological processes, such as 
oogenesis in the ovaries. 
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Figure 6.3. Light microscopy of anterior Malpighian tubules, distal segments 
of Drosophila melanogaster. a) Normal diet. The lumen is filled with type-I 
concretions. b) 72 hours after feeding with 5g/kg carbonic anhydrase inhibitor 
(hydrochlorothiazide). This carbonic anhydrase inhibitor prevents the formation 
of phosphate stones. Bar=100 nm. Reproduced with permission from (Wessing 
and Zierold, 1999). 
 
6.2.5 Inorganic phosphate transporters in Drosophila 
A recent study has provided evidence that the anterior tubules of Drosophila 
store calcium as phosphate-rich mineral concretions in the enlarged initial 
segments (Chintapalli et al., 2012) and transport Ca2+ at a high rate (Dube et al., 
2000). The tubule transcriptome of the anterior tubule is enriched by the genes 
implicated in the transport of calcium and phosphate and for peroxisomal 
biogenesis, resulting in the formation of spherites. Calcium is enriched in the 
specialised peroxisome by entry through trp-like plasma membrane channel and 
phosphate is provided by Na+/phosphate cotransporter, NaPi-T. In Drosophila 
MTs, NaPi-T is one of the major phosphate cotransporters which elevates 
intraluminal concentration that contributes to the disease (Villa-Bellosta et al., 
2009, Chintapalli et al., 2012). In human studies, it has been shown that the 
sodium phosphate cotransporters are positioned in the apical membrane of renal 
proximal tubule cells, to move phosphate from lumen to the cell interior 
(Curthoys and Moe, 2014b). The primary driving force is Na+K+-ATPase generating 
an electrochemical gradient for apical phosphate entry (Virkki et al., 2007). 
Mutation of the phosphate cotransporters causes high accumulation of sodium 
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and phosphate intraluminally. Hence, we hypothesise that a similar mechanism 
is also conserved in the flies resulting in aggregation of the stones. 
To better understand the significance of NaPi-T in renal stones formation we 
genetically inhibited NaPi-T, which markedly increased the accumulation of 
stones within the fly MTs. These findings were corroborated by colorimetric 
analysis, which helped us to elucidate that the stones were composed of 
phosphate and helped us to quantify the total phosphate content within MTs. 
Further, we compared the binding capacity of the intraluminal calcium by 
measuring the total quantity of phosphate stones alone and in combination with 
sodium oxalate. It is known that oxalate and phosphate bind with calcium to 
form calcium oxalate/calcium phosphate stones, hence measuring phosphate in 
NaPi-T knockdown flies helps to recognise the role of phosphate transporters in 
phosphate stones formation. 
Herein, we hypothesise that NaPi-T plays an essential role in the formation of 
kidney stones. Our data support the idea that NaPi-T facilitates phosphate 
stones formation and represents a possible target for developing preventive and 
therapeutic strategies against kidney stone formation. 
6.3 Results 
6.3.1 The orientation of the tubules and gender alters Drosophila 
stone formation 
Male and female tubules have markedly distinct expression profiles of various 
classes of genes. According to the transcriptomes, there is also renal asymmetry 
with anterior and posterior tubules in both male and female flies (Chintapalli et 
al., 2012). To determine whether kidney stone formation varies between gender 
and orientation of the tubules we dissected seven days old wildtype flies and 
quantified the stones. Upon dissection, the intraluminal concretions looked like 
small stones, and their hardness could be felt between ones’ fingers. Under light 
microscopic analysis, concretions were visible as dark intraluminal contents 
within the MTs and had the appearance of small stones Figure 6.4. Given their 
dark physical appearance under light microscopic examination, we suggest these 
abundant concretions as fly stones composed of phosphate, based on their 
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similar location of formation to those described by Wessing (Wessing and 
Zierold, 1999, Wessing et al., 1992) and Southall (Southall et al., 2006).  
 
Figure 6.4. Representative tubule images of control flies of both the sexes. 
Visually, anterior tubules have prominent concretions in an initial segment as 
compared to the posterior tubules. Bar=500 µm. 
 
Next, using Image-J software, I quantified the total concretion content within 
both the tubules of male and female flies. The total stone content in anterior 
tubules of female flies is significantly higher (2-fold) as compared to a posterior 
tubule. However, we did not observe any significant difference in the total 
quantity of stones in between anterior and posterior tubules of male flies Figure 
6.5.  
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Figure 6.5. Measurement of the total luminal area of the tubules occupied by 
concretions. Anterior tubules accumulate significantly more concretions as 
compared to posterior tubules, but no difference was observed in the quantity of 
concretions content between anterior and posterior tubules in male flies. 
Similarly, the quantity of stones accumulated in female MTs is significantly high 
compared to male MTs. Data are expressed as mean ± SEM, N=3. ***p<0.001, 
two-way ANOVA. 
 
 
6.3.2 Intraluminally accumulated crystals are composed of 
Phosphate 
To analyse the chemical nature of these fly stones, we performed a colorimetric 
assay and confirmed that these stones are composed of phosphate. The intensity 
of the colour of the sample was plotted based on the absorbance at 620nm as a 
function of phosphate concentration in the sample. The colour intensity in 30 µM 
standard solution was high as compared to the 1.875 µm standard solution (the 
inset of Figure 6.6), which could be observed directly with the naked eye. The 
resultant linear regression equation for the female flies was: Abs= 
0.03031+0.01670x (R2=0.9860) and for male was Abs=0.0007857+0.01691x 
(R2=0.9903).  
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Figure 6.6. The calibration curve corresponding to Phosphate concentration 
in MTs of female and male flies. Inset: the corresponding photograph of the 
coloured products for reaction with different phosphate concentrations; dark 
blue= high concentration. 
 
To examine the selectivity of this system towards the phosphate detection on 
the basis of gender and tubule orientation, we measured phosphate 
concentration in both anterior and posterior tubules of flies of both sexes. The 
results are displayed in Figure 6.7. The total phosphate concentration in the 
anterior MTs of female flies is 6-fold higher than in posterior tubules. Similarly, 
the total phosphate concentration in the anterior MTs of male flies is 2-fold 
higher than posterior tubules. The results obtained herein clearly supports our 
quantification results, suggesting that anterior tubules have more stone content, 
compared to the posterior tubules. 
As previously known, female flies have more calcium content as compared to 
male. Hence excess intraluminal calcium can bind with phosphate forming 
calcium phosphate stones in high rate in female flies as compared to males 
(Chintapalli et al., 2012, Davies and Terhzaz, 2009). Additionally, most of the 
calcium transporters are expressed more in anterior tubules than the posterior 
tubules. Therefore, the presence of high phosphate stones in anterior female 
tubules suggests that stone formation is gender and tubule specific.  
172 
 
 
Figure 6.7. Intraluminal phosphate concentration is enriched in anterior 
tubules. The total phosphate concentration in anterior tubules is significantly 
high in both male and female flies as compared to posterior tubules. Similarly, 
female MTs has a significantly high accumulation of phosphate compared to male 
MTs.  Data are expressed as mean ± SEM, N=3. **p<0.01, ***p<0.001 two-way 
ANOVA. 
 
6.3.3 Cell-specific knockdown of NaPi-T promotes lithiasis within 
the Drosophila MTs 
Seeking Drosophila genes (orthologues of human genes), for urinary stone 
formation, we examined the consequences of cell-specific knockdown of Napi-T 
in principal tubule cells under the control of CapaR-GAL4 in adult Drosophila 
MTs. In our fly model, we observed that RNAi inhibition of NaPi-T (CapaR-
Gla4>UAS-Napi-T RNAi) conferred a significant increase of the tubular luminal 
space occupied by fly stones as compared to parental lines (CapaR-Gal/+, UAS-
NaPi-T RNAi/+), highlighting the critical role of NaPi-T in the kidney stone 
formation process. In female flies, the total quantity of stones accumulated in 
the knockdown condition was significantly higher (1.5 fold) in both the tubules 
as compared to the parental lines Figure 6.8, A. A similar result was observed in 
male anterior tubules, where the total stones in knockdown flies was 
significantly higher as compared to parental lines Figure 6.8, B. However, there 
was no significant accumulation of crystals in male posterior tubules of 
knockdown flies as compared to parental lines. 
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The Vienna UAS-NaPi-T RNAi line produced a significant (>65%) silencing of NaPi-
T in principal cells Figure 6.9. The RNAi knockdown efficiency was confirmed by 
qPCR. Taken together, our result shows that NaPi-T suppression leads to the 
accumulation of phosphate crystals. These results in Drosophila recapitulate the 
findings and demonstrate the conserved role for NaPi-T in enhancing stones 
formation in the fly tubular lumen. 
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Figure 6.8. Knockdown of NaPi-T increases the quantity of stones in anterior 
tubules of both male and female flies. A. With silencing of NaPi-T, the quantity 
of stones increases dramatically in CapaR-GAL4>UAS-NaPi-T RNAi group as 
compared to the control groups, i.e. CapaR-GAL4 /+, NaPi-T RNAi/+ in both the 
anterior and posterior tubules of female flies. B. However, in male flies, 
knockdown of NaPi-T increases the total quantity of stones in the anterior tubule 
of CapaR-GAL4>UAS-NaPi-T RNAi compared to parental lines, (CapaR-GAL4 /+, 
NaPi-T RNAi/+) but no significant difference was observed in posterior tubules. 
Data are represented in a bar graph as mean ± SEM, N=5. **p <0.01, ***p <0.001. 
two-way ANOVA. 
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Figure 6.9. Downregulation of NaPi-T expression in the fly lines. Expression of 
NaPi-T was significantly reduced in CapaR-GAL4 driven UAS-NaPi-T RNAi fly line 
as compared with the parental UAS-NaPi-T RNAi/+ and CapaR-GAL4/+ enhancer 
trap lines. Data are represented in a bar graph as mean ± SEM, N=3. ***p<0.001, 
One-way ANOVA followed by Dunnett’s test.  
 
6.3.4 Calcium phosphate crystallisation with and without oxalate 
Biochemical studies have shown that human kidney stones are composed of 
multiple calcium oxalate monohydrate (COM) crystals encasing a calcium 
phosphate nucleation. Further, it has been known that amorphous calcium 
phosphate is a rapidly forming precursor to the formation of calcium phosphate 
minerals in vivo (Lotsari et al., 2018). Investigation on the events of nucleation 
mechanism of the crystals has revealed that amorphous calcium phosphate plays 
a crucial role in the nucleation of calcium oxalate stones by promoting the 
aggregation of amorphous calcium oxalate precursors at early induction times 
(Ruiz-Agudo et al., 2017). Hence, I hypothesised that the existence of 
amorphous calcium phosphate complexes and their coaggregation with 
amorphous calcium oxalate might be a critical initial step in the mechanism 
leading to the formation of stones. 
In our model, I quantified phosphate stones in the MTs of NaPi-T knockdown flies 
and parental lines, with and without feeding with oxalate to observe any 
interaction between CaOx and phosphate stone formation. This analysis 
demonstrated that the quantity of phosphate stones in female MTs decreased 
significantly after feeding with oxalate in all three conditions Figure 6.10, A. 
However, we did not observe consistent results in male flies (Figure 6.10, B). 
The sex dimorphic results were expected, given that female flies have higher 
calcium content compared to males. Throughout the experiment, opaque stones 
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were scored by brightfield, whereas birefringent oxalate stones were 
determined by polarisation microscopy. The most important causes of these 
differences in compositional distributions is related to the conversion of 
phosphate stones to oxalate stones. These results suggest that stones within MTs 
of NaPi-T knockdown flies are indeed composed of phosphate. Hence, once flies 
are fed with oxalate, calcium binds with oxalate forming oxalate stones, thereby 
decreasing phosphate stone concentration and increasing concentration of 
oxalate stones. Taken together, these data demonstrate a role of NaPi-T in 
modulating oxalate stone formation. 
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Figure 6.10. Phosphate stones accumulation is altered by oxalate stones 
formation (A) Typical tubule images are taken from CapaR-GAL4/+, UAS-NaPi-T 
RNAi/+ and CapaR-GAL4>UAS-NaPi-T RNAi, male flies after feeding them with 
sodium oxalate. (B) The images were taken from CapaR-GAL4/+, UAS-NaPi-T 
RNAi/+ and CapaR-GAL4>UAS-NaPi-T RNAi, female flies before and after feeding 
them with sodium oxalate, and the stones being accumulated in both the 
conditions was quantified. The extent of stones formation was quantified as the 
percentage of the tubule lumen occupied by mineralised material.  Data are 
represented in a bar graph as mean ± SEM, N=5. ***p <0.001, two-way ANOVA. 
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6.4 Discussion 
Over the past few decades, a breakthrough has not been achieved in the 
discovery of novel drugs for the treatment of kidney stones due to an incomplete 
understanding of the mechanisms of the disease and the lack of suitable model 
system. Among various causes of kidney stone, genetics has been one of the 
significant instigating factors (Dow and Romero, 2010, Hirata et al., 2012). In 
this section, we discuss the role of putative inorganic phosphate co-transporter 
NaPi-T in the MTs and its involvement in kidney stone formation.  
Several previous studies have predicted that the accumulation of stones is 
caused due to monogenic (Griffin, 2004) or polygenic mutation (Braun et al., 
2016, Sayer, 2017). High throughput screening of the genes by next-generation 
sequencing has revealed that 15% of renal stones form due to monogenic causes 
(Halbritter et al., 2015). Homozygous and compound heterozygous mutations 
were found in the autosomal recessive genes including ATP6V1B1, ATP6V0A4, 
CLDN16, SLC3A1, CYP24A1, SLC12A1, and AGXT. Heterozygous variants were 
described in putatively dominantly-inherited disease genes including ADCY10, 
SLC4A1, SLC9A3R1, SLC34A1, and VDR (Schlingmann et al., 2016). Presence of 
evidence showing the role of phosphate co-transporters in kidney stone 
formation highlights the potential role of phosphate co-transports in the 
calcification process (Wagner et al., 2017) (Reed et al., 2002) The consistent 
presence of the sodium-phosphate co-transporters in the transport of sodium 
and phosphate across the kidney in higher organism encourages us to investigate 
the role of phosphate transporters in invertebrates like Drosophila, to 
understand the detailed mechanism of phosphate stone formation.  
The regulation, transport and storage of minerals such as phosphate and calcium 
are essential processes in all cells and tissues. Phosphate is the third most 
abundant anion in the body required for the proper mineralisation and biological 
function. Hindrances in the balance between absorption and excretion of 
circulating phosphate in the body is a result in either hypo or hyper 
phosphatemic states (Prié et al., 2002, Prié et al., 2009). Further, 
hypophosphatemia leads to bone mineralisation and also may result in cardiac 
dysfunction, whereas hyperphosphatemia is linked to hyperparathyroidism and 
reduced life expectancy (Jüppner, 2007). In humans, phosphate transporters are 
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associated with various diseases, including kidney stone formation. In this study, 
stones formation was studied in the Drosophila Malpighian tubule utilising a 
background of inhibition of NaPi-T in principal cells.  
We have shown that stones are formed naturally in the anterior tubules and 
postulated that this is the way that tubules maintain phosphate balance in wild-
type flies with the normal homeostatic function. The concretions were small 
visible spherules with a dark black appearance. The physical and visual 
appearance of the concretions in our model was similar to that observed by 
Wessing and his colleagues in previous studies (Wessing and Zierold, 1999, 
Wessing et al., 1992). We believe that these concretions mix with each other in 
forming the larger mineralised particles. Further, we used quantitative and 
chemical analysis which confirmed that these stones were composed of 
phosphate. We believe that our result represents two distinct phenomena (a). 
Female flies significantly accumulate more stone as compared to male flies (b). 
Drosophila stones are highly formed in the initial segment of the anterior 
tubules.  
Sodium phosphate cotransporters play a crucial role in the reabsorption of Pi 
from the proximal tubule with minimal contribution of the distal segments. 
Several Na-dependent Pi co-transporters from the SLC34 and SLC20 families of 
solute carriers, NaPi-IIa (SLC34A1) (Custer et al., 1994), NaPi-IIc (SLC34A3) 
(Segawa et al., 2002), and PiT2 (SLC20A2) (Villa-Bellosta et al., 2009) are 
expressed in the brush border membrane (BBM) of proximal tubular cells. Among 
them, NaPi-IIa deficient mice are hypophosphatemia due to increased urinary 
excretion of Pi despite a substantial upregulation of NaPi-IIc (Beck et al., 1998). 
These findings, together with the lack of phenotype of NaPi-IIc deficient mice 
regarding Pi balance (Shenolikar et al., 2002), indicate that NaPi-IIa is the major 
phosphate cotransporter in the kidney. Knockout of both NaPi-IIa (Chau et al., 
2003) and NaPi-IIc (Segawa et al., 2002) results in hypercalcemia and 
hypercalciuria. In the absence of apparent orthologs of different phosphate 
transports of human in flies, it is difficult to understand the ancestral gene 
function. Here, inhibition of the function of NaPi-T resulted in the rapid 
accumulation of the concretions, centred in the initial segment of the 
Malpighian tubules. The physical appearance of the stones was similar to 
180 
 
phosphate stones. Further, the result was validated chemically which 
demonstrated the accumulation of phosphate crystals in anterior tubules of 
NaPi-T knockdown flies suggesting the role of NaPi-T in the modulation of 
phosphate concretion formation.  
The mechanisms of stone accumulation due to the involvement of sodium 
phosphate transporters in basically unknown. One of the possible mechanisms 
elucidating mineralisation is the formation of the vesicles, i.e. matrix vesicle 
(MV)-mediated mineralisation which may involve these transporters (Anderson et 
al., 1997). Based on these findings, phosphate transporters especially, PiT1/2 
may mediate transport of Pi into the osteoblasts/chondrocytes to initiate 
mineralisation via the MV route. MVs are small cellular vesicles which bud off 
from mineralised tissue cells and within which mineral can be observed 
(Anderson et al., 1975). Previous observations made in fly Malpighian tubules 
have reported that calcium phosphate stones are stored in the form of spherites 
within the peroxisomes of the tubules (Southall et al., 2006, Wessing and 
Zierold, 1999, Chintapalli et al., 2012). 
Further, calcium is admitted to specialised peroxisomes by trp-like membrane 
transporters, and phosphate is provided by NaPi-T (Chintapalli et al., 2012). 
Calcium is stabilised in the peroxisome by binding with phosphate forming the 
calcium phosphate crystals. Hence, the demonstration of the development 
mechanism of phosphate stones due to knockdown of NaPi-T reflects a conserved 
role of sodium phosphate transporters in kidney stones formation. Our results in 
Drosophila reiterate these findings and demonstrate a conserved mechanism of 
calcification in the fly tubular lumen. 
To test whether all the calcium within the tubule binds with phosphate forming 
phosphate stones, we fed flies with oxalate diet and measured the quantity of 
phosphate stones before and after feeding with oxalate. The central role for the 
phosphate or oxalate stone formation is the quantity of calcium content in the 
body. Ca2+ homeostasis in the body is maintained through the interchange of 
calcium in between intestines, bone, and kidney (Sayer, 2017). Ca2+ present in 
the diet is absorbed via the intestine into the blood, which subsequently is 
filtered by the glomerulus, and then reabsorbed along the nephron or stored in 
bone for the long term. However, the excess calcium which is not reabsorbed by 
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the nephrons will be excreted by the kidney, demonstrating the role of the 
kidney in the maintenance of calcium balance in the body. An inappropriate 
excretion of calcium in the urine also termed as hypercalciuria contributes to 
the development of osteoporosis and kidney stone formation (Coe et al., 2016, 
Asplin et al., 2006).  
It is known that ~10% of all kidney stones are calcium-phosphate stones (Timio et 
al., 2003). These findings demonstrated that short-term dietary changes could 
result in hypercalciuria and phosphaturia, which are important risk factors for 
stone formation (Ferraro et al., 2016). We show that flies develop fewer 
phosphate stones after feeding flies with oxalate. Nucleation analysis of calcium 
oxalate crystals  in the previous study has shown that stable clusters are formed 
with the composition of [Ca-(HPO4)1+x·nH2O]2x. In the presence of phosphate, the 
existence of negative Ca-P complexes, [Ca-(HPO4)1+x·nH2O]2x−, will promote the 
aggregation of positive CaOx clusters, [Ca2Ox·H2O]2+ by electrostatic attraction 
and form the CaP-CaOx coaggregation structure. In the meantime, some calcium 
ions released from slow condensation of [Ca2Ox· H2O]2+ clusters forms complex 
with more HPO42− and persuades hydrolysis H2PO4 −, resulting in a slow pH 
decrease during the induction period (Lei et al., 2018). The coaggregation effect 
from Ca-P promotes the formation of large calcium oxalate complexes, which 
promote the formation of CaOx perinuclei, increasing the size of spherical 
thereby forming stable nuclei (Xie et al., 2015). Once the circular structure is 
formed various CaOx clusters aggregating around the Ca-P sphere provide 
multiple sites for subsequent nucleation and growth, resulting in multiple 
calcium oxalate crystals encapsulating the calcium phosphate phase. This is 
similar to a Ca−Ox renal stone. The agglomerate structure of multiple CaOx 
crystals aggregating around the calcium phosphate crystals results in a simulated 
kidney stone which is too large to pass the urinary tract. 
These results confirm that Drosophila can be used as a model to study phosphate 
stone formation mechanism. This approach is particularly valuable because there 
are very few studies conducted to observe the interaction between phosphate 
and oxalate stones. Many forces are at work balancing the absorption and 
secretion of Pi or Ca2+ from the kidney, and a better understanding of the 
interplay can lead to new therapeutic strategies. This manipulation of the 
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function of NaPi-T could be leveraged as a therapeutic target for the prevention 
of many forms of stones formation. Our findings in Drosophila may appear near 
translation to human physiology. However, an in-depth study of the mechanism 
of the formation of Pi in flies. To date, no evidence supports the use of NaPi-T in 
kidney stones formation. Future studies should aim at understanding the 
underlying molecular effects of low-salt and high-K+ diet on the progression of 
age-related bone loss and the development of kidney stones. 
6.5 Conclusion 
Knowing the vital role of Pi in various physiological processes, considerable 
advances have been made in our understanding of the various mechanisms 
involved in Pi homeostasis. The pathophysiology underlying renal stone 
formation is a complex process due to the influence of genes in polygenic and 
monogenic forms. Understanding the kidney stone disease has evolved 
dramatically over the past century, eliciting an appreciation for the 
participatory role of proteins, including transporters channels and receptors.  
The work in this chapter reports on the function of NaPi-T in renal phosphate 
stone formation mainly in the anterior tubule of female flies, which supports the 
findings of previous mammalian studies. While these studies provide important 
new data on NaPi-T function, to date, the mechanism of how NaPi-T knockdown 
causes kidney stone is still unknown. Based on the physiological and chemical 
analysis of the observed stone, we hypothesise that NaPi-T is involved in renal 
phosphate stone formation in flies. However, the results do not provide the 
conclusive data regarding the mechanism of phosphate stone formation due to 
mutation of phosphate cotransporters. In the future, an in-depth understanding 
of the role of NaPi-T and further studies into the mechanism, opening an avenue 
for the identification of new therapeutic targets and approaches to treatment is 
required. 
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Chapter 7 Conclusion and Future work 
 
7.1 Summary 
This chapter interconnects the outcomes obtained in each chapter and helps to 
derive the final conclusion of this thesis. These include the summary of results 
obtained from different chapters of my PhD, followed by the problems faced 
during the experiments and most importantly, the follow-up projects which can 
be done in future. In brief, this thesis entitled “Identifying Genetic Loci for 
Metabolic Disorders Affecting the Renal Tract” is devoted to the understanding 
of the role of genes and environmental condition in management and prevention 
of the kidney stones. Further, the significant consequence of this study is the 
validation of the use of Drosophila melanogaster as a physiological model for 
kidney stone studies. Our work also complements previous work by identifying a 
genetic means to modulate fly mineralisation. 
7.2 Introduction 
Nephrolithiasis is the process of aggregation of the crystals in the urinary tract 
resulting in stone formation. It is a common and complex metabolic disorder 
effecting the, quality of life and an economic burden on the individual and the 
health system of the country. Various intrinsic and extrinsic factors contribute to 
the formation of kidney stones. Among intrinsic factors are race, sex, and 
genetics (detail section 1.4.2) (Stamatelou et al., 2003). However, the 
pathophysiology of nephrolithiasis remains poorly understood, and there have 
been very few advances in the treatment of the disease in the last decades. 
Thus, finding the cause and pathophysiology underlying nephrolithiasis will help 
to reduce the consequences and complications of the disease thereby reducing 
the cost of treatment by establishing preventative measures in addition to 
patient education (Curhan, 2007).  
Even though the prevalence of nephrolithiasis is increasing, our understanding of 
the pathophysiology has not kept the same pace, and new therapeutic 
approaches have not emerged. Genetic factors play an essential role in the 
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aetiology of urolithiasis as a polygenic (common) or monogenic (rare) (Mahdieh 
and Rabbani, 2013). Hence, knowledge about the stones and early diagnosis are 
essential to achieve the goals of reducing patient suffering and economic 
burdens. Therefore, efforts have been made in this thesis to continue research 
to be directed to unveiling the underlying pathophysiology of kidney stone 
formation. 
7.3 Results 
The conclusion obtained from each chapter are enlisted below: 
Chapter 1: The first chapter of this thesis discusses various causes of kidney 
stones, and reason how genetic, environmental, and metabolic factors act singly 
or in concert to trigger stone formation. Similarly, it also explains the 
significance of different model organisms that elucidate the pathophysiology of 
CaOx stone formation in combination with clinical research in the hope for 
advancing the field and leading to the development of new therapeutic 
approaches that have the potential to reduce the morbidity, mortality, and cost 
associated with this disease. Further, this chapter elucidates the use of 
Drosophila melanogaster as an invertebrate model in understanding 
mineralisation.  
Chapter 2: Chapter 2 discusses different experimental protocols and materials 
used during this thesis and summarises the rearing conditions of Drosophila 
melanogaster for different experiments. Appropriate references for methods 
used are listed where applicable. 
Chapter 3: Evidence presented in the third chapter of this thesis helps us to 
understand of the role of genetics in kidney stone crystallisation. In this chapter, 
I explained about the screening of different potential genes to understand the 
mechanisms behind its involvement in CaOx nephrolithiasis. Among twenty 
independent RNAi or mutant panel of flies screened, only eight RNAi lines 
showed significant variation in accumulation of CaOx stones compared to 
parental lines. The knockdown flies cause an increase or decrease in 
intraluminal oxalate concentration as compared to the control conditions. These 
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genes were identified as hits and the following chapters of this thesis discuss the 
role of some of these genes in stone formation. 
Chapter 4: Experimental outcomes of chapter 4 demonstrate the role of age and 
temperature in the stone formation. In this chapter, I found that an elevation in 
the temperature of residence increases the incidence of nephrolithiasis, 
furthermore the higher the age of the flies the greater the risk of stone 
formation. Analysing the results, I found that change in stone accumulation was 
due to a change in expression of phosphate transporters NaPi-T and Picot which 
causes accumulation of phosphate within the lumen of tubules. This led to a 
state where an excess of intraluminal calcium binds with phosphate causing 
higher sodium phosphate concentrations, which facilitates the crystallisation of 
substances in urine triggering stone formation. 
In chapter 5 and 6 I discuss monogenic forms of kidney stone formation. Genes 
play an important role in the aetiology of nephrolithiasis. There are two forms of 
genetic involvement, the common polygenic and the rare monogenic forms. 
Clinical recognition of the monogenic hereditary forms of nephrolithiasis can be 
challenging, due to their rarity, broad spectrum of disease, expression time and 
overlap with calcium oxalate nephrolithiasis.  
Chapter 5: Evidence presented in chapter 5 of this thesis characterises the novel 
role of Drosophila SRY interacting protein1 (Sip1), in renal stone formation. Sip1 
was selectively knocked down in Stellate Cells (SCs) resulting in stone formation 
within MTs which physically and chemically was similar to uric acid stones. The 
outcome was validated by physiological, chemical, pharmacological and genetic 
analyses including the development of a chemical approach to quantify uric acid 
accumulation in MTs. In addition to that, localisation of SIP1, Moesin, and NHE2 
in wild-type, Sip1 mutant, and Moesin mutant flies, showed that Sip1 functions 
with Moesin and NHE2 to promote the increase of H+ into the lumen using an 
inward Na+ chemical gradient thereby decreasing luminal [Na+] and increasing 
luminal [H+], resulting in a favourable environment for uric acid stone formation. 
Chapter 6: In chapter 6, I discuss the role of NaPi-T in phosphate stones 
formation in MTs. I found that knockdown of NaPi-T in MTs results in the 
accumulation of phosphate stones. Based on the results I hypothesise that the 
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intracellular stones of inorganic phosphate are maintained by NaPi-T, which on 
downregulation causes accumulation of phosphate concretions intraluminally 
larger than predicted. The result was further verified by physiological and 
chemical assays. However, future research is required in order to know details 
about the role of phosphate transporter in phosphate balance. 
7.4 Limitations of the study 
Chapter 1: 
1. Throughout the experiment, I used Drosophila as a model organism. There 
are advantages of the Drosophila system that should be noted, namely, 
(1) The low cost of maintaining Drosophila colonies, (2) the rapid 
deployment of new transgenic lines, and (3) the ability to test hypotheses 
in lower-species in vivo systems before embarking on studies in higher 
organisms. The key limitation is that the insect renal system is 
aglomerular, and thus the composition of the final tubular fluid is based 
entirely on active secretion rather than ultrafiltration followed by a 
combination of reabsorption and secretion.  The absence of a filtration 
structure is explained by the physical relationship between the blood 
supply and the tubules: the tubules freely float in the hemocoel (blood-
filled body cavity) rather than having a vascular system that hugs the 
tubules, as in the mammalian renal system. 
Chapter 3: 
1. In this chapter, the genes were selected based on the previous results 
from published articles. This limits the unbiased selection and 
identification of the  group of genes represented in the screening list.  
2. Although nephrolithiasis is roughly 50% heritable, the presence of a family 
history usually does not affect treatment since most stone disease is 
regarded as polygenic, i.e. not attributable to a single gene. However, in 
this investigation, I only focused on the monogenic cause (2% of stones). 
Hence, the orientation of research towards polygenic cause of stones 
formation  might demonstrate the clinical outcome. This intriguing 
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possibility holds the potential to change the management paradigm in 
stone prevention and understanding of the complex trait with 
environmental and polygenic determinants. 
3. The successful identification of the role of 8 genes in stone formation in 
Drosophila was restricted by the investigative techniques utilised. RNAi is 
a useful molecular tool when combined with the UAS/GAL4 system, but it 
also has shortcomings. During the screening of the genes, I could not get 
high knockdown of the gene in RNAi lines. Hence, I was not assured 
whether renal stones are related to that particular gene activity or not. 
Although every effort was made to get an RNAi flies which are gene-
specific and may still cause an off-target silencing effect on other genes 
when inserted into the Drosophila genome and expressed, the results of 
these experiments do not exclude the effects of off-target silencing on 
other genes, which could be assessed by further microarray studies on 
each UAS-RNAi fly-line. Despite these limitations, the sensitised 
background offers a screen platform in a whole panel of RNAi lines and 
this cover the Drosophila genome without selection bias. 
 
Chapter 4 
1. In humans, the mechanism for pathogenesis causing stone disease is 
attributed to heat-induced sweating, loss of water and ions. Loss of 
extracellular fluid leads to an increase in serum osmolarity that in turn 
leads to change in hormones, leading to an increase in urinary 
concentration thereby reducing the urinary volume and causing kidney 
stones. As urine volume decreases the concentration of relatively 
insoluble salts such as calcium oxalate or phosphate increases thereby 
reaching an upper limit of solubility, hence the salts precipitate out of 
the solution forming solid crystals developing stones. The results observed 
in this chapter were consistent with a study performed in male flies 
irrespective of the days of exposure but not in the female flies. Further, I 
did not consider evaluating any changes in the loss of ions in the MTs in 
male and female flies. It should be predicted that, as in humans, 
Drosophila tubules should secrete less fluid under heat or desiccation 
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stress. This would be relatively easy to test. Similarly, the role of 
humidity was never explored throughout the study. Hence the 
understanding of the mechanism of how humidity affects the urinary 
volume and urinary concentration of ions should be studied.   
Chapter 5 
1. This thesis is the first study to use Drosophila as a model organism for uric 
acid stone formation. Mutation of Sip1 and stellate cell-specific 
knockdown caused an accumulation of uric acid stones. The results were 
verified by molecular assays; however, if I had performed a metabolomic 
assay comparing mutant lines and control flies, the result so obtained 
could have verified the change in expression of the genes and also have 
helped to discover other candidate genes. 
2. The Sip1, Moesin and NHE2 antibodies designed show specific expression 
in immunostaining. However, when the same antibody was used during co-
immunoprecipitation and Western blotting, I did not observe a specific 
band size. The putative antigenic areas were checked on flybase.org, but 
I could not see any specificity. The antigenic region, which was most 
likely to produce a specific, working antibody was not functioning which 
limited our study to perform co-immunoprecipitation. Throughout the 
experiment, we minimised non-specific binding by using the lowest 
antibody concentration possible, and by using antibody solutions which 
had been preabsorbed on other tissues, which had little effect on the 
number of proteins identified during Western blotting.  
 
Chapter 6 
1. In the results, I found that knockdown of NaPi-T results in higher 
accumulation of intraluminal oxalate concentration compared to parental 
lines. The results were validated by physiological and chemical analysis. 
However, limited success was achieved in collecting the secreted fluid. 
Collection of the intraluminal fluid and analysing of the concentration of 
ions in knockdown and parental lines would have given an idea about the 
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roles of different factors which influence the stone concentration, such as 
pH, hormones, and subcellular compartmentalisation. 
2. Human studies have shown that many enzymes of key metabolic pathways 
are regulated by phosphate; these pathways include those for anaerobic 
glycolysis, gluconeogenesis, mitochondrial metabolism, glutamine, purine 
and nucleic acid metabolism. Although I performed chemical analysis to 
validate presence of phosphate but did not perform any immunostaining 
experiments to validate its localisation in the  organs/cells.   
Further, previous articles have shown successful targeting localisation of 
phosphate transporters only in mammals. Whether these mammalian 
pharmacological agents block homologueous genes in Drosophila is not yet 
known, but they could prove to be a useful way of controlling the efficacy 
of transporter function without interfering with transcription or 
translation. 
 
7.5 Future work 
Many aspects of the work described in this thesis would benefit from further 
investigation. These studies could not only help to find new genes involved in 
kidney stone formation but could also increase our understanding of the 
mechanism behind the stone formation. Further ways of extending the data 
include additional characterisation of the nature of the gene to determine 
whether the genes investigated would be successful kidney stone targets. 
Despite advances, there are still vast areas in nephrolithiasis that are poorly 
understood or even unexplored. To further the progression of research and 
clinical management of kidney stones, multilevel translational approaches are 
needed.  
1. Improved laboratory studies and animal and cell culture models are 
needed, and greater effort needs to be made to identify candidate loci 
and genes. The metabolomic studies are beneficial and a powerful 
method in the biological fields, in the normal as well as in the disease 
states. The expression of the genes identified in this thesis can be tested 
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in mammalian samples which could validate our findings in higher 
organisms.  
2. In chapter 3, I performed extensive research by knocking down the genes 
(section 3.3.2) and introducing calcium oxalate stones by feeding with 
NaOx, but there remain many unanswered and unexplored areas of this 
disease. E.g. is it the only gene involved in calcium oxalate stone 
origination? Is there an influence of any other lithogenic agents other than 
NaOx in the accumulation of the stones? The availability and use of the 
other lithogenic agents would have strengthened our observation. The 
mode of inheritance of idiopathic nephrolithiasis has been discussed for 
decades and is usually regarded polygenic. Previous articles have shown 
that most rare genetic causes of stones bear their metabolic signatures, 
and as such should be recognised and diagnosed based on clinical findings 
and stepwise metabolic testing using metabolomics, proteomics or 
transcriptomic analysis.  
3. In chapter 3, I believe that the stones are accumulated in the tubules 
because of two distinct phenomena; one being of pathological, ectopic, 
and exuberant calcification while the former is a normal, physiologic 
process. The pathologic fly stone is the foundation upon which our model 
is built. Studies have shown that mutation or specific knockdown of the 
gene should have some impact on the life span of the flies. It is assumed 
that this excessive intraluminal stone accumulation might be harmful to 
the fly. The reduced lifespan appears to be due to the presence of 
excessive, enlarged, ectopic, and consistently obstructive fly stones. 
Hence performing lifespan extension would help in identification for the 
role of gene or genes which modulates both stone formation and 
survivorship independent of one another. 
4. In our temperature vs kidney stone formation experiment (chapter 4), I 
have found causal links between age and ambient temperature with stone 
prevalence are surprisingly sparse and complicated by other variables. 
Given the preponderance of evidence from different human study across 
the globe, it seems undeniable that climate, whether it is through 
temperature, humidity, or sunlight, has at least some role in the 
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development of urinary calculi. Hence, maintenance of constant humidity 
throughout the experiment in all the conditions would provide an 
accurate correlation between temperature in kidney stone formation. 
5. In chapter 5 our experimental results allow a model for the formation of 
uric acid stones in the MTs of D. melanogaster. Previous results, been 
shown the genetic interaction between Sip1 and Moesin through co-
immunoprecipitation experiments in mammals and S2 cells. However, I 
was not able to show the interaction between SIP1, Moesin and NHE2 
using co-immunoprecipitation due to non-specific binding of antibodies. 
Hence,  purchase of a commercially available antibody to validate our 
result which would be a milestone for an understanding of the formation 
of uric acid stones. 
6. To have new insights about causal genes of nephrolithiasis, technology 
and  skills should be coupled for the faster screening of the genes with 
standardised and precise clinical methods. The work presented in this 
thesis hopefully represents another step along the path to understanding 
the genetic principles that determine the role of genetic and 
environmental factors in kidney stone formation and the mechanisms 
behind the process.  
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